|
1
| 1 | UNITED STATES FEDERAL TRADE COMMISSION
|
| 2 | and
|
| 3 | UNITED STATES DEPARTMENT OF JUSTICE
|
| 4 |
|
| 5 |
|
| 6 |
|
| 7 | SHERMAN ACT SECTION 2 JOINT HEARING
|
| 8 | UNDERSTANDING SINGLE-FIRM BEHAVIOR:
|
| 9 | MONOPOLY POWER SESSION
|
| 10 | WEDNESDAY, MARCH 7, 2007
|
| 11 |
|
| 12 |
|
| 13 |
|
| 14 |
|
| 15 | HELD AT:
|
| 16 | UNITED STATES FEDERAL TRADE COMMISSION
|
| 17 | 601 NEW JERSEY AVENUE, N.W.
|
| 18 | WASHINGTON, D.C.
|
| 19 | 9:30 A.M. TO 4:30 P.M.
|
| 20 |
|
| 21 |
|
| 22 |
|
| 23 |
|
| 24 | Reported and transcribed by:
|
| 25 | Susanne Bergling, RMR-CLR |
2
| 1 | MODERATORS:
|
| 2 | DENNIS W. CARLTON
|
| 3 | Deputy Assistant Attorney General for Economic Analysis
|
| 4 | Antitrust Division, Department of Justice
|
| 5 | and
|
| 6 | JOEL L. SCHRAG
|
| 7 | Economist
|
| 8 | Bureau of Economics, Federal Trade Commission
|
| 9 |
|
| 10 | PANELISTS:
|
| 11 |
|
| 12 | Morning Session:
|
| 13 | Andrew J. Gavil
|
| 14 | Richard J. Gilbert
|
| 15 | Michael L. Katz
|
| 16 | Philip B. Nelson
|
| 17 | Joseph J. Simon
|
| 18 | Lawrence J. White
|
| 19 |
|
| 20 | Afternoon Session:
|
| 21 | Simon Bishop
|
| 22 | Thomas G. Krattenmaker
|
| 23 | Miguel de la Mano
|
| 24 | Joe Sims
|
| 25 | Irwin M. Stelzer |
3
4
| 1 | P R O C E E D I N G S
|
| 2 | - - - - -
|
| 3 | MR. SCHRAG: Good morning. Sorry about the
|
| 4 | technical issues. Welcome.
|
| 5 | My name is Joel Schrag. I am an economist at
|
| 6 | the Bureau of Economics here at the Federal Trade
|
| 7 | Commission, and I am one of the moderators for this
|
| 8 | panel. My co-moderator, standing next to me, is Dennis
|
| 9 | Carlton, Deputy Assistant Attorney General for Economic
|
| 10 | Analysis at the Antitrust Division of the Department of
|
| 11 | Justice.
|
| 12 | Before we get into the substance of the program,
|
| 13 | on behalf of the FTC staff who have worked on this
|
| 14 | session, I would like to take the opportunity to thank
|
| 15 | all of our colleagues from DOJ for their hard work and
|
| 16 | their efforts to jointly present this session.
|
| 17 | In addition, after today's and tomorrow's
|
| 18 | hearings on monopoly power, the hearings will next turn
|
| 19 | to issues involving remedies later this month, and so I
|
| 20 | urge you all to be sure to check our agencies'
|
| 21 | respective web sites for updates on these future
|
| 22 | hearings.
|
| 23 | As the FTC representative, I do have just a few
|
| 24 | housekeeping matters to cover before we begin. First of
|
| 25 | all, please turn off all of your cell phones, |
5
| 1 | BlackBerries and other noise-making electronic devices.
|
| 2 | Second, the restrooms are located out through the double
|
| 3 | doors and across the lobby. If you need help to find
|
| 4 | them, there are signs that should guide you.
|
| 5 | Third, one safety tip, especially for visitors,
|
| 6 | in the unlikely event that the building alarms go off,
|
| 7 | please proceed calmly and quickly as instructed. If we
|
| 8 | must leave the building, you exit out the New Jersey
|
| 9 | Avenue doors by the guard station. Please follow the
|
| 10 | stream of FTC employees to a gathering point across the
|
| 11 | street and await further instruction, but hopefully that
|
| 12 | won't be necessary.
|
| 13 | Finally, we request that you please not make
|
| 14 | comments or ask questions during the session. Thank
|
| 15 | you.
|
| 16 | Let me just say a few things about the session.
|
| 17 | Many of the prior sessions of the hearings addressed
|
| 18 | particular conduct that's been challenged under Section
|
| 19 | 2 of the Sherman Act. Today, the hearings turn to
|
| 20 | issues of monopoly power and market definition, and
|
| 21 | these issues we believe are very important.
|
| 22 | In fact, if you were at the opening day of the
|
| 23 | hearings back in June, both Herbert Hovenkamp and my
|
| 24 | co-moderator, Dennis Carlton, were given the opportunity
|
| 25 | to place the issues for the subsequent hearings in |
6
| 1 | context. Both identified monopoly power and market
|
| 2 | definition as areas where there are difficult, uncertain
|
| 3 | questions that must be addressed in many cases, and I
|
| 4 | expect that today's panel will help to clarify, if not
|
| 5 | completely resolve, these difficult questions.
|
| 6 | The hearings will be organized as follows:
|
| 7 | First, we'll hear an approximately 15-minute
|
| 8 | presentation from each of our six distinguished
|
| 9 | panelists. We'll probably take a break after the fourth
|
| 10 | panelist and then come back from the break and hear from
|
| 11 | the two remaining panelists. After that, the panelists
|
| 12 | will have an opportunity to comment on each other's
|
| 13 | presentations, and we'll have a moderated discussion.
|
| 14 | So, I think I'd now like to turn things over to
|
| 15 | my co-moderator, Dennis Carlton, who will introduce our
|
| 16 | distinguished panelists.
|
| 17 | Thank you very much.
|
| 18 | DR. CARLTON: Okay, thank you. I am Dennis
|
| 19 | Carlton. I am a Deputy Assistant Attorney General in
|
| 20 | the Antitrust Division, and it is a pleasure to welcome
|
| 21 | all of you to these joint FTC/DOJ hearings.
|
| 22 | I had the privilege of participating in the
|
| 23 | opening session of the hearings, and one of the topics I
|
| 24 | said that needed clarification was precisely the topic
|
| 25 | of the panels today and tomorrow, a focus on what we |
7
| 1 | mean by "market power" and "market definition" in
|
| 2 | Section 2 cases I think is really important.
|
| 3 | I am also a Commissioner on the Antitrust
|
| 4 | Modernization Commission, and despite my attempting to
|
| 5 | do so was not able to convince the Commission to study
|
| 6 | in depth the definition of market power and market
|
| 7 | definition in Section 2 cases and to report on it. So,
|
| 8 | that, I think, emphasizes all the more how important
|
| 9 | this session, this panel discussion, is today, and the
|
| 10 | real question is, can we reach consensus on any of the
|
| 11 | hard questions or at least can we reach a consensus that
|
| 12 | there's a lot of ambiguity and arbitrariness in what is
|
| 13 | going on?
|
| 14 | I am honored to chair such a distinguished
|
| 15 | panel. All of the members of the panel have extensive
|
| 16 | experience, both academic and nonacademic, in antitrust
|
| 17 | and have served both in the private sector and in the
|
| 18 | government sector.
|
| 19 | In the interest of saving time, I am going to
|
| 20 | introduce them all at once and hopefully by that time
|
| 21 | the computer will work. So, starting with Phil, Phil
|
| 22 | Nelson is a principal at Economists, Inc., an economic
|
| 23 | consulting firm. Previously, he served as the Assistant
|
| 24 | Director for Competition Analysis at the FTC and as an
|
| 25 | Adjunct Professor at Fordham Law School. He has written |
8
| 1 | numerous articles and two books on antitrust topics, and
|
| 2 | he edited the ABA's antitrust section of market power --
|
| 3 | The Market Power Handbook. He currently is the
|
| 4 | vice-chair of the section's Healthcare and
|
| 5 | Pharmaceuticals Committee.
|
| 6 | Beside Phil is Joe Simons. Joe is a well-known
|
| 7 | attorney. He's a partner and co-chair of the antitrust
|
| 8 | group at Paul Weiss. Previous to that, Joe was the
|
| 9 | chief antitrust enforcer at the Federal Trade
|
| 10 | Commission, serving as the Director of the Bureau of
|
| 11 | Competition from June 2001 until August of 2003. He has
|
| 12 | the interesting characteristic of once being the tenth
|
| 13 | largest wireless carrier in the country, because I
|
| 14 | believe he was a trustee and had a lot of wireless
|
| 15 | licenses, but in addition to that, he has achieved
|
| 16 | something that's actually quite rare for attorneys to
|
| 17 | do, and that is he's written an article that economists
|
| 18 | cite all the time and is associated with critical loss
|
| 19 | analysis.
|
| 20 | Beside Joe, in a missing seat, is Larry White,
|
| 21 | who I am sure is on his way. Larry is the Arthur
|
| 22 | Imperatore Professor of Economics at NYU School of
|
| 23 | Business. He's the Deputy Chair of the Department of
|
| 24 | Economics. Previously, in the early eighties, Larry
|
| 25 | served as the Director of the Economic Policy Office in |
9
| 1 | the Antitrust Division. Larry has written several books
|
| 2 | and articles, one of which is well-known to antitrust
|
| 3 | practitioners called The Antitrust Revolution:
|
| 4 | Economics Competition and Policy. He's currently the
|
| 5 | editor of The Review of Industrial Organization. Prior
|
| 6 | to serving at the Justice Department, he did extensive
|
| 7 | government service both for the Federal Home Loan Bank
|
| 8 | Board and for the Council of Economic Advisers.
|
| 9 | Andy Gavil is a Professor of Law at Howard
|
| 10 | University where he not only teaches antitrust, but he
|
| 11 | has also extensively written on antitrust many articles
|
| 12 | and has a very well-known case book with Bill Kovacic
|
| 13 | and Jonathan Baker, Antitrust Law in Perspective. He is
|
| 14 | about to publish or co-author a book called Microsoft
|
| 15 | and the Globalization of Competition Policy, which I am
|
| 16 | sure has focused on Section 2 type behavior. He's
|
| 17 | currently the articles editor of The Antitrust Magazine
|
| 18 | and serves on the ABA Antitrust Section's Liaison Task
|
| 19 | Force to the Antitrust Modernization Commission. He is
|
| 20 | Of counsel to the Sonnenschein Law Firm.
|
| 21 | To Andy's left is Rich Gilbert. Rich is a
|
| 22 | Professor of Economics at the University of California
|
| 23 | at Berkeley. He served as the Deputy Assistant Attorney
|
| 24 | General in the Antitrust Division in the mid-nineties,
|
| 25 | and at that time, he led the effort to write the |
10
| 1 | Antitrust Guidelines for the Licensing of Intellectual
|
| 2 | Property. He has written widely on antitrust topics.
|
| 3 | He is currently the Director of the Competition Policy
|
| 4 | Center at Berkeley and is associated with the economic
|
| 5 | consulting firm of COMPASS.
|
| 6 | Finally, Mike Katz at the end of the table.
|
| 7 | Mike is currently the holder of the Sarin Chair in
|
| 8 | Strategy and Leadership at Berkeley, the Business
|
| 9 | School, and also holds an appointment in the Economics
|
| 10 | Department. Mike served as the Deputy Assistant
|
| 11 | Attorney General in the early 2000s, and he also served
|
| 12 | as the Chief Economist at the Federal Communications
|
| 13 | Commission. He's written numerous articles on economics
|
| 14 | and antitrust and has specialized in many topics,
|
| 15 | including network industries.
|
| 16 | So, with that introduction, I'll turn it over to
|
| 17 | our first speaker, Phil, and just let me remind the
|
| 18 | speakers, we're kind of running tight because we started
|
| 19 | late, so if you could keep to the 15 minutes, that would
|
| 20 | be good. The organization of this is going to be four
|
| 21 | speakers will go, 15 minutes, we'll take a 10-minute
|
| 22 | break, we'll have two more speakers. We will give the
|
| 23 | speakers a brief opportunity to talk to each other, and
|
| 24 | then I'll moderate a discussion for about an hour or so.
|
| 25 | Thank you. |
11
| 1 | MR. NELSON: So, we have a -- are we moments
|
| 2 | away or should I just proceed without slides?
|
| 3 | DR. CARLTON: Is the computer still not working?
|
| 4 | MR. NELSON: Well, okay, the reason they put me
|
| 5 | first is the slides that you can't see are really sort
|
| 6 | of a background deck that gives you the background on
|
| 7 | market power. The first slide cites the definition of
|
| 8 | market power that's at the front of the monograph that
|
| 9 | the ABA published that was referred to earlier, which is
|
| 10 | market power is the ability of a firm or a group of
|
| 11 | firms within a market to profitably charge prices above
|
| 12 | the competitive level for a sustained period of time,
|
| 13 | and as you can't see on the screen, the word
|
| 14 | "profitably" is in italics, and so one of the important
|
| 15 | things in the definition is that a monopolist profit by
|
| 16 | doing this.
|
| 17 | If entry is easy, you may be able to raise
|
| 18 | prices, but not profitably, because somebody will enter,
|
| 19 | and if there are a lot of competitors, they can steal
|
| 20 | customers away from you, so you can't profit. That may
|
| 21 | become of importance in some of the discussion as to
|
| 22 | what type of performance evidence one might use in
|
| 23 | determining whether a firm has market power or not.
|
| 24 | A price above the competitive level, the
|
| 25 | "competitive level" was in italics, because people talk |
12
| 1 | about the standard monopoly raising prices, and if you
|
| 2 | are not raising them above the competitive level,
|
| 3 | usually people don't care.
|
| 4 | Then a "sustained period of time" is in the
|
| 5 | definition because you may be able to opportunistically
|
| 6 | raise prices for a little bit, but again, entry or
|
| 7 | something might undermine the ability to do that.
|
| 8 | Now, in some of the legal cases, you see
|
| 9 | reference to the ability to exclude competition, and I
|
| 10 | will suggest that is something worth consideration,
|
| 11 | because in some contexts -- and there were FTC hearings
|
| 12 | many years ago about standard-setting organizations
|
| 13 | where there might be a collection of, let's say, 10 or
|
| 14 | more people making a particular product, and there might
|
| 15 | be enough competitors that they compete and charge a
|
| 16 | competitive price because there's so many people
|
| 17 | operating under that standard.
|
| 18 | Well, somebody may develop a new technology that
|
| 19 | would come in and completely take the market away from
|
| 20 | the incumbent competitors with the older technology.
|
| 21 | Acting jointly in that case, they might be able to block
|
| 22 | entry by controlling the standard-setting organization.
|
| 23 | Are they raising prices above the competitive level?
|
| 24 | They're excluding an entrant, somebody that would
|
| 25 | dynamically help the market with a new technology that |
13
| 1 | might have better performance characteristics and be
|
| 2 | able to be sold at a lower price. What they get out of
|
| 3 | it is where their profit is, is that they get to earn
|
| 4 | the competitive rate of return rather than being maybe
|
| 5 | in bankruptcy court.
|
| 6 | So, while I gave you the standard definition,
|
| 7 | there are other things and other contexts, as you can
|
| 8 | see from the get-go, that you have to worry about in
|
| 9 | deciding whether a firm or a group of firms have market
|
| 10 | power. And today, largely we'll focus on dominant
|
| 11 | firms, but there are contexts where a group of firms
|
| 12 | acting together might have trouble. And if a dominant
|
| 13 | firm has control over a patent that's a blocking patent
|
| 14 | that blocks a new technology, he might have an interest
|
| 15 | in blocking the new technology just like the group of
|
| 16 | firms that ran the standard-setting organization has an
|
| 17 | incentive to block technology. So, that's one thing.
|
| 18 | The other thing that I wanted to highlight at
|
| 19 | the beginning is, some people talk about market power;
|
| 20 | some people talk about monopoly power. Often,
|
| 21 | economists mean the same thing, but in some contexts,
|
| 22 | people have defined them differently. Greg Werden is
|
| 23 | sitting there, and he's drawn a distinction in one of
|
| 24 | his articles and alludes to other people that
|
| 25 | distinguish market power and monopoly power perhaps in |
14
| 1 | terms of the time period over which people have the
|
| 2 | ability to raise prices and the like.
|
| 3 | There are articles out there that talk about
|
| 4 | antitrust monopoly power, again, trying to make a
|
| 5 | distinction. And there, often the thought is if you
|
| 6 | have a differentiated product and thus have a
|
| 7 | downward-sloping demand curve for your product, you
|
| 8 | might have some degree of ability to raise prices above
|
| 9 | costs and you might in that sense have market power, but
|
| 10 | you might not have a substantial ability to do it.
|
| 11 | Because there are a lot of products out there that are
|
| 12 | roughly close substitutes, not exactly the same thing,
|
| 13 | and you might in that context have some market power but
|
| 14 | not antitrust monopoly power or antitrust market power,
|
| 15 | because you don't really have substantial ability to
|
| 16 | earn substantial profits and the like. So, some people
|
| 17 | try to distinguish that downward-sloping demand curve
|
| 18 | idea by talking about antitrust monopoly power.
|
| 19 | I think with that background, we're talking
|
| 20 | about antitrust market power. Something that's somewhat
|
| 21 | significant. And then different panelists may have
|
| 22 | different degrees of market power in mind when deciding
|
| 23 | how you go about measuring whether it is significant
|
| 24 | enough market power. So, with that sort of definition
|
| 25 | of market power, the next slide was going to lay out |
15
| 1 | sort of the touchstones in a typical market power proof
|
| 2 | that you sort of run through, and the first thing people
|
| 3 | often define is product market definition. Then they go
|
| 4 | to defining geographic market definition.
|
| 5 | Once you have a relevant product/geographic
|
| 6 | market combination, often it is standard to look at
|
| 7 | market concentration in a monopoly case, and once you
|
| 8 | clear that hurdle and see that maybe it is substantially
|
| 9 | concentrated or a firm has a dominant market share, a
|
| 10 | high-level market share, you then start looking at
|
| 11 | things like entry conditions, other structural
|
| 12 | characteristics of the market. Maybe you look at in
|
| 13 | some contexts, you know, the structure of the buyer-side
|
| 14 | of the market, and if it is a collusion case type of
|
| 15 | monopoly power issue, maybe you look at the
|
| 16 | characteristics of the market that make it easier or
|
| 17 | harder for firms to collude in that market.
|
| 18 | Then finally, in a lot of the monopolization
|
| 19 | cases, you see a consideration of market performance
|
| 20 | evidence, and that's where you start having things like
|
| 21 | profit rates of return, profit margins, looking at
|
| 22 | prices over time or across geographic areas. You look
|
| 23 | at output patterns and how they vary with prices. And
|
| 24 | you look at new product introductions. You can either
|
| 25 | look at them in terms of formal econometric analysis or |
16
| 1 | often you look at events -- market events that allow you
|
| 2 | to sort of control for some things -- and look at how if
|
| 3 | the events give you insights either directly into the
|
| 4 | market power or at some of the related issues like
|
| 5 | market definition.
|
| 6 | Now, increasingly, because of the success of the
|
| 7 | Merger Guidelines, you see references to the approach
|
| 8 | used in the Merger Guidelines of developing a relevant
|
| 9 | market in the context of monopolization cases, and there
|
| 10 | were a couple slides that sort of just quoted the
|
| 11 | Guidelines. I suspect with this audience, there is no
|
| 12 | reason to go through it, but it is the hypothetical
|
| 13 | monopolist test. Can the monopolist raise prices above
|
| 14 | the -- in the Guidelines, they talk more or less about
|
| 15 | the current level as opposed to the competitive level
|
| 16 | and see if that's profitable.
|
| 17 | Now, one thing that is worth pointing out,
|
| 18 | especially in transferring that concept, is that in the
|
| 19 | Guidelines themselves, Section 1.11 says that while you
|
| 20 | might look at prevailing prices in the Guidelines, there
|
| 21 | is a caveat that says if pre-merger circumstances are
|
| 22 | strongly suggestive of coordinated interaction, in that
|
| 23 | situation, the agency will use a price more reflective
|
| 24 | of the competitive price. So, there is a caveat in
|
| 25 | there where they don't always use prevailing prices. |
17
| 1 | One sort of footnote is that the original
|
| 2 | guidelines were focused on coordinated effects, and then
|
| 3 | they later on added more information about unilateral
|
| 4 | effects. I think there's a little glitch here, because
|
| 5 | I think the Merger Guidelines actually should make a
|
| 6 | reference not only to coordinated interaction, but also
|
| 7 | if the dominant firms raise prices above the competitive
|
| 8 | level, then you might want to look at the competitive
|
| 9 | price level.
|
| 10 | Why might you want to do that? Well, that is
|
| 11 | because you get a different elasticity and different
|
| 12 | substitutes depending on at what price level you measure
|
| 13 | the substitution. And this is where the lack of slides
|
| 14 | really hurt us the most, because I put together an
|
| 15 | illustrative example of a demand curve with a concrete
|
| 16 | slope and all the rest, calculated the marginal revenue
|
| 17 | curve from that, showed where the competitive price
|
| 18 | would be, where basically price equals marginal cost,
|
| 19 | then showed where the monopolist would operate, which is
|
| 20 | at a higher price, and then estimated the elasticities
|
| 21 | of a couple of the different points along the demand
|
| 22 | curve.
|
| 23 | What you see is that even though a demand curve
|
| 24 | is a straight line and thus the slope is constant over
|
| 25 | the whole curve, the elasticity changes. And at the |
18
| 1 | higher prices, the demand is more elastic. And, the
|
| 2 | reason that that makes sense is that a monopolist is
|
| 3 | going to keep raising its price, you know, and find a
|
| 4 | price that is more profitable. And in the monopolistic
|
| 5 | equilibrium, he has got a high enough price that demand
|
| 6 | becomes elastic and a further price increase would lose
|
| 7 | a lot of customers to other products. That is called
|
| 8 | the Cellophane fallacy -- that sets up the Cellophane
|
| 9 | fallacy, which is if you measure the elasticities at the
|
| 10 | monopoly price, you are going to run into problems
|
| 11 | because there are a lot of substitutes out there that
|
| 12 | are not substitutes at the competitive price. You can
|
| 13 | do all the econometrics you want and estimate the
|
| 14 | elasticities, but if you do not know whether you were at
|
| 15 | a competitive price or a monopoly price, that elasticity
|
| 16 | estimate does not tell you anything when you are doing a
|
| 17 | monopolization case particularly.
|
| 18 | So, then you get into this tautological
|
| 19 | situation. If you think about the paradigm of starting
|
| 20 | with a monopoly case and saying, "Well, do I have a
|
| 21 | monopoly here?" And you have to define the market, and
|
| 22 | you have to define a monopoly price to define the
|
| 23 | market, then why bother defining the market? So, you
|
| 24 | have got a couple of issues here that suggest, what do
|
| 25 | you do about it? And the rest of my deck talks about |
19
| 1 | the sorts of things that one might look at. But, the
|
| 2 | basic thing that I wanted to suggest is -- while I think
|
| 3 | there are great problems with a simplistic analysis of
|
| 4 | the standard paradigm I outlined -- I think there are
|
| 5 | elements of it that, if you can go through it all, can
|
| 6 | help you in many circumstances unravel this thing and
|
| 7 | cross-check your conclusion.
|
| 8 | So, it is a way of organizing your story.
|
| 9 | Making sure that you look at your story or your analysis
|
| 10 | as consistent, and that it gives you insights into what
|
| 11 | you might look at. And where it leads you, I think, is
|
| 12 | looking more and more at some of the performance
|
| 13 | evidence. But you have got to be careful in looking at
|
| 14 | the performance evidence, because as economists have
|
| 15 | shown, things like profits and accounting data are
|
| 16 | tricky.
|
| 17 | Having said that, I also think that how
|
| 18 | difficult a problem it is varies a lot from market
|
| 19 | circumstance to market circumstance. I think it is
|
| 20 | probably trickiest when you are dealing with
|
| 21 | consumer-differentiated products, like Cellophane
|
| 22 | wrapping paper or something. It may be less of a
|
| 23 | problem when you are dealing with an input into an
|
| 24 | industrial process, where you can look at substitutes in
|
| 25 | a more maybe engineering approach type of way. |
20
| 1 | My time is basically up, so to keep us on
|
| 2 | schedule, I would recommend -- they are going to post
|
| 3 | the slides later on, and they are written in a way that
|
| 4 | they are readable -- so I suggest you look at the slides
|
| 5 | for the rest of the story.
|
| 6 | Thanks.
|
| 7 | (Applause.)
|
| 8 | DR. CARLTON: Thank you.
|
| 9 | Our next speaker is Joe Simons.
|
| 10 | MR. SIMONS: Thanks, and good morning, everyone.
|
| 11 | I would like to start out by complimenting the
|
| 12 | FTC and the Department of Justice in holding these
|
| 13 | hearings and doing a terrific job. I am really quite
|
| 14 | encouraged that something really valuable will come out
|
| 15 | of this.
|
| 16 | So, one of the first things that happened this
|
| 17 | morning is the audience was instructed not to ask any
|
| 18 | questions or make any comments. So, I thought, well,
|
| 19 | gee, I was planning to hear you violate that restriction
|
| 20 | right away, but maybe we'll try something a little bit
|
| 21 | different.
|
| 22 | Perhaps by a show of hands, who in here would
|
| 23 | say that the 1982 Department of Justice Merger
|
| 24 | Guidelines market definition paradigm was the most
|
| 25 | significant development in market definition in the last |
21
| 1 | 30 years?
|
| 2 | So, we have got most of the panelists and maybe
|
| 3 | half of the audience. That is pretty good for one
|
| 4 | thing. I would have expected it might have been a
|
| 5 | little bit higher.
|
| 6 | But in any case, what that showing would
|
| 7 | demonstrate is an enormous amount of success for that
|
| 8 | effort, I think by any standard, and why is that the
|
| 9 | case? Why were those guidelines on the market
|
| 10 | definition paradigm so successful?
|
| 11 | In my view, it is because those guidelines
|
| 12 | reflected an understanding that the tools of antitrust
|
| 13 | analysis should be designed for a specific purpose.
|
| 14 | Previously, you had market definition which was pulled
|
| 15 | out of the economics literature and it was not designed
|
| 16 | to do an antitrust analysis. The merger guidelines
|
| 17 | market definitions was done specifically for that
|
| 18 | purpose.
|
| 19 | The other thing that was really important is
|
| 20 | that the agency, the DOJ in that case, was willing to be
|
| 21 | out in front of the case law. I think there was a
|
| 22 | pretty good argument that those guidelines, the market
|
| 23 | definition therein, did not really reflect the case law.
|
| 24 | So, I thought it would be useful to do a little case
|
| 25 | study and talk about first principles and market |
22
| 1 | definition.
|
| 2 | The Guidelines, the Merger Guidelines, were
|
| 3 | built around the goals defined right in the Guidelines
|
| 4 | of preventing mergers from creating or increasing market
|
| 5 | power -- initially through coordinated interaction and
|
| 6 | then later unilateral effects. And as I said, they
|
| 7 | geared this market definition specifically to this
|
| 8 | overall goal of the Merger Guidelines. So, it was
|
| 9 | designed to identify that universe of firms that were
|
| 10 | necessary to profitably engage in coordinated
|
| 11 | interaction or in unilateral effects. Then for the
|
| 12 | unilateral effects, arguably the analysis could collapse
|
| 13 | the market definition into the competitive effects
|
| 14 | analysis. The market definition in the Guidelines is
|
| 15 | rigorous, it is logical, and it is transparent.
|
| 16 | Now, sitting here today, 25 years later, and
|
| 17 | seeing what a success this was, you might forget what it
|
| 18 | was like when these things were first issued. There
|
| 19 | were hoots and howls from all sectors of the Antitrust
|
| 20 | Bar and the academic community. These guidelines were
|
| 21 | ivory tower nonsense; they were completely hypothetical;
|
| 22 | they were totally inoperable and just downright
|
| 23 | impractical; a complete waste of time. These were
|
| 24 | comments that people made very regularly, and some
|
| 25 | people even said it was a conspiracy to do away with the |
23
| 1 | antitrust laws.
|
| 2 | There was a little bit of a kernel of truth to
|
| 3 | some of those complaints, not the conspiracy stuff, but
|
| 4 | to the practicality of this test. There were a lot of
|
| 5 | people who saw the initial attempts to implement this by
|
| 6 | the agencies in the following way. One of the staff
|
| 7 | lawyers would have a conversation with the customers and
|
| 8 | say, "Gee, do you think that the sellers in this market
|
| 9 | could profitably raise price 5 or 10 percent?" You are
|
| 10 | shaking your head, but I heard people do that, Greg, and
|
| 11 | the customer has no concept of what it takes for it to
|
| 12 | be profitable. There is no context to the question.
|
| 13 | So, there were reasonable criticisms.
|
| 14 | But what happened is that because the algorithm
|
| 15 | was rigorous and logical and transparent, it enabled the
|
| 16 | development of applications basically, tools, to
|
| 17 | implement this approach, econometric tools. Examples
|
| 18 | are Baker and Bresnahan and Scheffman and Spiller, Greg
|
| 19 | Werden as well, something near and dear to me, critical
|
| 20 | loss. These things did not exist when those guidelines
|
| 21 | were first issued, and that really was an important
|
| 22 | lesson to learn, that if you have the right structure,
|
| 23 | then you have created a platform on which you can build
|
| 24 | something that really works.
|
| 25 | So, what does this translate into in terms of |
24
| 1 | what we should do for section 2? Well, what are the
|
| 2 | goals of section 2? What are we trying to accomplish?
|
| 3 | Is there a consensus? You know, there has been a lot of
|
| 4 | ink been spilled in relation to the Trinko case, for
|
| 5 | example. There are differences already between the way
|
| 6 | the DOJ and the FTC look at this. There is the profit
|
| 7 | sacrifice test, the no economic sense test; there is the
|
| 8 | disproportionate harm relative to efficiencies test.
|
| 9 | So, where does that leave us for market
|
| 10 | definition? Does that create a problem? Can we rely on
|
| 11 | what is in the case law? Reasonable interchangeability,
|
| 12 | what does that mean? How much interchangeability is
|
| 13 | reasonable? It is basically relying on
|
| 14 | cross-elasticities of demand. How high does the
|
| 15 | cross-elasticity have to be? Is that even something you
|
| 16 | can look at? Can we rely on the Merger Guidelines
|
| 17 | market definition? Does the hypothetical monopolist
|
| 18 | paradigm, as applied in the Merger Guidelines, really
|
| 19 | work for section 2? And one of the issues in section 2
|
| 20 | is, are we focused on the same phenomenon that we are
|
| 21 | for section 7?
|
| 22 | The Merger Guidelines, the Horizontal Merger
|
| 23 | Guidelines, are basically focused on collusion, an
|
| 24 | extreme form of which is unilateral behavior. So you
|
| 25 | are talking about situations in which a group of firms |
25
| 1 | is trying to restrict their own output, whereas in
|
| 2 | section 2, what you are dealing with is a situation in
|
| 3 | which one firm, the large firm, the dominant firm, is
|
| 4 | trying to restrict the output of somebody else in most
|
| 5 | cases and maybe sometimes themselves as well. So, what
|
| 6 | do we do with all of that?
|
| 7 | One possible thing to do -- and I am just
|
| 8 | throwing this out -- would be to come up with a set of
|
| 9 | goals for section 2, what is the purpose, what are we
|
| 10 | trying to do, and then work through various scenarios as
|
| 11 | to what the market definition would be under each of
|
| 12 | those. So, one potential scenario is, we are going to
|
| 13 | say that the goal of section 2 is to prevent unilateral
|
| 14 | conduct that is reasonably likely to significantly raise
|
| 15 | price or reduce quality. Reasonably significantly, you
|
| 16 | can come up with other adjectives, number one.
|
| 17 | Number two, and you are going to focus on
|
| 18 | conduct that either, A, has no efficiencies, B, has
|
| 19 | disproportionately low efficiencies relative to their
|
| 20 | exclusionary effect, or C, would make no economic sense
|
| 21 | in the absence of exclusionary effect, and potentially
|
| 22 | D, permits recoupment of the exclusionary conduct. So,
|
| 23 | kind of a menu from which to choose.
|
| 24 | Well, one could argue that the first condition,
|
| 25 | that the unilateral conduct be such that it is |
26
| 1 | reasonably likely to significantly raise price and/or
|
| 2 | reduce quality, may be a necessary condition. That
|
| 3 | defines the universe in which something bad can happen.
|
| 4 | If you do not have that condition, then you might be
|
| 5 | able to say that nothing bad can really happen. So, you
|
| 6 | can use market definition in that sense, to focus on
|
| 7 | that aspect as a screen.
|
| 8 | You then could ask, "Well, gee, would the market
|
| 9 | definition need to change depending on your choice of 2A
|
| 10 | through D?" And at least at a first cut, I would say
|
| 11 | probably not, that these factors relate to what might be
|
| 12 | considered defenses or separate prongs of the analysis.
|
| 13 | They would not be necessary to worry about in the first
|
| 14 | market power screen, where you use market power or
|
| 15 | market definition as the screen.
|
| 16 | All right, so what would be the relevant
|
| 17 | context, then, for measuring profitability of a price
|
| 18 | increase? Well, obviously the options are before,
|
| 19 | during or after the execution of the alleged conduct.
|
| 20 | Well, we are concerned with the price going up as a
|
| 21 | result of this conduct, so it seems to me you want to
|
| 22 | focus on whether there might be a significant price
|
| 23 | increase, whether a significant price increase might be
|
| 24 | profitable during or after this alleged conduct.
|
| 25 | Then similarly, if the conduct is already in |
27
| 1 | place, so you cannot observe it over time, then the
|
| 2 | question might be the reverse, which is, absent this
|
| 3 | conduct, would the price be lower, right?
|
| 4 | You see, I think there is the same problem here
|
| 5 | that you have -- not really a problem, but an issue in
|
| 6 | the Merger Guidelines -- where for the most part, you
|
| 7 | are measuring the profitability of a price increase
|
| 8 | going forward. You are not looking at the current
|
| 9 | level. You are really looking at a change in the
|
| 10 | current level that is brought about by the conduct that
|
| 11 | you are worried about. So, in the merger case, it is
|
| 12 | the merger; in this case, it would be the alleged
|
| 13 | exclusionary conduct.
|
| 14 | You know, one of the things that is near and
|
| 15 | dear to me, critical loss, might be a tool to help in
|
| 16 | this analysis, and it would not be exclusive by any
|
| 17 | means. Just like in the Merger Guidelines you can use
|
| 18 | critical loss, you can use all kinds of other estimation
|
| 19 | techniques, and they are not exclusive.
|
| 20 | So, one way to think about this would be that
|
| 21 | the burden would be on the plaintiff to show the likely
|
| 22 | extent to which the alleged conduct restrains
|
| 23 | third-party producers; in other words, whatever the
|
| 24 | conduct is, exclusive dealing, refusal to deal,
|
| 25 | whatever, what is the likely impact on third-party |
28
| 1 | producers? How much restraint does this have on their
|
| 2 | ability to supply the market?
|
| 3 | Then the plaintiff would have to show that it
|
| 4 | would be profitable for the monopolist to raise price
|
| 5 | significantly -- whatever the number is, 5, 10 percent,
|
| 6 | whatever -- as a result of that exclusionary conduct.
|
| 7 | You could calculate a critical loss for the monopolist
|
| 8 | that would be based on margins, and you could estimate
|
| 9 | whether a 10 percent price increase after or during the
|
| 10 | alleged conduct would leave sufficient residual supply
|
| 11 | such that a monopolist would lose in excess of the
|
| 12 | critical loss. So, that would get you the market
|
| 13 | definition part of this. Then what do you do?
|
| 14 | One strategy would be to not even bother with
|
| 15 | shares, because you have basically concluded that the
|
| 16 | single firm was able to engage in this alleged conduct
|
| 17 | and get the price up, and in terms of that, one could
|
| 18 | say, "Well, that's what we needed to know," and we will
|
| 19 | now we go through the rest of the analysis and determine
|
| 20 | what are the efficiencies, and maybe you want to talk
|
| 21 | about recoupment as well. So, one could reasonably say,
|
| 22 | "Well, we don't really need a market share threshold."
|
| 23 | Other people could say, "Well, gee, it is in the case
|
| 24 | law. We want to try to make it consistent. It is
|
| 25 | really important. So, we need a market share |
29
| 1 | threshold." How would that work?
|
| 2 | Well, one way to think about it in the context
|
| 3 | that I have just outlined would be you could say, "Well,
|
| 4 | the firms in the market would be obviously the alleged
|
| 5 | predator, and then potentially also other firms that
|
| 6 | have also benefitted from a price increase as a result
|
| 7 | of this exclusionary conduct," and you might base their
|
| 8 | share calculations on their sales of that product for
|
| 9 | which the price increase was experienced.
|
| 10 | But then you ask the question, "Well, why have a
|
| 11 | share requirement? What does that do for you?" You
|
| 12 | might say, "Well, it gives us some comfort because
|
| 13 | predatory conduct is only likely to occur where the
|
| 14 | shares are high." Well, there is an issue about that,
|
| 15 | because some exclusionary conduct is really cheap, and
|
| 16 | some exclusionary conduct is really expensive. So, if
|
| 17 | you are going to engage in really expensive exclusionary
|
| 18 | conduct, yes, then you probably want to have a big
|
| 19 | share, because you need to recover that expense that you
|
| 20 | laid out to execute the exclusionary conduct, but if you
|
| 21 | are executing really cheap exclusion involving, a
|
| 22 | Hatch-Waxman type of scenario or something like that,
|
| 23 | which costs virtually nothing, well, then, what does the
|
| 24 | market share do for you? So, that is unclear.
|
| 25 | I have got about 30 seconds left, and I just |
30
| 1 | wanted to sum up by saying I think there are some really
|
| 2 | important lessons to be learned from the Horizontal
|
| 3 | Merger Guidelines market definition, and I am hopeful
|
| 4 | that what will come out of this is we will get a bunch
|
| 5 | of smart people in a room, maybe Greg and some of his
|
| 6 | colleagues from the Antitrust Division and the FTC will
|
| 7 | sit in a room, take all of this together, and come out
|
| 8 | with an algorithm that is of similar significance to
|
| 9 | what they did with the Merger Guidelines -- use the
|
| 10 | first principles integrated approach, not worry about
|
| 11 | the fact that what they might come out with is a
|
| 12 | theoretic framework, theoretic algorithm that is not
|
| 13 | immediately implementable, and then not be afraid to
|
| 14 | consider a market definition guideline that deviates
|
| 15 | from traditional case law, because what happened with
|
| 16 | the Merger Guidelines is people originally said, "Oh,
|
| 17 | this is nothing like the original case law," and now we
|
| 18 | have been able to bring the two together, and the courts
|
| 19 | have seemed to have adopted what is in the Guidelines.
|
| 20 | Thanks very much.
|
| 21 | (Applause.)
|
| 22 | DR. CARLTON: Thank you, Joe.
|
| 23 | Our next speaker is Larry White, who has arrived
|
| 24 | in time. You have already been introduced, Larry.
|
| 25 | DR. WHITE: Well, thank you. |
31
| 1 | DR. CARLTON: And the ground rules are we are
|
| 2 | running a little late, so if you could keep to 15
|
| 3 | minutes.
|
| 4 | DR. WHITE: Right.
|
| 5 | DR. CARLTON: Does the computer work?
|
| 6 | UNIDENTIFIED SPEAKER: Yes.
|
| 7 | DR. CARLTON: And you are the first person who
|
| 8 | has the use of the computer.
|
| 9 | DR. WHITE: All right, great. Well, thank you.
|
| 10 | I am very pleased to be here this morning, and sorry for
|
| 11 | the delay of my arrival. I flew down from New York this
|
| 12 | morning, and every once in a while you get hit with a --
|
| 13 | I do not know whether it is the right-hand tale or
|
| 14 | left-hand tale on variance, but we were an hour late
|
| 15 | taking off. So, here I am. I am very pleased to be
|
| 16 | here.
|
| 17 | I think this is a terrifically important issue,
|
| 18 | and it is an issue where unfortunately too many mistakes
|
| 19 | have been made, too many mistakes continue to be made,
|
| 20 | and I want to walk you through what I consider to be
|
| 21 | some important issues. I have got a few call it partial
|
| 22 | answers. I do not have the complete answer. At the
|
| 23 | end, I am going to be echoing Joe Simons' call. We need
|
| 24 | a new paradigm; a paradigm is missing.
|
| 25 | So, like any good business school professor, I |
32
| 1 | am going to tell you what I am going to say, and then I
|
| 2 | am going to say it, and then I am going to tell you what
|
| 3 | I said. I will frame the issue, I will remind you what
|
| 4 | the standard monopoly model looks like, I will remind
|
| 5 | you what the implications of that model are, I will
|
| 6 | point out the loose language that has been used by
|
| 7 | people who do know better or who ought to know better,
|
| 8 | and I'll tell you about the danger of that loose
|
| 9 | language. That will bring me to the Cellophane fallacy.
|
| 10 | Everybody is going to talk -- you cannot not talk about
|
| 11 | the Cellophane fallacy when we're addressing this topic,
|
| 12 | remind you of an ongoing dilemma, put out some partial
|
| 13 | suggestions, and wrap it up.
|
| 14 | What's the issue? I am not going to get into
|
| 15 | this market power versus monopoly power. The way I was
|
| 16 | taught, it is all the same thing, and the exercise of
|
| 17 | this thing, call it monopoly power or market power, is
|
| 18 | the seller can sell at prices above marginal cost and
|
| 19 | earn rents, and I should have added for a sustained
|
| 20 | period of time, but I will go ahead with my story. That
|
| 21 | is the picture that we carry around in our head of what
|
| 22 | monopoly power, market power, is about, the sustained
|
| 23 | charging of a price above marginal cost, maintaining --
|
| 24 | I am going to use that word over and over again --
|
| 25 | maintaining a price substantially above marginal cost. |
33
| 1 | All right, now, what also gets talked about,
|
| 2 | especially in an antitrust context, is actions --
|
| 3 | exclusionary, predatory actions -- that can create or
|
| 4 | enhance market power. So, somebody who did not have it,
|
| 5 | can create it. Somebody who has it through an
|
| 6 | exclusionary or predatory action can enhance it, make
|
| 7 | the demand curve yet less elastic or inelastic and earn
|
| 8 | even higher rents.
|
| 9 | If the seller is engaging in this kind of
|
| 10 | activity, whether he is exercising the market power or
|
| 11 | enhancing, a likely precondition is that the seller has
|
| 12 | a large share of its market. So, that is not necessary.
|
| 13 | You can come up with examples where if the overall
|
| 14 | supply is limited, where other suppliers cannot expand
|
| 15 | their output very much, where demand is quite inelastic,
|
| 16 | even somebody with a relatively small share of a
|
| 17 | commodity market by his unilateral actions can affect
|
| 18 | the price, but more generally, a large share of
|
| 19 | something called a market is going to be necessary. But
|
| 20 | that then raises this threshold or safe harbor issue,
|
| 21 | what is the market, and there is no standard paradigm
|
| 22 | for that determination.
|
| 23 | So, this is the picture we carry around in our
|
| 24 | head, and the implications of that picture, the
|
| 25 | monopolist maintains its price at a level above the |
34
| 1 | competitive price. He would not want to raise his price
|
| 2 | any further unless demand changed or costs changed. He
|
| 3 | is already where he wants to be. In trying to raise his
|
| 4 | price, he would lose too many customers to sellers of
|
| 5 | something else, and, of course, if the market changes
|
| 6 | from a competitive structure to a monopoly -- because of
|
| 7 | cartelization, because of exclusion -- then the price
|
| 8 | changes, then the price increases, the seller, newly
|
| 9 | feeling this market power, raises the price from the
|
| 10 | competitive to the noncompetitive monopoly level, but as
|
| 11 | a characterization of what is going on when we take a
|
| 12 | snapshot of the market, he is maintaining the price at a
|
| 13 | level above the competitive level. That is clear in
|
| 14 | this standard model.
|
| 15 | About 40 years ago, George Stigler developed an
|
| 16 | expanded version of this, the dominant firm and the
|
| 17 | inverted price umbrella, where he described a firm that
|
| 18 | was not strictly a monopolist, he faced a reactive
|
| 19 | fringe of smaller firms that were limited in their
|
| 20 | supply response, and he showed basically you get a
|
| 21 | similar type of outcome. The dominant firm is able to
|
| 22 | charge, maintain a price above competitive levels, but
|
| 23 | he doesn't want to go any higher because -- and there,
|
| 24 | in the Stigler model, it is implicit -- he would lose
|
| 25 | too many sales to that competitive fringe. |
35
| 1 | Okay, why am I making such a big deal out of
|
| 2 | this? Because there has been loose language out there,
|
| 3 | first by my colleagues, all of whom do know better, and
|
| 4 | they describe the phenomenon of monopoly power, market
|
| 5 | power, in terms of the ability of the firm to raise
|
| 6 | prices. In other words, I have put in italics over and
|
| 7 | over again, this language of "raise prices," or in the
|
| 8 | context of the Microsoft case, Fisher and Rubinfeld
|
| 9 | making this claim that, "Gee, Microsoft could have
|
| 10 | raised its price substantially and wouldn't have lost
|
| 11 | customers," and you have got to scratch your head, how
|
| 12 | come they didn't? Then Evans and Schmalensee on the
|
| 13 | other side, again, talking the language of "raise."
|
| 14 | Even earlier, as I walked in the door, I heard
|
| 15 | Phil Nelson talking about the monopolist "raising" the
|
| 16 | price. Maintaining is what we're talking about, but I
|
| 17 | am sure I in my looser moments fall into this "raising."
|
| 18 | It is an easy thing to do, but I am going to show you
|
| 19 | the dangers of it in just a minute.
|
| 20 | I'll go over to some noted legal cases and legal
|
| 21 | opinions, and again, you have got the same -- oh, did
|
| 22 | I -- no, I forgot to put the italics in there, but you
|
| 23 | can see the word "raise" in each of those -- in each of
|
| 24 | those quotations from those cases.
|
| 25 | All right, what is the danger? The danger in |
36
| 1 | the "raise" terminology is that if we think market power
|
| 2 | and monopoly power are the ability to raise the price,
|
| 3 | then it is easy to then think, "Ah, well, the test of
|
| 4 | whether somebody has market power or not is whether the
|
| 5 | seller can raise prices above currently observed
|
| 6 | levels." Remember, that is what Fisher and Rubinfeld
|
| 7 | were talking about there.
|
| 8 | Conversely, if the seller is constrained from
|
| 9 | raising prices because of its fears of losing too many
|
| 10 | customers, then does that imply that it does not have
|
| 11 | market power? The trouble is, even in the standard
|
| 12 | paradigm where the monopolist is maintaining a price
|
| 13 | above competitive levels, it cannot profitably raise its
|
| 14 | price because it would lose too many customers to
|
| 15 | sellers of something else.
|
| 16 | That, of course, then leads us to the Cellophane
|
| 17 | fallacy, the U.S. v. Dupont case, where the issue was,
|
| 18 | was the market a narrow market of cellophane, in which
|
| 19 | case it is clear, Dupont had market power. There was
|
| 20 | one other seller of cellophane, Sylvania. It was under
|
| 21 | license from Dupont, and so, effectively, no question.
|
| 22 | If the market was cellophane, Dupont had market power.
|
| 23 | Or was it, as Dupont claimed, flexible wrapping
|
| 24 | materials, in which case Dupont only had a 17.9 percent
|
| 25 | share and didn't have market power? |
37
| 1 | The Supreme Court majority said it was
|
| 2 | interchangeability that carried the day, that cellophane
|
| 3 | was interchangeable with other materials mentioned --
|
| 4 | there was wax paper and brown wrapping paper and
|
| 5 | aluminum foil and glassine and lots of other things --
|
| 6 | and the majority said, "Ah, look, it is interchangeable.
|
| 7 | Dupont can't raise its price. So, it must be part of
|
| 8 | that larger market."
|
| 9 | The minority pointed out the fallacy of that
|
| 10 | reasoning and also pointed out the comparison with
|
| 11 | rayon, where Dupont also faced 15 to 18 other producers,
|
| 12 | also had a market share that was below 20 percent, and
|
| 13 | made much less profits. They also pointed out that
|
| 14 | Dupont's price of cellophane did not move around when
|
| 15 | those other flexible materials' prices changed.
|
| 16 | So, we have this ongoing dilemma. Profit data
|
| 17 | nowadays are relied on a whole lot less than was the
|
| 18 | case back in the fifties when Stocking and Mueller were
|
| 19 | writing, when the Supreme Court minority relied on those
|
| 20 | profit data. The Horizontal Merger Guidelines cannot be
|
| 21 | used, because they are a forward look, as you have heard
|
| 22 | already, they are a forward-looking test.
|
| 23 | The one exception, which Greg Werden has pointed
|
| 24 | out, is that if we are talking about a practice that is
|
| 25 | not yet in place, say an exclusive dealing plan that is |
38
| 1 | going to be put in place. A plaintiff comes in, asks
|
| 2 | for an injunction. We are talking about something where
|
| 3 | it is a prospective practice. Then the prospective,
|
| 4 | forward-looking paradigm of the Merger Guidelines will
|
| 5 | work. To the extent that that is what we are looking
|
| 6 | at, fine, we have got an answer, but lots of instances
|
| 7 | are not of that kind.
|
| 8 | As Phil remarked earlier, elasticities do not
|
| 9 | help us very much. You cannot tell the difference
|
| 10 | between a true monopolist and just a different -- a
|
| 11 | seller of a differentiated product, a Chamberlin/
|
| 12 | Robinson monopolistic competitor.
|
| 13 | Okay, what to do? Well, sometimes a complaint
|
| 14 | will involve a prospective practice, and then we have
|
| 15 | got the Merger Guidelines. Sometimes there will be
|
| 16 | cross-sectional or time-series evidence involving prices
|
| 17 | where we can tell that concentration matters, and when
|
| 18 | concentration matters, you have got a market, and retail
|
| 19 | services are an area where cross-sectional data may be
|
| 20 | available.
|
| 21 | I harken back now ten years to the Staples case,
|
| 22 | where cross-section data showed that prices were
|
| 23 | different, higher where only Staples or Office Depot was
|
| 24 | present in the market, lower when both were there, yet
|
| 25 | lower when they and a third office superstore were |
39
| 1 | there. That evidence carried the day, and I think
|
| 2 | correctly, that there was a problem -- there would be a
|
| 3 | problem if the two firms merged, and it told us office
|
| 4 | superstores were a market.
|
| 5 | Think of the American Airlines predatory
|
| 6 | behavior case. Why do we think that city pairs are a
|
| 7 | market, city pairs airline transportation? Because
|
| 8 | there is lots of cross-sectional evidence that shows
|
| 9 | that, controlling for other things, prices matter and
|
| 10 | prices are related to concentration. Sometimes profit
|
| 11 | data will be useful.
|
| 12 | I mean, if you think the Microsoft case was a
|
| 13 | good case, if you thought that Microsoft's behavior was
|
| 14 | a problem, why did you think that? And I think at least
|
| 15 | part of the story was those profits. They were so large
|
| 16 | that even with all the problems that we know about
|
| 17 | profits, they were telling us something. But what if
|
| 18 | none of these possibilities are available?
|
| 19 | Well, Phil Nelson and I a few years ago made a
|
| 20 | proposal. It turns out similar language can be found in
|
| 21 | a 20-year-old article by Tom Krattenmaker. Greg had a
|
| 22 | version of this proposal in an article he wrote in 2000,
|
| 23 | where basically it is asking in the presence of an
|
| 24 | allegation of exclusion, what would have been the
|
| 25 | consequences of the absence of exclusion? It requires a |
40
| 1 | two-step investigation.
|
| 2 | First you have got to ask, in the absence of
|
| 3 | exclusion, what would the plaintiff's sales have been?
|
| 4 | And then you have got to ask, what would the price
|
| 5 | consequences of those additional sales have been as
|
| 6 | well?
|
| 7 | Now, as was indicated earlier, this would focus
|
| 8 | directly on effect, and it implicitly delineates a
|
| 9 | market, but if you think about what the unilateral
|
| 10 | effects analysis under the Horizontal Merger Guidelines
|
| 11 | does, it is basically doing the same thing. It is
|
| 12 | looking for an effect, and then, if somebody goes ahead
|
| 13 | and then tries to delineate a market, that is sort of
|
| 14 | redundant. You have already found the effect.
|
| 15 | Implicitly, you have said there must be a market there,
|
| 16 | and that is basically what the Nelson and White proposal
|
| 17 | does as well.
|
| 18 | But I think the best approach would be let's try
|
| 19 | to develop -- you know, I have thought hard about it.
|
| 20 | The best I could come up with was this joint proposal
|
| 21 | with Phil. It may not be good enough. Can the world
|
| 22 | come up -- can the Division, can the FTC, can a bunch of
|
| 23 | smart people out there -- come up with a paradigm that
|
| 24 | will have the power and eventual universality of the
|
| 25 | Horizontal Merger Guidelines? |
41
| 1 | I urge you, remember what the world looked like
|
| 2 | before 1982. Remember what 1981, 1980 and 1979 looked
|
| 3 | like. We did not have a paradigm. We had
|
| 4 | Elzinga-Hogarty. We had Ira Horowitz's suggestion.
|
| 5 | There were other ideas out there. George Hay was going
|
| 6 | around talking about how the Division defined markets,
|
| 7 | and he would say, "Well, we would look for whether there
|
| 8 | was a specialized trade journal that the sellers in a
|
| 9 | marketplace all submitted their data to." Those were
|
| 10 | the kinds of indicia that people looked to. The Merger
|
| 11 | Guidelines brushed all that stuff away, and we have now
|
| 12 | got a powerful paradigm. I hope that some smart people
|
| 13 | out there somewhere will be able to develop something
|
| 14 | with similar power.
|
| 15 | So, winding up, we have got an unsatisfactory
|
| 16 | state for market definition. I would hope we are in
|
| 17 | 1981, and next year, somebody is going to come up with
|
| 18 | something that will have the same kind of power as the
|
| 19 | Horizontal Merger Guidelines. I have shown you some
|
| 20 | partial remedies, but the best remedy would be a new
|
| 21 | paradigm.
|
| 22 | Thank you very much. I am very pleased to have
|
| 23 | this opportunity today.
|
| 24 | (Applause.)
|
| 25 | DR. CARLTON: Okay, thank you, Larry. |
42
| 1 | Our next speaker is Andy Gavil.
|
| 2 | DR. GAVIL: Good morning, everyone. Thank you
|
| 3 | to the organizers for inviting me to join everyone
|
| 4 | today. I am delighted to be here and agree with
|
| 5 | everyone else that these are some very important --
|
| 6 | indeed, fundamental -- issues to how we go about
|
| 7 | analyzing antitrust cases, and in truth, they are not at
|
| 8 | all unique to section 2. Questions of power and effects
|
| 9 | really cut across all kinds of cases today. So,
|
| 10 | resolving one area clearly is going to influence and
|
| 11 | affect the others just as the Merger Guidelines has
|
| 12 | affected many areas.
|
| 13 | So, I start with my first slide in talking about
|
| 14 | it is all about anticompetitive effects, and I think I
|
| 15 | would add to that, and legal process. At the end of the
|
| 16 | day -- that is a great phrase, "At the end of the
|
| 17 | day" -- "At the end of the day, in the final
|
| 18 | analysis" -- but at the end of the day, in the final
|
| 19 | analysis, whatever we conclude as a matter of economics
|
| 20 | is the right approach, we have to translate that into a
|
| 21 | legal system of decision-making. It has to work in
|
| 22 | courts. It has to work in a context where we have
|
| 23 | burdens of pleading and burdens of production and
|
| 24 | burdens of proof. It has to work in a context where we
|
| 25 | have various methods for discovery of evidence, where we |
43
| 1 | have a role for expert witnesses, where we have judges
|
| 2 | and juries, and if it cannot work in that context, then
|
| 3 | perhaps there is a problem with what we have come up
|
| 4 | with as a theoretical matter.
|
| 5 | I forget who it was, I think it was Joe talking
|
| 6 | earlier about how the Merger Guidelines were originally
|
| 7 | received. Well, part of the problem in how they were
|
| 8 | received is that they were received by a legal community
|
| 9 | accustomed to looking at cases in one particular way.
|
| 10 | They suggested that we needed to look at those cases in
|
| 11 | a very different way, and it was very unclear in 1982
|
| 12 | how you would translate, how you would take something
|
| 13 | like SSNIP and what evidence would you need?
|
| 14 | The lawyers that were asking the questions of,
|
| 15 | what witness am I going to need to do this? What
|
| 16 | evidence will I need from my client, from the other
|
| 17 | parties? How will I assemble it? How will I present
|
| 18 | it? There can be no doubt at all I think in anybody's
|
| 19 | mind that the Merger Guidelines and subsequent
|
| 20 | developments have been an economist's full employment
|
| 21 | act, and certainly that has been evidenced in the
|
| 22 | antitrust area. It is hard to imagine today proving any
|
| 23 | kind of case, plaintiff or defense, without the role of
|
| 24 | economists, and that is a result of the writing into our
|
| 25 | substantive standards various economic ideas. |
44
| 1 | So, as I go through these slides, I want you to
|
| 2 | sort of keep that in mind. The focus I have tried to
|
| 3 | bring to my comments today is, how do we make it work in
|
| 4 | this legal system? Well, common issues in antitrust are
|
| 5 | effects, and we have certain ways that we go about
|
| 6 | establishing them. We have irrebuttable presumptions --
|
| 7 | that is what the per se rule is all about -- and we have
|
| 8 | rebuttable presumptions; whether we are using direct
|
| 9 | evidence or circumstantial evidence -- and that is going
|
| 10 | to be an important issue that I am going to look at
|
| 11 | today -- we have different ways that we go about trying
|
| 12 | to establish effects.
|
| 13 | Direct evidence, defined here, is the actual
|
| 14 | exercise of market power. It may come out in
|
| 15 | performance evidence. It may come out in before and
|
| 16 | after studies of price. It is reflected to some degree
|
| 17 | in our use of "quick look." The "inherently suspect"
|
| 18 | formulation is also a way of looking at things that are
|
| 19 | obvious, and a question I will be asking today is, do we
|
| 20 | have equivalents for section 2 and would it make sense
|
| 21 | to use them in section 2?
|
| 22 | On the circumstantial evidence side, we have
|
| 23 | something that I have called a "double inference." We
|
| 24 | define a market, we calculate market shares from a
|
| 25 | certain level of market share, we infer market power, |
45
| 1 | and in truth, from that, we then infer the capacity for
|
| 2 | anticompetitive effect. In litigating terms, we are
|
| 3 | dealing with two very standard paradigms of how to go
|
| 4 | about proving something.
|
| 5 | Well, power, of course, is a condition precedent
|
| 6 | of effects, but if you look in the cases, there is a lot
|
| 7 | of confusion -- again, loose language -- about how it is
|
| 8 | used. Some cases say, "Well, what we need is market
|
| 9 | power," and even in cases like NCAA and Indiana
|
| 10 | Federation of Dentists that really were out in the
|
| 11 | forefront in this quick look idea and the use of direct
|
| 12 | evidence of actual effects, there is confusing language
|
| 13 | about what "market power" means.
|
| 14 | Well, power is the condition precedent of
|
| 15 | effects. If you have the effects, the power is there.
|
| 16 | So, part of the point of Indiana Federation, talking
|
| 17 | about market definition and market power as surrogates,
|
| 18 | was to make the point that when you have the actual
|
| 19 | effects evidence, going sort of back around the
|
| 20 | circumstantial evidence route, trying to define a market
|
| 21 | and determine whether there are large market shares, may
|
| 22 | be beside the point. Those things are surrogates for
|
| 23 | direct evidence.
|
| 24 | Well, as in many areas of antitrust, that leads
|
| 25 | us to a point where we can identify easy cases and hard |
46
| 1 | cases. A good example I think of the easy cases, when
|
| 2 | the direct and circumstantial evidence are aligned, when
|
| 3 | they are pointing in the same direction, when you have
|
| 4 | evidence of actual effects and you have high market
|
| 5 | shares, those are easy cases. We do not argue about
|
| 6 | those very much. The D.C. Circuit in Microsoft actually
|
| 7 | structured its discussion of monopoly power that way,
|
| 8 | looking at both direct evidence, circumstantial
|
| 9 | evidence, they are both pointing in the same direction,
|
| 10 | easy case.
|
| 11 | On the other hand, for safe harbor ideas, if you
|
| 12 | have de minimus evidence and no effects and you have low
|
| 13 | market shares, again, pointing in the same direction,
|
| 14 | and I would make this point -- I'll raise it a little
|
| 15 | bit later -- in terms of safe harbors, I do not think
|
| 16 | you can rely just on market shares alone. It has to be
|
| 17 | market shares plus certain other factors, and I will
|
| 18 | also suggest that if we are going to have safe harbors,
|
| 19 | we need some danger zones, and again, it might be market
|
| 20 | share plus some other characteristics.
|
| 21 | But evidence and power effects are interrelated,
|
| 22 | and I think this is what makes part of our current
|
| 23 | framework very difficult to think about. Courts do
|
| 24 | think, because of years and years of case law, first
|
| 25 | monopoly power, then willful acquisition or maintenance, |
47
| 1 | when in truth, the evidence of conduct and effects in
|
| 2 | the evidence of power is going to be very interrelated.
|
| 3 | Well, again, thinking about direct and
|
| 4 | circumstantial evidence, the benchmark for
|
| 5 | circumstantial evidence is clearly the Horizontal Merger
|
| 6 | Guidelines. They really did advance the science of
|
| 7 | thinking in terms of circumstantial evidence. Recall,
|
| 8 | though, that Cellophane was a section 2 case, and maybe
|
| 9 | there are some different problems that come up when we
|
| 10 | are doing prospective predictions about likely market
|
| 11 | power versus retrospective methods when we have, you
|
| 12 | know, the before and after ability to actually look at
|
| 13 | the effect of conducts, but the Merger Guidelines in any
|
| 14 | paradigm we come up with are probably going to have some
|
| 15 | continuing significance. They have been cited by courts
|
| 16 | outside of section 7. They are cited in section 1 cases
|
| 17 | and section 2 cases. Basic ideas and concepts are
|
| 18 | clearly interrelated.
|
| 19 | So, my suggestion at this stage of our
|
| 20 | development is we need something of a similar to the
|
| 21 | Merger Guidelines to refine "actual exercise" standards
|
| 22 | and to harmonize those standards across different
|
| 23 | offenses. A critical question, I think, is how much and
|
| 24 | what kinds of effects evidence should be sufficient to
|
| 25 | shift a burden? And here I remind, again, that outside |
48
| 1 | the area of exercising prosecutorial discretion, outside
|
| 2 | the walls of the agencies when they are deciding whether
|
| 3 | to bring a case, if the decision to bring a case is made
|
| 4 | and the economists agree, the next question the lawyers
|
| 5 | are going to have is, "Well, how do we meet our burden
|
| 6 | of production? What evidence are we going to assemble?
|
| 7 | What is going to make us win this case?"
|
| 8 | I think when you are thinking about direct
|
| 9 | effects evidence, and market share as well, a critical
|
| 10 | question in section 2 is, what does it take to shift a
|
| 11 | burden? Frequently what you see defendants arguing in
|
| 12 | cases is the burden didn't shift, the burden didn't
|
| 13 | shift, the burden didn't shift. Well, what does that
|
| 14 | mean?
|
| 15 | It means that there is no requirement on the
|
| 16 | part of the defendants to actually justify their
|
| 17 | conduct. If they claim there are efficiencies, where is
|
| 18 | the evidence of efficiencies? That does not happen
|
| 19 | until the burden shift takes place. That is a critical
|
| 20 | stage. It is a critical stage that has to be focused
|
| 21 | on, and I have given some examples here of various cases
|
| 22 | that raise some of those questions.
|
| 23 | I think we are also feeling the weight of the
|
| 24 | Alcoa paradigm. In looking back at Alcoa and the cases
|
| 25 | that preceded it, all Judge Hand did was he surveyed the |
49
| 1 | previous cases and looked at winners and losers to come
|
| 2 | up with his three famous sort of -- you know, 33, not
|
| 3 | enough; 66, maybe; over 90, definitely. Well, where did
|
| 4 | he get that from?
|
| 5 | If you look at the prior Supreme Court cases,
|
| 6 | you will see that there were cases falling into each of
|
| 7 | those categories. He sort of synthesized them and came
|
| 8 | up with this benchmark. I think an important question
|
| 9 | for us is, are we ready to move beyond the total
|
| 10 | reliance on market shares, which sends us off in this
|
| 11 | direction of conflicting evidence, plaintiffs and
|
| 12 | defendants having experts -- the market is big, the
|
| 13 | market is small -- and is that really where we want to
|
| 14 | be? What can the role of direct evidence be?
|
| 15 | The Re/Max case was an example of a court
|
| 16 | relying on direct evidence, actual price effects
|
| 17 | evidence in a section 2 case. The 7th Circuit in
|
| 18 | Republic Tobacco rejected such an approach, said that
|
| 19 | Indiana Federation did not apply and NCAA did not apply
|
| 20 | to a vertical case. Is Staples -- and the unilateral
|
| 21 | effects that people have alluded to already -- is it
|
| 22 | related? I think it is. It is a way of trying to more
|
| 23 | directly gauge. We have talked about the monopoly
|
| 24 | versus market power being kind of a silly distinction.
|
| 25 | So, I will move on. |
50
| 1 | I think there is an important role here for
|
| 2 | decision theory, which obviously has begun to influence
|
| 3 | our thinking. The emphasis tends to be on fear of error
|
| 4 | costs, and often that motivates calls for more and
|
| 5 | better evidence. We need more before that burden
|
| 6 | shifts. One point I would like to walk away with today
|
| 7 | is urging that we also consider the second half of
|
| 8 | decision theory, which is process and information costs.
|
| 9 | Is more evidence really always better?
|
| 10 | In that regard, I sort of suggest -- and it is
|
| 11 | not really new, there is a lot of general literature out
|
| 12 | there on the economics of evidence. Richard Posner has
|
| 13 | a long article on an economic analysis of evidence, and
|
| 14 | I put forward the question, "When does the marginal
|
| 15 | value of additional evidence in terms of economic
|
| 16 | certainty (minimizing error costs) outweigh the costs of
|
| 17 | obtaining and processing that evidence, taking into
|
| 18 | account whether it is reasonably accessible to the party
|
| 19 | bearing the risk of non-persuasion?" What I tried to do
|
| 20 | in that question is integrate some economic ideas and
|
| 21 | some legal process ideas from both the rules of
|
| 22 | procedure and the rules of evidence. It is always easy
|
| 23 | to demand more. It is always easy to pursue some kind
|
| 24 | of level of absolute certainty and minimal error costs.
|
| 25 | The question is, as a legal standard, when we take that |
51
| 1 | into court, is that really going to strike the right
|
| 2 | balance for us in resolving cases?
|
| 3 | Antitrust is not always rocket science, and I
|
| 4 | think we need to get over the idea that it always is.
|
| 5 | Yes, we need safe harbors to guard against false
|
| 6 | positives. I think we also should be emphasizing
|
| 7 | equally defining danger zones where we might be running
|
| 8 | into false negatives.
|
| 9 | Is monopoly power all that puzzling? I would
|
| 10 | point out to everyone that neither 3M nor U.S. Tobacco,
|
| 11 | in two U.S. Courts of Appeals monopolization cases, even
|
| 12 | contested that they had monopoly power. In the
|
| 13 | Microsoft case, they contested it, but rather
|
| 14 | unpersuasively, and every agency and every court to look
|
| 15 | at it has concluded that yes, indeed, Microsoft had
|
| 16 | monopoly power.
|
| 17 | We could go on with a couple other examples,
|
| 18 | American Airlines, Dentsply. Were these really such
|
| 19 | difficult cases? If they were not, then why were they
|
| 20 | so difficult? Why would parties not even litigate the
|
| 21 | point about their power? There must be, there must be
|
| 22 | cases where -- again, market share plus -- where there
|
| 23 | must be additional factors, information on entry
|
| 24 | barriers. Entry barriers will always, for example, be
|
| 25 | important. |
52
| 1 | Finally on this slide, sliding scales, not all
|
| 2 | burden shifts are created equally. You see this in
|
| 3 | cases like Baker Hughes and Heinz in the merger area,
|
| 4 | the realization that sometimes when a burden shifts, it
|
| 5 | really shifts, and the presumption is very strong, and
|
| 6 | other times, it kind of is just enough to shift. Well,
|
| 7 | in responding to those sorts of cases, we might want to
|
| 8 | respond in different ways by considering what is
|
| 9 | required to shift and what is required to shift back a
|
| 10 | burden in different ways.
|
| 11 | On legal standards and decision-making, I think
|
| 12 | that the balancing of effects idea is a straw man. We
|
| 13 | could cite, as Larry White did, we could put up lots of
|
| 14 | slides with courts saying, "Anticompetitive effects; the
|
| 15 | burden shifts. Efficiencies; then we balance one
|
| 16 | against the other." We do not really do that. I have
|
| 17 | looked; you can all look. If you can find me a Section
|
| 18 | 1 litigated case in which the case was actually decided
|
| 19 | on balancing effects versus efficiency effects, consumer
|
| 20 | surplus diminution versus increased producer surplus,
|
| 21 | find me such a case. I would like to see it. It is not
|
| 22 | what we do.
|
| 23 | What we do is weigh evidence. What juries do is
|
| 24 | they compare the evidence of anticompetitive effects
|
| 25 | with the evidence of efficiencies, and they make a |
53
| 1 | decision about where the weight of the evidence is.
|
| 2 | That has to do with credibility; it has to do with
|
| 3 | persuasiveness. It does not have to do with $10 of
|
| 4 | anticompetitive effect and $11 of efficiency.
|
| 5 | Finally, a word about caricatures and corrosion
|
| 6 | of the rule of law. The level of discourse and the
|
| 7 | level of criticism of antitrust, as we all know, has
|
| 8 | continued for quite some time. It has continued despite
|
| 9 | the fact that in the last 40 years, we have seen some
|
| 10 | pretty major corrections to antitrust.
|
| 11 | I say caricature -- and this is not my
|
| 12 | caricature -- but this is what you see in a lot of the
|
| 13 | criticisms of antitrust, and I think it is a caricature
|
| 14 | that ignores this last period of adjustment over the
|
| 15 | last 30 years. Incompetence -- judges, just
|
| 16 | incompetent. They can do habeus corpus, they can do
|
| 17 | environmental, they can do securities law, but antitrust
|
| 18 | is rocket science, keep them away.
|
| 19 | The same thing with juries. They just do not
|
| 20 | know the difference between somebody who is full of it
|
| 21 | and somebody who really knows what they are doing. They
|
| 22 | cannot tell the difference between economists in this
|
| 23 | case and, of course, neither can they decide any other
|
| 24 | possible case.
|
| 25 | And, of course, enforcers. I have the asterisk |
54
| 1 | there just to remind me to say that. Typically it is
|
| 2 | enforcers themselves who make this argument, God, we are
|
| 3 | so stupid. You shouldn't really trust us to make any
|
| 4 | decisions, and although we may -- and it gets very
|
| 5 | personal -- we may be able to make the decision, but
|
| 6 | other enforcers are really stupid, especially those guys
|
| 7 | at the offices of the states.
|
| 8 | Who are the untrustworthy self-interesteds, the
|
| 9 | self-interesteds who are untrustworthy? Rivals, oh,
|
| 10 | they are always full of it. They are always complaining
|
| 11 | about more competition. Dealers, yeah, what's that
|
| 12 | freedom of dealer stuff? You know, manufacturers,
|
| 13 | consumers, aligned; dealers, out in left field. And
|
| 14 | plaintiffs pretty much all are full of it, especially
|
| 15 | class action reps.
|
| 16 | Ah, but who can we trust? Dominant firms.
|
| 17 | Dominant firms articulating efficiencies. Fear of error
|
| 18 | cost? That's truth. We need to put a lot of weight in
|
| 19 | that. We need to be concerned about it. Other
|
| 20 | defendants, generally yeah, and especially efficiencies.
|
| 21 | Two problems I have with this sort of
|
| 22 | caricaturing of antitrust. One is, I don't think it is
|
| 23 | true. I would like to see the list of false positives
|
| 24 | in the last 25 years. We have been moving towards
|
| 25 | reduced error costs, and here I think it would be |
55
| 1 | helpful to have the economists really define what they
|
| 2 | mean as "false positive." It is not a case on which
|
| 3 | reasonable people can differ. It is a case that sort
|
| 4 | of -- again, borrowing from procedure -- no reasonable
|
| 5 | party could have come out that way. To me, that would
|
| 6 | be a false positive or a false negative. It is not a
|
| 7 | case that we simply disagree about.
|
| 8 | LePage's has, you know, been frequently used as
|
| 9 | sort of this example of a false positive. Be reminded
|
| 10 | that 3M did not contest its market power, and if it did
|
| 11 | offer any evidence of efficiencies, nobody who looked at
|
| 12 | it found it very convincing. Did the Court of Appeals
|
| 13 | give us a useful standard for bundled pricing? No, but
|
| 14 | neither has anybody else yet. So, to call that a false
|
| 15 | positive and say, "This is an example of how we're going
|
| 16 | to inhibit all kinds of other cases," I am not sure that
|
| 17 | that is justified.
|
| 18 | The final point and I will sit down. As I said
|
| 19 | at the start, Larry said at the end, you say what you
|
| 20 | said at the beginning. At the end of the day, these
|
| 21 | cases have to go to court sometimes, and this kind of
|
| 22 | rhetoric of criticism ultimately is corrosive of the
|
| 23 | rule of law. I think it is heard in curious ways
|
| 24 | outside the United States. These criticisms really go
|
| 25 | to the heart of whether we are willing, at the end of |
56
| 1 | the day, to rely on courts to make decisions.
|
| 2 | We have numerous procedural devices, summary
|
| 3 | judgment, judgment as a matter of law, Daubert
|
| 4 | standards, appeal rights. If after all of that has
|
| 5 | occurred a plaintiff actually wins a case, which does
|
| 6 | not happen very often, I think we ought to be a little
|
| 7 | bit more cautious about tossing the rhetoric around
|
| 8 | about the incompetence and the untrustworthy
|
| 9 | self-interesteds, all right?
|
| 10 | Thanks very much.
|
| 11 | (Applause.)
|
| 12 | DR. CARLTON: Thank you very much, Andy. I was
|
| 13 | pleased to hear I am not as incompetent as once
|
| 14 | enforcers were thought to be, and to prove that I am
|
| 15 | still competent, we are going to have a break, and it
|
| 16 | will be a 10-minute break, and we will reconvene
|
| 17 | promptly so that we can try and stay roughly on
|
| 18 | schedule. Thank you.
|
| 19 | (A brief recess was taken.)
|
| 20 | DR. CARLTON: Why don't we try and start. Our
|
| 21 | next speaker is Rich Gilbert.
|
| 22 | DR. GILBERT: I would like to thank the
|
| 23 | organizers for the opportunity to be here. I was
|
| 24 | invited to talk about technology markets, so if any ink
|
| 25 | gets spilled on this issue as a result of my comments, |
57
| 1 | you can be sure it will be Independent Ink, though I
|
| 2 | will not talk about the presumption of market power for
|
| 3 | patents. I thought we resolved that issue in the IP
|
| 4 | Guidelines, although it is not the case that the Supreme
|
| 5 | Court immediately adopts everything that the agencies
|
| 6 | come up with.
|
| 7 | Now, when we talk about market definition, there
|
| 8 | is a real sense in which we are talking about either
|
| 9 | guide posts or lamp posts. Now, lamp posts, as you
|
| 10 | know, shed light on a subject but do not necessarily
|
| 11 | shed truth about the subject. A lamp post might
|
| 12 | illuminate the ground, but that does not mean that the
|
| 13 | dollar that we are looking for is around the lamp post,
|
| 14 | even though if it were, perhaps we could see it.
|
| 15 | Guide posts, on the other hand, serve to focus
|
| 16 | the analysis. The guide posts lead the way. The way
|
| 17 | may be very foggy and very complicated and very
|
| 18 | difficult, but can be very useful.
|
| 19 | Now, my take, sort of in the spirit of Andy's
|
| 20 | comments, the courts and defendants like the market
|
| 21 | definition exercise, even though it is often used much
|
| 22 | more as a lamp post than a guide post. They like the
|
| 23 | exercise because, of course, for a defendant, if you can
|
| 24 | show the market is very broad, chances are there is no
|
| 25 | antitrust case there. For a court, they are all very |
58
| 1 | busy. They have full dockets. If you can show the
|
| 2 | market is very broad, they do not have to worry about
|
| 3 | it.
|
| 4 | Plaintiffs also seem to like market definition
|
| 5 | or many of them like market definition, because if you
|
| 6 | can prove that or demonstrate or make a convincing case
|
| 7 | that the market is narrow, well, chances are then there
|
| 8 | will be an issue, but as I think everybody on this panel
|
| 9 | is implying, none of those conditions, whether it is
|
| 10 | broad or narrow, presumptive of a case or not
|
| 11 | presumptive of a case, none of them are really relevant
|
| 12 | directly to the analysis. We would rather have market
|
| 13 | definition serve as the guide post to lead the way to
|
| 14 | the right analysis rather than defining whether there is
|
| 15 | or is not a case.
|
| 16 | Now, so, if we talk about markets for
|
| 17 | technology -- first I should distinguish, I am going to
|
| 18 | focus more on technology markets than on markets for
|
| 19 | technology. Markets for technology can be analyzed
|
| 20 | using conventional goods markets, often using
|
| 21 | conventional goods markets, which are sufficient for
|
| 22 | analysis in many high technology industries, whereas
|
| 23 | technology markets are useful when what is at issue is a
|
| 24 | right or rights to a technology that are licensed rather
|
| 25 | than embodied in a patent. So, I am focusing more on |
59
| 1 | technology markets than markets for technology, although
|
| 2 | maybe in discussion, we will get to that distinction,
|
| 3 | whether there should be a distinction.
|
| 4 | Technology markets are defined in the IP
|
| 5 | Guidelines. Technology markets consist of the
|
| 6 | intellectual property that is licensed that are close
|
| 7 | substitutes. Of course, here now, as in all market
|
| 8 | definition exercises, the issue is, what are the close
|
| 9 | substitutes? And when you are talking about technology
|
| 10 | markets, the close substitutes are not only other
|
| 11 | intellectual property rights, but also goods and
|
| 12 | services that may substitute for those intellectual
|
| 13 | property rights.
|
| 14 | It adds another layer of difficulty and
|
| 15 | complexity to the analysis, because just like in
|
| 16 | conventional -- other section 2 goods market definition,
|
| 17 | exactly what to sweep into that analysis and how, it
|
| 18 | depends upon the prices, prevailing prices, and whether
|
| 19 | the conduct is prospective or retrospective, these are
|
| 20 | all challenging issues, which I am not going to entirely
|
| 21 | resolve.
|
| 22 | Now, technology markets also are -- there is an
|
| 23 | upstream analysis for inputs which I think raises some
|
| 24 | interesting questions by itself. Technology markets
|
| 25 | have been used I think with some success to analyze the |
60
| 1 | licensing of technology to manufacture float glass, for
|
| 2 | blending clean gasoline in the UNOCAL case, the float
|
| 3 | glass with the Pilkington case, for designing fast
|
| 4 | computer memory chips, as in the DRAM cases, perform
|
| 5 | laser eye surgery, or to incorporate genetically
|
| 6 | modified traits into agricultural seeds. These are all
|
| 7 | some examples, I think, of markets that have been
|
| 8 | analyzed using basically an upstream analysis for
|
| 9 | licensed inputs.
|
| 10 | Now, on the geographic market side, this is an
|
| 11 | area where using technology markets in some cases
|
| 12 | simplifies things. It is fair, I believe, to presume in
|
| 13 | many cases -- not all, of course -- the geographic scope
|
| 14 | for technology markets is very wide, because it is not
|
| 15 | very difficult for a potential licensee to negotiate
|
| 16 | with even quite distant licensors unless there are legal
|
| 17 | or regulatory or some other restrictions that prevent
|
| 18 | the use of licensed technology in different locations,
|
| 19 | as there was, for example, with the UNOCAL case, but in
|
| 20 | these other cases, the enforcement agencies I think have
|
| 21 | correctly concluded that the technology markets are very
|
| 22 | broad, U.S.-wide and sometimes worldwide.
|
| 23 | Now, technology fees, should these be indicators
|
| 24 | of market power? Interesting question which has not
|
| 25 | been quite directly addressed. Marginal cost of |
61
| 1 | licensing is typically very low. It suggests that there
|
| 2 | is market power if we define market power as the ability
|
| 3 | to sustain prices above marginal cost, then looking at
|
| 4 | technology fees, gives you an immediate read on whether
|
| 5 | or not there is market power, not necessarily monopoly
|
| 6 | power, but, as economists have said, that is a difficult
|
| 7 | line to draw between market power and monopoly power.
|
| 8 | Now, again, the relevant question is the ability
|
| 9 | to increase or maintain technology fees significantly
|
| 10 | above marginal cost for an extended time. In this
|
| 11 | dispute about market power versus monopoly power, I am
|
| 12 | certainly in the camp that says that monopoly power is a
|
| 13 | lot of market power and that there is no clear dividing
|
| 14 | line between the two, and the question is, the relevant
|
| 15 | question is, is there conduct that leads to either
|
| 16 | increasing or maintaining technology fees significantly
|
| 17 | above marginal cost for an extended period of time and
|
| 18 | whether it is prospective or retrospective?
|
| 19 | If it is prospective, perhaps the ability is to
|
| 20 | increase technology fees. If it is retrospective, then
|
| 21 | the question is more has conduct contributed to the
|
| 22 | ability to maintain technology fees significantly above
|
| 23 | marginal cost?
|
| 24 | This is now more in the spirit of what Larry
|
| 25 | White was saying in his approach to section 2 market |
62
| 1 | definition. Also for technology fees, a related and
|
| 2 | relevant question in a section 2 context is whether
|
| 3 | competition, whether injecting more competition, would
|
| 4 | result in a significantly lower technology fee if the
|
| 5 | competition were not excluded.
|
| 6 | I also agree that this opens up a lot of
|
| 7 | interesting and unresolved issues, as in how much
|
| 8 | competition should be enough to consider? What should
|
| 9 | the price effect of that competition be in order to
|
| 10 | define a relevant market? Is an elasticity of demand
|
| 11 | faced at the existing prices for the fees and other
|
| 12 | goods and services? Is an elasticity of demand minus
|
| 13 | two, is that low enough, small enough in magnitude, or
|
| 14 | does it have to be minus 1.1 or 1.5 or is minus 3
|
| 15 | enough?
|
| 16 | These are very important and serious questions
|
| 17 | that need to be addressed if we are going to do this
|
| 18 | kind of hypothetical decrease in price through a
|
| 19 | hypothetical increase in output as a way to identify a
|
| 20 | relevant market.
|
| 21 | So, the focus on that additional competition and
|
| 22 | whether it lowers the fee I do believe can get around
|
| 23 | the Cellophane fallacy, and I think another important
|
| 24 | aspect of that approach is that it focuses the analysis,
|
| 25 | the definition of the market, on the analysis of the |
63
| 1 | competitive effects of the conduct. So, I think
|
| 2 | sometimes it is a criticism of the hypothetical decrease
|
| 3 | in price approach that it is too related to the conduct
|
| 4 | that is being alleged as anticompetitive.
|
| 5 | I turn it around and say that no, I think it is
|
| 6 | an advantage of this approach, because it connects the
|
| 7 | conduct at issue to the analysis of the impacts at
|
| 8 | issue. Too often, I think many of us would agree that
|
| 9 | the market definition exercise puts the cart in front of
|
| 10 | the horse. We should be thinking about where are the
|
| 11 | competitive effects, how significant can the competitive
|
| 12 | effects be, and then let the market definition respond
|
| 13 | to that rather than defining where the competitive
|
| 14 | effects are. Again, this stems from the problem of the
|
| 15 | Cellophane fallacy that a profit-maximizing firm has no
|
| 16 | incentive to raise or lower its technology fee.
|
| 17 | Another question about analysis of inputs, in
|
| 18 | principle, the antitrust analysis for a technology input
|
| 19 | is not qualitatively different from the analysis of any
|
| 20 | other upstream good or service. The demand for the
|
| 21 | input is derived from the demand for the final good or
|
| 22 | service, and one thing to point out is the
|
| 23 | Hicks-Marshall Law of derived demand, which says that
|
| 24 | the elasticity of Derived Demand is proportional to the
|
| 25 | cost share of the input. It is roughly the cost share |
64
| 1 | of the input times the elasticity of demand for the
|
| 2 | output. That will generally lead to a conclusion that
|
| 3 | the elasticity of demand is pretty small in magnitude.
|
| 4 | Indeed, in the Microsoft case, Microsoft made
|
| 5 | the argument that if you do this calculation, the
|
| 6 | profit-maximizing price for Windows was I think, like,
|
| 7 | $1,500 or something like that, and therefore, we could
|
| 8 | not have market power because we are not charging
|
| 9 | $1,500. I think it was an argument that was never
|
| 10 | really entirely responded to, but one does find that as
|
| 11 | you go upstream, you are going to generally get less
|
| 12 | elastic demands, derived demands; therefore, more
|
| 13 | potential to raise prices; therefore, more possibility
|
| 14 | of competitive effects.
|
| 15 | Of course, while it implies relatively inelastic
|
| 16 | demand for inputs and the ability to affect the input
|
| 17 | price, the input price has only an indirect effect on
|
| 18 | the final consumer prices, which is why the elasticity
|
| 19 | of demand is low. So, it turns around and gets you the
|
| 20 | other way. So, upstream analysis can overstate the
|
| 21 | ability to affect consumer prices.
|
| 22 | As you move downstream, though, the question is,
|
| 23 | how far downstream do you go? If you go far enough
|
| 24 | downstream, almost everything competes with everything
|
| 25 | else. If you move all the way downstream, eventually |
65
| 1 | you are competing for the consumer's entire budget
|
| 2 | allocation, and whether you are talking about movies or
|
| 3 | sports or buying a car or whatever, everything competes,
|
| 4 | and the overall elasticity of demand for all goods and
|
| 5 | services is one, because you only have so much income.
|
| 6 | So, it is my view -- my strong view, but it is a
|
| 7 | view -- that analysis should take place where the firm
|
| 8 | has the ability and incentive to raise or maintain a
|
| 9 | price paid for an input or a final good, and the
|
| 10 | question should be, is the conduct the type of conduct
|
| 11 | that we want to prevent? And if it is, let's analyze it
|
| 12 | where the conduct might have an effect and let the
|
| 13 | market definition follow from where the conduct could
|
| 14 | have an impact.
|
| 15 | I just have a very quick example to end with of
|
| 16 | genetically modified seeds, which express a desired
|
| 17 | characteristic, like insect resistance in corn or
|
| 18 | tolerance of some herbicide. Do conventional seeds
|
| 19 | compete with licenses for seed traits? So, that gets
|
| 20 | back to the IP Guidelines definition, where do the goods
|
| 21 | come in to compete with the traits? It is a complicated
|
| 22 | question, not one I am here to answer, but I would just
|
| 23 | point out that these agricultural markets are moving
|
| 24 | increasingly to genetically modified traits, which is
|
| 25 | now way above 80 percent in soybeans and up above 50 |
66
| 1 | percent in corn, and if you are looking at questions
|
| 2 | about whether conduct is maintaining high prices for
|
| 3 | these characteristics and ultimately higher corn prices,
|
| 4 | it is my view that you should look at the trait markets
|
| 5 | for where this conduct is expressed, because that is
|
| 6 | where the effect could be.
|
| 7 | It may be that the conduct is not the type of
|
| 8 | conduct that should be subject to an antitrust sanction,
|
| 9 | but that is the right place to look. It goes back to
|
| 10 | the lamp post and the guide post. Let's look where
|
| 11 | there could be effects. Let's let the market definition
|
| 12 | exercise follow from the inquiry into competitive
|
| 13 | effects. Let's not use market definition as a lamp post
|
| 14 | to illuminate a problem that may or may not exist.
|
| 15 | Thank you.
|
| 16 | (Applause.)
|
| 17 | DR. CARLTON: Okay, thanks, Rich.
|
| 18 | Our last speaker is Michael Katz.
|
| 19 | DR. KATZ: I would like to thank the organizers
|
| 20 | for inviting me here, but I do not have time.
|
| 21 | I want to talk about -- it is a bit of a grab
|
| 22 | bag, but I will start about something systematic, which
|
| 23 | addresses the question of why delineate relevant markets
|
| 24 | in a section 2 case, and what I want to start with is
|
| 25 | really the first principle, what is the point of all |
67
| 1 | this, and we really try to answer this question of a
|
| 2 | given practice harms competition and consumers, and what
|
| 3 | I want to talk about for a few minutes is how that gets
|
| 4 | us to talking about relevant markets, and I am going to
|
| 5 | talk about at least three things that relevant markets
|
| 6 | might be doing to help us answer that question.
|
| 7 | Okay, so the first one is you can think of --
|
| 8 | what you are trying to do is you are defining relevant
|
| 9 | markets so you can calculate market shares and
|
| 10 | concentrations, and we are doing that because we want to
|
| 11 | know whether the defendant or the firm under
|
| 12 | investigation, whether the defendant currently has
|
| 13 | monopoly power. Now, as everyone has been talking
|
| 14 | about, this is where the hypothetical monopolist test
|
| 15 | breaks down, so there is an issue there.
|
| 16 | It seems to me where we have gotten, actually,
|
| 17 | in a bunch of the recent cases -- and maybe this also
|
| 18 | goes to Andy Gavil's point about somebody showing me a
|
| 19 | false positive -- but I think if you look at Dentsply
|
| 20 | and Microsoft, there was plenty of expert testimony, but
|
| 21 | in the end it just came down to hard core pornography,
|
| 22 | the thing is you know it when you see it. People have a
|
| 23 | good idea that false teeth are a product and they are
|
| 24 | not really worried about a lot of other substitutes. I
|
| 25 | mean, there is sewing your lips shut and things like |
68
| 1 | that, but I think in both of those, that was not really
|
| 2 | the issue.
|
| 3 | Now, I want to make a couple of other points
|
| 4 | about concentration as an indicator of market power
|
| 5 | here. One, if we are going to look at market shares, I
|
| 6 | think we really ought to ask ourselves, where did the
|
| 7 | market shares come from? Because it matters. Think
|
| 8 | about it. In some cases it is because of product
|
| 9 | differentiation, and some producers have much more
|
| 10 | successful products that match up with consumer tastes.
|
| 11 | There can be very different managements of different
|
| 12 | producers have different strategies, and one of the
|
| 13 | firms decided to have a high-volume, low-price strategy.
|
| 14 | I think the conclusions one would typically want
|
| 15 | to draw about the implications of them for competition
|
| 16 | are very different, and so I think it is important to
|
| 17 | try to have such a theory, and I think it is often
|
| 18 | lacking in antitrust cases. People just talk about the
|
| 19 | shares but not what they really mean or where they came
|
| 20 | from.
|
| 21 | The other thing is we want to ask ourselves why
|
| 22 | we care whether the defendant currently has monopoly
|
| 23 | power, and I will say at least I think one reason is you
|
| 24 | can think of it as a one-sided test in a monopoly
|
| 25 | maintenance case, which is to say, if you are in there |
69
| 1 | arguing that some particular practice successfully
|
| 2 | maintained a monopoly and you come up with a credible
|
| 3 | analysis that says the firm had a very low share, that
|
| 4 | is likely to undermine the case. Now, it certainly does
|
| 5 | not work in the other direction, right? Just because
|
| 6 | you have a high market share does not mean you are
|
| 7 | guilty of any sort of offense at all and it may be that
|
| 8 | you got it because you deserve it. Okay, so that is a
|
| 9 | particular use.
|
| 10 | Now, I want to distinguish that from some
|
| 11 | others, because I think they often get rolled together,
|
| 12 | and they really are different, although they are
|
| 13 | related. Okay, so another one that is related is
|
| 14 | concentration as a screen for potential harm to
|
| 15 | competition. Now, in a sense what I just said, it is a
|
| 16 | screen, the one I just said, which is you are saying,
|
| 17 | look, if they have a tiny market share, is it really
|
| 18 | plausible that they have harmed competition
|
| 19 | significantly in the past, but I also want to worry
|
| 20 | about it going forward, and there it is not at all
|
| 21 | clear -- in fact, I think it is not a general
|
| 22 | proposition -- that you want to look at concentrations
|
| 23 | to understand the potential for harm to competition,
|
| 24 | because if you are looking at a case on a going-forward
|
| 25 | basis, sometimes the current share of the defendant is |
70
| 1 | relevant, but other times, it is not, right? You are
|
| 2 | not worried about their share now. You are worried
|
| 3 | about what their share is going to become or what the
|
| 4 | state of competition will become going forward.
|
| 5 | Okay, so, notice I hedged it. I am an
|
| 6 | economist, so lots of "on the one hands, but on the
|
| 7 | other hands." So, in some cases where you are looking
|
| 8 | on a going-forward basis, current shares may be largely
|
| 9 | irrelevant. In other cases -- and I have the example
|
| 10 | here of exclusive dealing -- even when you are looking
|
| 11 | on a going-forward basis, market shares could be
|
| 12 | relevant, and I would think that would have been true in
|
| 13 | Dentsply.
|
| 14 | Now, as it turns out, in Dentsply, it was
|
| 15 | looking backwards, but if one had brought the case much
|
| 16 | earlier, I think what one could have done is say, look,
|
| 17 | Dentsply has this large market share, and I think by any
|
| 18 | sensible measure they had a huge market share, and we
|
| 19 | could argue about the source, but let me just
|
| 20 | hypothesize here without anyone arguing that it is
|
| 21 | because they did have teeth that were more popular and
|
| 22 | more attractive, that there was something about their
|
| 23 | product that they did have an advantage, and others were
|
| 24 | not able to imitate, and then you could use that fact to
|
| 25 | say, okay, that is going to tell us something about how |
71
| 1 | exclusive dealing is going to work going forward, and
|
| 2 | even exclusive dealing with at will contracts, which is
|
| 3 | what was present in Dentsply, because this one firm's
|
| 4 | products were such a better fit with consumer tastes,
|
| 5 | that if you have exclusive dealing, that is where the
|
| 6 | dealers are going to go.
|
| 7 | So, in that case, concentration would be
|
| 8 | relevant as a screen or a way to think about what is
|
| 9 | going to happen but through a much more complex chain of
|
| 10 | reasoning than to just say, well, they have a high
|
| 11 | market share; therefore, they must have market power.
|
| 12 | It is really a very different kind of analysis, and that
|
| 13 | is the kind of analysis that I think needs to be done.
|
| 14 | Okay, the third one -- and actually, this is the
|
| 15 | one that is my favorite -- is say, look, we need to
|
| 16 | identify relevant markets, because if we are talking
|
| 17 | about harm to competition, we need to have some sense of
|
| 18 | who the competitors are, and actually, I think that is
|
| 19 | what the role should be in the merger analysis I will
|
| 20 | say as well, this really should be about identifying the
|
| 21 | competitors and then seeing where that takes us in terms
|
| 22 | of the but-for world, what needs to be the scope of the
|
| 23 | but-for world, and this is an unfashionable view,
|
| 24 | because it is low tech and it does not drive you to come
|
| 25 | up with algorithms, but I think it is important to |
72
| 1 | remember in the end, this really is what we are trying
|
| 2 | to do.
|
| 3 | We are trying to figure out who are the
|
| 4 | competitors, because then we can ask, does this practice
|
| 5 | harm them? And if it does, does that matter for
|
| 6 | competition and does it matter for consumer welfare?
|
| 7 | Okay, so again, I think this takes us in a somewhat
|
| 8 | different direction, and notice, in this one, you may
|
| 9 | not be worrying about concentration very much directly
|
| 10 | at all.
|
| 11 | Also, since I had promised -- but so far have
|
| 12 | not done it -- the organizers that I would talk about
|
| 13 | innovation, let me say a little bit about that. When
|
| 14 | innovation competition is really significant, and this
|
| 15 | is not a point that is new to me by any stretch of the
|
| 16 | imagination, current market shares may not tell us very
|
| 17 | much, right, the extreme model being Schumpeterian
|
| 18 | competition, where we see a string of product market
|
| 19 | monopolies, but the real way competition works in the
|
| 20 | industry would be that you have firms that come in with
|
| 21 | major innovations, become the new monopolist, but then
|
| 22 | there is this battle for the next round of drastic
|
| 23 | innovation. If you are looking at a market like that,
|
| 24 | looking at market shares is not going to tell you very
|
| 25 | much. |
73
| 1 | Okay, a couple things about market definition
|
| 2 | and uncertainty. First off, we have talked about burden
|
| 3 | shifting a little bit. As everyone in this room who
|
| 4 | works for the Government knows, right, meeting the
|
| 5 | market definition burden can be difficult, and that is
|
| 6 | true even if you do not have innovation, and I will come
|
| 7 | back to innovation in a minute. One of the difficulties
|
| 8 | is when courts say we want a zero-one boundary. Every
|
| 9 | firm is either in the market or they are out of the
|
| 10 | market; none of this wishy-washy stuff.
|
| 11 | The problem with that is it can be really hard
|
| 12 | to do. I know Oracle is a merger case, but it is really
|
| 13 | striking because it is a case where Judge Walker said,
|
| 14 | all right, look, here are the economics of why you
|
| 15 | cannot draw zero-one boundaries. You have got product
|
| 16 | differentiation. You have got a continuum of products.
|
| 17 | There is no way there is going to be a sensible
|
| 18 | boundary. He did not say, "And oh, guess what, that
|
| 19 | means you lose."
|
| 20 | I mean, I think Judge Walker was right about the
|
| 21 | first part. It is just the notion that that is where it
|
| 22 | takes you I think is a little troublesome. It is
|
| 23 | particularly troublesome as well because if you believe
|
| 24 | that these are differentiated product markets and you
|
| 25 | believe competition is localized, then you really have |
74
| 1 | to ask yourself, why are we worrying about a broader
|
| 2 | market anyway? I mean, what is the relevance of this
|
| 3 | alleged relevant market if what really matters is
|
| 4 | defined structure?
|
| 5 | So, it seems to me that where we have gone with
|
| 6 | a lot of -- just to jump back to mergers for a second
|
| 7 | where I think there is a broader lesson here -- with
|
| 8 | mergers, is worrying about unilateral effects cases in
|
| 9 | markets with differentiation -- and everyone seems to
|
| 10 | have conveniently forgotten that you can have a
|
| 11 | unilateral effects case with homogenous products -- but
|
| 12 | we have spent all this time worrying about market
|
| 13 | definitions in precisely the wrong places.
|
| 14 | Now, although this gets worse if you have
|
| 15 | innovation, because you can have things constantly
|
| 16 | changing, you can have products -- the characteristics
|
| 17 | of products are changing, I just want to make two points
|
| 18 | on this and then move on quickly. One, there are a lot
|
| 19 | of people who seem to be of the belief that what
|
| 20 | innovation means is markets are constantly getting
|
| 21 | broader, okay, and there is a set of people who will
|
| 22 | say, look, you have got all these things, you have got
|
| 23 | innovation, markets are always going to be so broad
|
| 24 | because new products can keep coming in, that really,
|
| 25 | there is nothing for antitrust to do. I would just like |
75
| 1 | to remind people that, in fact, markets could be getting
|
| 2 | narrower, because these products are evolving, they are
|
| 3 | moving targets, and it is quite possible that some
|
| 4 | products or the producers of those products are falling
|
| 5 | behind in terms of innovation and they are dropping out
|
| 6 | of the relevant market.
|
| 7 | Okay, the point I have already made, that if you
|
| 8 | are looking at differentiated products and then you
|
| 9 | throw in the complexities of innovation, you just really
|
| 10 | may make it impossible to meet the burden. As we have
|
| 11 | talked about, since I think there is a fairly broad
|
| 12 | consensus, you do not really need to have a rigid market
|
| 13 | definition. That is unfortunate, but that is how a case
|
| 14 | would be decided.
|
| 15 | Now, I have to have a diagram. So, what this
|
| 16 | one shows, just very quickly, suppose there is
|
| 17 | disagreement on the scope of the relevant market here,
|
| 18 | and I am interested in a case where I will just suppose
|
| 19 | that one has beaten up on two, okay, these are suppliers
|
| 20 | markets, and this line represents some notion of product
|
| 21 | differentiation, and there is a debate. It is hard to
|
| 22 | know whether the market boundaries are -- the ones who
|
| 23 | have the narrow subscripts, so only include one and two,
|
| 24 | or they have the broad, and then they would include
|
| 25 | producer three as well. Suppose we get the debate down |
76
| 1 | to that level. This is a dramatic oversimplification.
|
| 2 | Well, you can imagine a court, Judge Walker
|
| 3 | saying, "Look, Government, you cannot tell me whether it
|
| 4 | is the narrow definition or the broad one with
|
| 5 | certainty, so you lose." But suppose it does not make
|
| 6 | any difference whether you include three in the market,
|
| 7 | okay, to what you think are the competitive effects,
|
| 8 | then why does it matter that you cannot say which one is
|
| 9 | which, okay? So, what you really want to ask is not
|
| 10 | whether or not the plaintiffs can prove a market
|
| 11 | definition with certainty, but you want to ask can they
|
| 12 | tell you, "Look, we know well enough where it matters
|
| 13 | with a high degree of certainty."
|
| 14 | So, the approach to this would be to then ask,
|
| 15 | "Where does the dividing line matter," okay? Go back to
|
| 16 | this, "Does it matter whether we include five in or
|
| 17 | not?" If it turns out what is critical in the end is
|
| 18 | whether three is in the market, let's fight about that.
|
| 19 | Let's not fight about, no, you have to come up with the
|
| 20 | definition.
|
| 21 | Okay, a quick thing on decision theory. I have
|
| 22 | a pretty picture, I have to show it. What this is
|
| 23 | saying is -- I just want to make the following point, I
|
| 24 | probably will not actually go through the picture, so
|
| 25 | just admire it while I talk. It was not easy drawing |
77
| 1 | this on the train while it was jerking around -- but is
|
| 2 | the following, that there is a lot of focus, I think, in
|
| 3 | court cases, at least, in actual legal decision-making
|
| 4 | on doing things like asking are probabilities above
|
| 5 | certain thresholds or is one probability higher than the
|
| 6 | other, something like that.
|
| 7 | This would be a diagram where if you weigh
|
| 8 | evidence, you would just ask, is the probability of harm
|
| 9 | bigger or less than the probability of efficiencies?
|
| 10 | So, you would get in that red zone, because that's where
|
| 11 | the probability of harm, P, would be viewed as being
|
| 12 | higher than the probability of the efficiencies, Q, and
|
| 13 | you would just sort of -- that is one interpretation of
|
| 14 | weighing the evidence. There are others, I will note,
|
| 15 | and if I had a longer time, I would tell you some of the
|
| 16 | others.
|
| 17 | Now, but if you try to balance the effects, you
|
| 18 | do not just look at the probabilities. You have also
|
| 19 | got to look at the magnitudes, and I have given the
|
| 20 | example here where the harms, denoted by H, are bigger
|
| 21 | than the efficiencies. So, in fact, you want to condemn
|
| 22 | not just practices where the harm is more likely or
|
| 23 | equally likely as the efficiencies. You actually want
|
| 24 | to condemn some where the harm is less likely, but the
|
| 25 | problem is, well, it is less likely, but when it |
78
| 1 | happens, it is a worse thing, and that is where you get
|
| 2 | that purple area.
|
| 3 | I would say in the end, since we are worried
|
| 4 | about effects, the right thing to do, and if we do all
|
| 5 | this stuff, would be to condemn this bluish-purple area
|
| 6 | plus the red, but if you simply weigh the evidence, you
|
| 7 | are only going to get rid of the red. So, you are going
|
| 8 | to -- if there is enforcement, you are going to have
|
| 9 | false negatives. So, I think what is important in all
|
| 10 | of this, and there are many other interpretations of
|
| 11 | this, but the central point is I think we do have to
|
| 12 | worry about magnitudes more than we have in the last --
|
| 13 | okay, are you going to unplug this? This is like the
|
| 14 | Academy Awards, they start playing the music.
|
| 15 | Innovation, I will say one thing in support of
|
| 16 | innovation markets as a broad concept, because certainly
|
| 17 | they have been controversial in terms of actually using
|
| 18 | them, but if we are worrying about markets where
|
| 19 | innovation competition is really critical, then we need
|
| 20 | to worry about what is driving innovation, who the
|
| 21 | potential innovators are, and looking at markets in a
|
| 22 | product market may not tell you very much about it. It
|
| 23 | may be much more informative to look at the distribution
|
| 24 | of R&D capabilities and assets.
|
| 25 | As some people, one of them sitting near me, |
79
| 1 | have pointed out, that can be really hard, because it
|
| 2 | may not even be in this industry, but that is
|
| 3 | conceptually the right thing to do, and so I think we
|
| 4 | ought to be asking ourselves, how do we get there? If
|
| 5 | we conclude it is too hard to do, fine, but I don't
|
| 6 | think it makes sense to say -- and persons near me
|
| 7 | didn't say this -- "Oh, it is too hard to do; therefore,
|
| 8 | let's go and do something else that does not make any
|
| 9 | sense but is easier." I think we want to keep in mind,
|
| 10 | though, that the R&D capabilities and the distribution
|
| 11 | of the assets there may be much more important than
|
| 12 | current market shares in terms of understanding
|
| 13 | innovation.
|
| 14 | Okay, last thing, which does not have anything
|
| 15 | to do with anything except people always screw it up. I
|
| 16 | will make what has actually turned out to be a
|
| 17 | controversial statement in practice, that geographic
|
| 18 | markets are markets, by which I mean since they are
|
| 19 | markets, they have buyers and sellers, okay? In
|
| 20 | practice, at least my experience has been that people
|
| 21 | often forget about the buyers part of that description
|
| 22 | of markets, and then if we are going to talk about
|
| 23 | geographic markets, we need to think about the buyers
|
| 24 | and where they are and the sellers and where they are.
|
| 25 | Now, in some markets, in the end, there may be |
80
| 1 | global markets and those do not matter, but other times
|
| 2 | you want to ask something like, particularly in
|
| 3 | retailing, say, or certain kinds of manufacturing, you
|
| 4 | would want to say, let's look at a set of customers in a
|
| 5 | particular city and ask what producers, and in
|
| 6 | particular the producers' plants, can serve those
|
| 7 | customers, and look at it that way.
|
| 8 | Now, that may mean that a firm is in a lot of
|
| 9 | different geographic markets, and a single plant, by the
|
| 10 | way, could be in different geographic markets
|
| 11 | simultaneously, which drives people crazy, but if you
|
| 12 | want to think about what is really going on and take
|
| 13 | markets seriously, you have got to remember, markets are
|
| 14 | bringing together buyers and sellers, so we need to
|
| 15 | discuss or describe the locations of both of those.
|
| 16 | With that, I will stop.
|
| 17 | (Applause.)
|
| 18 | DR. CARLTON: Okay, thank you. The person close
|
| 19 | to you says, "Thank you very much."
|
| 20 | Okay, I would like to ask the panelists some
|
| 21 | questions. We have about 45 questions left, and I have
|
| 22 | a series of questions. I have about ten questions. I
|
| 23 | do not know if we will be able to get through them all.
|
| 24 | What I will do is I will ask the question, and then I
|
| 25 | will ask two of you to comment. If you could keep your |
81
| 1 | answers relatively brief, that would be good. If
|
| 2 | someone on the panel who we have not asked feels they
|
| 3 | want to comment, they should do so, but since there is
|
| 4 | an opportunity cost, that just means you may not get to
|
| 5 | answer a later question.
|
| 6 | Here is what it seems to me that the purpose of
|
| 7 | these hearings are. One, we want to define market
|
| 8 | power. Can we agree on a definition? If we can, do we
|
| 9 | think defining the market and then taking market shares
|
| 10 | helps us in a section case? Then, what are the hard
|
| 11 | questions where we think that that may or may not help?
|
| 12 | Then the ultimate question really is -- and this
|
| 13 | I will ask everybody to answer, it will be the last
|
| 14 | question -- do we really need market definition and is
|
| 15 | it more of a hindrance than a help?
|
| 16 | So, let me just start off on first asking the
|
| 17 | question about market definition. In the legal
|
| 18 | literature and in the cases, they stress not just the
|
| 19 | ability to control prices, which is what economists
|
| 20 | focus on, but they always add, "or the ability to
|
| 21 | exclude competition," and it is that second prong I want
|
| 22 | to focus on for a second.
|
| 23 | I understand -- and Andy spoke a little bit
|
| 24 | about this -- that a joint venture can get together and
|
| 25 | exclude people. Let's just talk about single-firm |
82
| 1 | behavior, and I am interested, in particular, from both
|
| 2 | Andy's point of view and Joe's point of view, with their
|
| 3 | sort of combined economic/legal backgrounds, if they
|
| 4 | could comment on whether they think the exclusion prong
|
| 5 | of the market power definition that is used in legal
|
| 6 | cases is useful. Do we need it? Can we do without it?
|
| 7 | For example, can we do without it by saying,
|
| 8 | "Well, it is the ability to control price, and if you
|
| 9 | say keeping it above the competitive level, obviously
|
| 10 | the competitive level is the level that arises when you
|
| 11 | do not exclude competition." If we can simplify the
|
| 12 | definition, it seems to me that helps things rather than
|
| 13 | complicates things. So, is your view that we need that
|
| 14 | second prong, exclude competition, in the definition of
|
| 15 | market power or not?
|
| 16 | So, let me first ask Andy and then I will ask
|
| 17 | Joe, and if you could keep your answers sort of
|
| 18 | relatively brief, that would be good.
|
| 19 | DR. GAVIL: I think in exclusion cases, the
|
| 20 | answer is yes, but it winds up being a first step. The
|
| 21 | ability to exclude competition -- I guess the "or" is
|
| 22 | the problem. Why do we have monopolization? We have
|
| 23 | monopolization cases because we want to prevent not just
|
| 24 | any exclusion of competition; it is exclusion of
|
| 25 | competition followed by the ability to either maintain |
83
| 1 | price, maybe raise price, but the two to me go hand in
|
| 2 | hand.
|
| 3 | In any section 2 case, the first step is going
|
| 4 | to be evidence of some exclusion, but I do not think you
|
| 5 | can stop there and conclude from that that there would
|
| 6 | automatically be monopoly power. You have to ask the
|
| 7 | second question of whether or not the exclusion will in
|
| 8 | some way facilitate the maintenance or the enhancement
|
| 9 | of the market power. So, I think it winds up being
|
| 10 | circular. You do come back to power over price.
|
| 11 | DR. CARLTON: Okay, Joe?
|
| 12 | MR. SIMONS: I agree with what Andy said, and
|
| 13 | also, just to follow up on what Rich said about the
|
| 14 | guide posts and the lamp posts. You know, what you see
|
| 15 | in the case law is an example of a lamp post. It is not
|
| 16 | an example of a guide post. That kind of definition is
|
| 17 | drawn generally from whatever you guys refer to in the
|
| 18 | equilibrium analysis or partial equilibrium analysis or
|
| 19 | whatever it is, and they just moved it over and said,
|
| 20 | "Here, this is what we are going to do," without
|
| 21 | thinking about why we really want to do it.
|
| 22 | The statute talks about monopoly, so you tend to
|
| 23 | have to have a big share and so it is natural that a
|
| 24 | share requirement gets imported into the law. But it
|
| 25 | does so without thinking, and so I do not think that |
84
| 1 | focusing on that question based on the case law is going
|
| 2 | to be terribly helpful.
|
| 3 | I think Andy is right, you want to focus on why
|
| 4 | are we asking this question, what are we trying actually
|
| 5 | to prevent, what is the goal.
|
| 6 | DR. CARLTON: Okay, I think I agree with that.
|
| 7 | I think probably that is a fair summary of what you
|
| 8 | said, that I think both of you say we can get rid of
|
| 9 | that second prong as long as you keep your eye on the
|
| 10 | ball. In effects cases, obviously you have done
|
| 11 | something bad, and then did you raise price. So, if you
|
| 12 | are wanting to define market power alone, it is whether
|
| 13 | you can raise the price above what it would otherwise
|
| 14 | be.
|
| 15 | MR. NELSON: Or prevent it from falling.
|
| 16 | DR. CARLTON: Or prevent it from falling, that
|
| 17 | is right.
|
| 18 | DR. GAVIL: I think the exclusion does tell you
|
| 19 | something. I would not eliminate it entirely. I think
|
| 20 | the problem is it does not tell you whether or not you
|
| 21 | have monopoly power, but it is like the first red flag.
|
| 22 | It is the first guide post that tells you there may be
|
| 23 | reason to be concerned about a particular situation, but
|
| 24 | you cannot stop there. You have to ask the second
|
| 25 | question. |
85
| 1 | Even going back to Salop and Krattenmaker, the
|
| 2 | title of the article was Raising Rivals' Costs to Obtain
|
| 3 | Power Over Price. So, the two really do go hand in
|
| 4 | hand, but the first sign of a problem may be the
|
| 5 | evidence of exclusion.
|
| 6 | DR. CARLTON: Right, but what is a mechanism to
|
| 7 | achieve the control of price? I agree, it is important
|
| 8 | to have both, but I am just trying to distinguish the
|
| 9 | two. One of the things that goes on in a section 2 case
|
| 10 | is you define markets and you have exclusion -- and I
|
| 11 | will come back to this later -- and the question is how
|
| 12 | you link the two. I am trying to keep them separate for
|
| 13 | a second.
|
| 14 | MR. SIMONS: I think in what Krattenmaker and
|
| 15 | Salop do with their article is they are linked. It is
|
| 16 | the exclusion that gives you the power over the price.
|
| 17 | What is the impact of the exclusion? Not kind of in a
|
| 18 | general sense, have you been able to exclude people, all
|
| 19 | right? Because maybe you have because you have such a
|
| 20 | terrific product or you have a patent or whatever it is.
|
| 21 | That is legal. The question then becomes, did you do
|
| 22 | something in addition to that that may not be so legal,
|
| 23 | and does that give you power over price?
|
| 24 | DR. CARLTON: Right.
|
| 25 | DR. GAVIL: Think of instances where the act of |
86
| 1 | exclusion raises entry barriers.
|
| 2 | DR. CARLTON: Yes.
|
| 3 | DR. GAVIL: That leads you to the second part of
|
| 4 | it.
|
| 5 | DR. CARLTON: Yes and no. What that tells you
|
| 6 | is that but for the act, which we are trying to claim is
|
| 7 | illegal, the price would have been lower, and therefore,
|
| 8 | you have the power to set price above the but-for price.
|
| 9 | It is just defining what the but-for price is.
|
| 10 | Okay, let me go on, because I am going to come
|
| 11 | back to this benchmark point. The definition that
|
| 12 | economists use a lot is that market power is the ability
|
| 13 | to set price profitably above the competitive level,
|
| 14 | presumably by a significant amount, for some significant
|
| 15 | amount of time. So, first, I have two parts to this
|
| 16 | question, and I am going to ask Phil and Larry.
|
| 17 | Assume that there are constant returns to scale,
|
| 18 | so competition is possible. So, first, do you agree
|
| 19 | that the definition I gave you is a reasonable one --
|
| 20 | put aside whether it is implementable, but is it a
|
| 21 | reasonable one -- and if so, what is a significant
|
| 22 | amount of the price increase and what is a significant
|
| 23 | amount of time?
|
| 24 | In particular, when you are answering, if you
|
| 25 | could talk about why we do not pay attention to dead |
87
| 1 | weight loss and why we just talk about numbers. I mean,
|
| 2 | we are economists, and 5 percent, 10 percent, we know
|
| 3 | that may not be meaningful depending upon the size of
|
| 4 | the market. So, if you could just address those.
|
| 5 | DR. WHITE: Are you looking at me? Look, you
|
| 6 | know, where do 5 and 10 percent come from? As Bill
|
| 7 | Baxter used to say, from these (indicating hands), and
|
| 8 | there's nothing magical about that. You know, it partly
|
| 9 | would also depend on how much noise you think is out
|
| 10 | there protecting ourselves against error that might be
|
| 11 | harmful. So, the real answer -- the first part is yes,
|
| 12 | under constant returns to scale, a price significantly
|
| 13 | above marginal cost, sustained for a sustained amount of
|
| 14 | time, would in my mind constitute an exercise of market
|
| 15 | power, and how much and for how long, I do not know.
|
| 16 | Sure, 10 percent sounds like a number to be
|
| 17 | thinking about and two years sounds like a number to be
|
| 18 | thinking about, but I have just picked those out of the
|
| 19 | air, and I do not have any further basis.
|
| 20 | DR. CARLTON: Okay, let me just say one thing.
|
| 21 | My preference would be it is probably better -- even
|
| 22 | though it is hard to choose a number, someone is going
|
| 23 | to choose a number, so you should think, as to your
|
| 24 | willingness to choose a number, would you rather some
|
| 25 | random judge choose a number or this panel? So, that is |
88
| 1 | why I am asking.
|
| 2 | DR. KATZ: I mean, I disagree with the premise.
|
| 3 | Why should you choose a number? I am almost
|
| 4 | certainly -- if you thought the court was going to do
|
| 5 | enough of the analysis -- and we would have to talk
|
| 6 | about the cost of the court and the time they have --
|
| 7 | but almost certainly you would say the number depends on
|
| 8 | the market. I mean, there are some markets where
|
| 9 | worrying about a price change within 5 or 10 percent, I
|
| 10 | mean it is completely lost in the noise, because the
|
| 11 | prices are changing 40 percent every year, so it does
|
| 12 | not mean a 10 percent price increase could not matter,
|
| 13 | but it becomes less plausible you could actually tell.
|
| 14 | In other markets, it might be that you could reliably
|
| 15 | predict a 3 percent price change.
|
| 16 | DR. CARLTON: Following that same logic,
|
| 17 | wouldn't you be concerned about a 1 percent change in a
|
| 18 | market that is huge?
|
| 19 | DR. KATZ: If you believed you could actually
|
| 20 | make reliable predictions at that level, yes. So, I
|
| 21 | think you need to look, as you were saying, at the
|
| 22 | magnitudes of the effects, and some of it comes within
|
| 23 | when do you want to bring cases and how to allocate
|
| 24 | resources and then also the various characteristics of
|
| 25 | the market that are going to affect the reliability of |
89
| 1 | your projections and whether you think that you really
|
| 2 | can discern at those levels, but I think it would be
|
| 3 | pretty clear that holding aside -- which is obviously a
|
| 4 | big thing to hold aside -- the various sorts of
|
| 5 | processing costs, there is no reason to think there is
|
| 6 | one right number, and, in fact, there certainly isn't.
|
| 7 | DR. CARLTON: The question is, should we give
|
| 8 | any guidance to the courts when they are trying to
|
| 9 | decide whether a firm has market power, and if you just
|
| 10 | say it is up to the discretion of the judge based on a
|
| 11 | lot of things -- I mean, I agree with you, it is hard to
|
| 12 | come up with one number. The question is, is it better
|
| 13 | leaving it completely to the discretion of the courts,
|
| 14 | or should we not -- I think one of the advantages of the
|
| 15 | Merger Guidelines, even though they make the point that
|
| 16 | the 5 percent is just a suggestion, is that it has
|
| 17 | focused thinking and clarified thinking. So, I agree
|
| 18 | with everything you have said, but in light of the
|
| 19 | decision-making of the court process, there can be a
|
| 20 | benefit to articulating some standards, maybe flexible
|
| 21 | standards.
|
| 22 | DR. KATZ: I would agree with that, but I think
|
| 23 | a question would be -- and this is just thinking off the
|
| 24 | top of my head -- could you say something like -- have
|
| 25 | some sort of relatively easily observable data, say like |
90
| 1 | the annual price changes or something, or try and do
|
| 2 | something that says that the standard you use should be
|
| 3 | proportional to some characteristic in the market? We
|
| 4 | would have to think a lot about what that is, and I
|
| 5 | think ideally, for the reasons you bring up, it would be
|
| 6 | something fairly mechanical, but it would still be an
|
| 7 | improvement over a one-size-fits-all.
|
| 8 | DR. CARLTON: Rich?
|
| 9 | DR. GILBERT: Well, I certainly agree that the
|
| 10 | number, however you define this number, depends on the
|
| 11 | nature of the conduct, the efficiencies that can be
|
| 12 | presumed to go along with that conduct, and maybe the
|
| 13 | size of the market and all of that, but I also think
|
| 14 | there is the case that can be made for shifting the
|
| 15 | inquiry to something like the firm-specific elasticity
|
| 16 | of demand, which often can be measured in many
|
| 17 | instances. I think Greg has pointed this out in some of
|
| 18 | his writings.
|
| 19 | It is not that hard to say if the elasticity of
|
| 20 | demand is bigger than 10, maybe we shouldn't be worried
|
| 21 | about this. On the other hand, if it is in the range of
|
| 22 | 2 to 3, maybe we should be worried about this.
|
| 23 | DR. CARLTON: Yeah, that raises a point I am
|
| 24 | always puzzled about, that if you are thinking about
|
| 25 | what is a magnitude that is important, an elasticity of, |
91
| 1 | say, 20, which everybody would say is a really high
|
| 2 | elasticity, that gives you a 5 percent upcharge over the
|
| 3 | competitive price. So, that should tell us something
|
| 4 | about our intuition versus sort of practical --
|
| 5 | DR. GILBERT: Well, on that, maybe I am
|
| 6 | differing from other people, I think of that 5 percent
|
| 7 | rule as being a derivative, not an absolute amount. So,
|
| 8 | we ask, if quantity goes down by 5 percent, will the
|
| 9 | price go up by 5 percent, that sort of thing, and rather
|
| 10 | than because we are really worried about the price going
|
| 11 | up by 5 percent. Now, some people I know would disagree
|
| 12 | with that and would say that that 5 percent is a
|
| 13 | threshold of concern. I think of it more as an
|
| 14 | elasticity test.
|
| 15 | DR. CARLTON: Okay.
|
| 16 | MR. NELSON: Since I was one of the original --
|
| 17 | DR. CARLTON: I am going to give you another
|
| 18 | question, okay? It is actually a harder question now.
|
| 19 | We are going to move on to something else. That was an
|
| 20 | easier question. If you remember, that was premised on
|
| 21 | constant returns to scale. So, it could actually define
|
| 22 | a competitive price.
|
| 23 | Let's suppose now that I am in an industry where
|
| 24 | there cannot be competition. There is a fixed cost of
|
| 25 | entry. There are constant returns to scale, and it is |
92
| 1 | Cournot competition, okay? What is the meaning of that
|
| 2 | common phrase that we use, can you profitably price
|
| 3 | above the competitive level? What in the world should
|
| 4 | we take as the competitive level in that situation? Is
|
| 5 | it the zero profit equilibrium or is it price equaling
|
| 6 | marginal cost?
|
| 7 | So, let's see, maybe Phil, if you want to take a
|
| 8 | crack at that.
|
| 9 | MR. NELSON: Well, one of the things that sort
|
| 10 | of concerns me about taking sort of the current level as
|
| 11 | opposed to something like marginal cost is you do have
|
| 12 | some of these monopolization cases that are really
|
| 13 | entrenchment theories, and is the question whether the
|
| 14 | entry is going to drive you significantly back towards
|
| 15 | competition, or this guy already has some market power,
|
| 16 | and he is going to --
|
| 17 | DR. CARLTON: Try to define the market
|
| 18 | equilibrium, free entry, fixed costs, constant returns
|
| 19 | to scale, Cournot equilibrium, do we want to call that
|
| 20 | market power?
|
| 21 | MR. NELSON: I guess I am saying that to answer
|
| 22 | that, you want to know sort of what your benchmark is as
|
| 23 | to where you're going.
|
| 24 | DR. CARLTON: Right, that is what I am asking
|
| 25 | you. |
93
| 1 | MR. NELSON: Yeah, and what I was going to say
|
| 2 | is that I think you would start to look, as N goes up,
|
| 3 | what happens to the equilibrium price? Then as N gets
|
| 4 | high enough, are you still at a price where somebody
|
| 5 | could make an economic profit? I mean, you are going to
|
| 6 | want to see if that is a tenable number of firms and
|
| 7 | start to use something like that as the equilibrium,
|
| 8 | which is higher. It is going to be a lower price and
|
| 9 | define market power in some circumstances where you
|
| 10 | might not find it if you are at your starting point.
|
| 11 | DR. CARLTON: So, the point of the question is
|
| 12 | to show that there is a difficulty in defining market
|
| 13 | power when you cannot define the competitive price. You
|
| 14 | can define a rate of return, and you can define marginal
|
| 15 | cost in this example and prices above marginal cost in
|
| 16 | this example, but profit is zero, and there seems to be
|
| 17 | a complete ambiguity between the willingness of people
|
| 18 | to distinguish which of those two definitions they are
|
| 19 | using.
|
| 20 | Is it price above marginal cost that is market
|
| 21 | power? Is it rate of return above a competitive level,
|
| 22 | or which of the two, or are those two different things?
|
| 23 | They obviously from an economic point of view are two
|
| 24 | different things, yet often, in the writings and in case
|
| 25 | law, they in my mind do not get distinguished. |
94
| 1 | MR. NELSON: I mean, yeah, you want to have
|
| 2 | profit -- you want to be able to make a monopoly profit.
|
| 3 | I mean, if you have got easy entry, as some of the
|
| 4 | different -- you know, if you don't have any profits,
|
| 5 | then they are not going to have enough -- but I --
|
| 6 | DR. CARLTON: Larry, did you want to say
|
| 7 | something?
|
| 8 | DR. WHITE: But why would we be interested in
|
| 9 | your hypothetical? If it is somebody coming in and
|
| 10 | saying, "That guy is charging an outrageously high
|
| 11 | price, Judge, find him guilty of a section 2 violation
|
| 12 | and mandate that he charge a lower price," we do not see
|
| 13 | that all that often, but that would be a problem. If it
|
| 14 | is, "Judge, that guy has excluded me from offering my
|
| 15 | rivalrous product, and had he not excluded me, I could
|
| 16 | have come in and the price could have been lower,"
|
| 17 | that's a different --
|
| 18 | DR. CARLTON: I agree, but that is mixing
|
| 19 | together two different questions. The first is, what is
|
| 20 | the effect of this action? If you can answer that
|
| 21 | question, you have answered the section 2 -- you have
|
| 22 | resolved the section 2 issue.
|
| 23 | DR. WHITE: And then we do not have to worry
|
| 24 | about it.
|
| 25 | DR. CARLTON: And then we do not have to worry |
95
| 1 | about market definition; however, the way the courts
|
| 2 | seem to use market definition in section 2 cases is not
|
| 3 | like that at all. Courts seem to do the following:
|
| 4 | Unlike a merger context where you ask, as a
|
| 5 | result of a merger, is market power going to go up, the
|
| 6 | courts define a market and then look to define market
|
| 7 | share. Courts do it. They do not look at the change in
|
| 8 | the market shares that arise as a result of the bad act.
|
| 9 | They do not do that. That would be an analogy to a
|
| 10 | merger case.
|
| 11 | Instead what they do is they ask, is there
|
| 12 | market power? They do not ask about the change in
|
| 13 | market power, but they ask, is there market power? They
|
| 14 | use that as a screen whether to then further
|
| 15 | investigate, and that distinction, that asymmetry
|
| 16 | between a merger case and a section 2 case, I think
|
| 17 | leads to peculiar discussions, but it also I think leads
|
| 18 | to exactly why I am asking this question, which is, if
|
| 19 | the courts are going to go this route and use market
|
| 20 | definition -- I agree with you, Larry, if you do an
|
| 21 | effects-based analysis, you can solve the problem -- but
|
| 22 | the first question the court is going to be asking, is
|
| 23 | there market power, and I am just trying to figure out,
|
| 24 | can we even define what we mean by that in this Cournot
|
| 25 | example? |
96
| 1 | MR. SIMONS: I think what you want to ask is why
|
| 2 | are we doing this, why are we engaged in an exercise,
|
| 3 | before you can even think about answering the question.
|
| 4 | DR. CARLTON: This firm has been sued, there is
|
| 5 | a bad act, and the first question is, does he have
|
| 6 | market power? And I am trying to find out -- I cannot
|
| 7 | answer that -- begin to answer that question unless we
|
| 8 | can agree on a definition of market power. So, is the
|
| 9 | definition price above marginal cost or is the
|
| 10 | definition rate of return above the competitive level?
|
| 11 | Mike?
|
| 12 | DR. KATZ: The problem is if you are going to
|
| 13 | say this has to be a screen that works for everything,
|
| 14 | then the most useful definition of market power would be
|
| 15 | does the firm have at least one employee or something
|
| 16 | that is equivalent of it so we throw this screen out,
|
| 17 | because what Larry has pointed out -- I think what in
|
| 18 | most cases makes sense is something that says -- and
|
| 19 | actually, I make a different distinction, and I think,
|
| 20 | actually, a lot of economists writing not as part of
|
| 21 | antitrust make a different distinction. I think a lot
|
| 22 | of people, economists, would say that market power would
|
| 23 | be facing downward-sloping demand curve and not having
|
| 24 | it perfectly elastic, which then would end up giving you
|
| 25 | the profit-maximizing price of that firm above marginal |
97
| 1 | cost. I think that is a useful definition of market
|
| 2 | power.
|
| 3 | Then I try to reserve monopoly power for being
|
| 4 | two parts. One, that you have a lot of market power,
|
| 5 | which is to say the price would be -- and again, I will
|
| 6 | be vague -- but significantly above marginal cost, and I
|
| 7 | would typically put in a test saying for I think most
|
| 8 | purposes or a lot of them, we do care whether or not the
|
| 9 | price is above average cost, whether or not there are
|
| 10 | profits, but what Larry has pointed out, I think
|
| 11 | correctly, is that test does not always work, that if
|
| 12 | what you are worried about is somebody who is in there
|
| 13 | now and is just breaking even but is narrowly keeping
|
| 14 | all sorts of more efficient entrants out who could make
|
| 15 | a profit, I think in that case, saying, "Well, look,
|
| 16 | they are not making money, there can't be a problem,"
|
| 17 | would give you a misleading answer.
|
| 18 | MR. NELSON: That was my standards example I
|
| 19 | gave in my opening talk.
|
| 20 | DR. CARLTON: I think, again, that is really
|
| 21 | asking the but-for price; in other words, price may
|
| 22 | equal marginal cost and price may be above average cost
|
| 23 | in the present environment, but but for the bad act,
|
| 24 | that would not occur, okay?
|
| 25 | The distinction you make between price above |
98
| 1 | marginal cost and then whether the rate of -- the price
|
| 2 | above average cost, the rate of return is above the
|
| 3 | anticipated return, is exactly the distinction that I
|
| 4 | made between market power and monopoly power. It is a
|
| 5 | logical distinction. I am not sure -- we may be the
|
| 6 | only two people who make that distinction, because I do
|
| 7 | not see the legal cases going in that direction.
|
| 8 | So, I guess I do have a question, and I think it
|
| 9 | is a relevant question, as to whether the distinction
|
| 10 | between monopoly power and market power that we do see
|
| 11 | in the cases, is that a useful distinction, and is it a
|
| 12 | useful legal distinction? Is it a useful economic
|
| 13 | distinction?
|
| 14 | So, maybe, Andy, you could answer that and maybe
|
| 15 | Rich.
|
| 16 | DR. GAVIL: Yeah, one point I wanted to make
|
| 17 | earlier and I think I can make it now in answering the
|
| 18 | question, I think historically the association of market
|
| 19 | power and monopoly power as being different things was
|
| 20 | linked to market share. It was linked to circumstantial
|
| 21 | evidence as the basic mind set that we used to approach
|
| 22 | cases, and I think a concrete example of this is the
|
| 23 | Supreme Court decision in Copperweld, where it says --
|
| 24 | it is known for the parent/subsidiary enterprise
|
| 25 | conspiracy issue, but it has a very interesting |
99
| 1 | discussion of the relationship between section 1 and
|
| 2 | section 2, and it says, "An unreasonable restraint of
|
| 3 | trade by a single firm is not reached under section 2,
|
| 4 | and therefore, the drafters of the Sherman Act left a
|
| 5 | gap between section 1 and section 2, and the implication
|
| 6 | was that for a section 2 case, you need something more."
|
| 7 | At that moment in time, the "something more" was the 70
|
| 8 | percent or more market share as opposed to the 40 to 60
|
| 9 | percent that was typical in rule of reason cases.
|
| 10 | If you let go of the commitment to the Alcoa
|
| 11 | framework and the market share associations and start
|
| 12 | thinking about market power in different ways as
|
| 13 | expressing itself in different ways, that kind of mind
|
| 14 | set of distinguishing market and monopoly power based on
|
| 15 | market shares goes away, and I think that that would
|
| 16 | make a big difference in how we think about antitrust
|
| 17 | generally.
|
| 18 | But you have said it several times, Dennis, and
|
| 19 | it is clearly the case, that courts say, "Okay, the
|
| 20 | first element under section 2, do you have monopoly
|
| 21 | power?" On your no profit example, if I could just
|
| 22 | throw in, what if the purpose of the conduct was to make
|
| 23 | that firm profitable and that is what it was trying to
|
| 24 | do? So, currently it is not profitable, but the whole
|
| 25 | point of the conduct, maybe it affects entry barriers, |
100
| 1 | was that they are trying to get profitable by engaging
|
| 2 | in conduct. Again, I think it shows the link between
|
| 3 | the conduct and the power increase.
|
| 4 | DR. CARLTON: Rich?
|
| 5 | DR. CARLTON: Rich?
|
| 6 | DR. GILBERT: Yeah, if I can answer this, as has
|
| 7 | been said before, in some sense I subscribe to the
|
| 8 | argument that monopoly power is a lot of market power,
|
| 9 | but it is also market power that is durable. Now,
|
| 10 | whether you define durable market power in terms of the
|
| 11 | ability to raise price above average cost, the ability
|
| 12 | to maintain price above average cost, or the ability to
|
| 13 | maintain price above long-run marginal cost, I do not
|
| 14 | think that is really critical. To me, it is the ability
|
| 15 | to exclude, and as you have noted, Dennis, yourself,
|
| 16 | that when you are talking about exclusion, obviously it
|
| 17 | also depends on thinking about entry barriers, and then
|
| 18 | when you think about entry barriers, you have to think
|
| 19 | occur.
|
| 20 | So, if you had an extremely competitive market
|
| 21 | post-entry, maybe a little bit of exclusion is enough to
|
| 22 | maintain a monopoly position, but I think the key issue
|
| 23 | is the ability to exclude is important to me, because it
|
| 24 | says something about the ability to maintain price above
|
| 25 | some measure of long-run profitability of an efficient |
101
| 1 | competitor.
|
| 2 | I want to add one other comment that I think is
|
| 3 | related to all of this, which is we are very good when
|
| 4 | we talk about impacts on competition to understand that
|
| 5 | impacts on competition is different from impacts on a
|
| 6 | competitor, I think we have learned that one, but when
|
| 7 | we talk about section 2 cases, we are often talking
|
| 8 | about the market share or monopoly power of a single
|
| 9 | firm. Shouldn't we be talking in many of these cases,
|
| 10 | at least, if not all of them, about the power in the
|
| 11 | market, not just the power of this firm, because
|
| 12 | obviously if the firm reduces supply so that its market
|
| 13 | share is below the Alcoa threshold, but in doing so,
|
| 14 | raises market power generally in the industry, that is a
|
| 15 | problem, and we want to look at that, not just what the
|
| 16 | firm's market share is or focusing on the firm.
|
| 17 | Now, if you did this firm-specific residual
|
| 18 | demand analysis, then you pick that up by looking at the
|
| 19 | elasticity of the residual demand. So, I think it is
|
| 20 | all right in that context.
|
| 21 | DR. CARLTON: Let me go back to something that
|
| 22 | sort of was a common theme in some of the presentations.
|
| 23 | Let me restate it as follows: It really has to do with
|
| 24 | what the benchmark price is.
|
| 25 | If you look at a firm in a section 2 case and it |
102
| 1 | is engaged in a bad act, can you then ask, "Well, does
|
| 2 | that firm have market power," which is what the courts
|
| 3 | first ask, and if the answer is no, they throw it out.
|
| 4 | In order to answer that question, you have to ask,
|
| 5 | "Well, what would the price --" depending on your
|
| 6 | definition of market power, you want to ask, "Does the
|
| 7 | firm have market power?" Whatever your definition is,
|
| 8 | whether it is pricing above the competitive level after
|
| 9 | the bad act, are they pricing above the level but for
|
| 10 | the bad act, whatever definition you want to use, and I
|
| 11 | think it is the latter definition that makes more sense,
|
| 12 | it is not obvious why market shares and market
|
| 13 | definition help you answer that question, because if you
|
| 14 | know the current price and you knew the benchmark price,
|
| 15 | it is just a comparison of two prices. So, calculating
|
| 16 | market share in that case does not advance the ball.
|
| 17 | If that is the typical case that we see in
|
| 18 | section 2, what really are we talking about when we are
|
| 19 | doing market definition? Are we really doing an
|
| 20 | analytic economic exercise, or are we doing something --
|
| 21 | or are the courts doing something much more -- I don't
|
| 22 | want to say sensible, but much more using common sense,
|
| 23 | which is there are five guys doing the same thing, don't
|
| 24 | bother me, and they're just using their common sense.
|
| 25 | Now, how you define "five guys doing the same |
103
| 1 | thing" may be hard, but it seems to me that is what a
|
| 2 | lot of courts are doing, and I am wondering if we are
|
| 3 | worrying too hard about defining markets in cases where
|
| 4 | market definition is just this seat-of-the-pants thing
|
| 5 | that the courts then use, and as long as they understand
|
| 6 | it is real seat-of-the-pants, don't bother me with
|
| 7 | details about market shares and get on to your
|
| 8 | competitive effects analysis.
|
| 9 | So, maybe, Joe and Mike, you could comment on
|
| 10 | that.
|
| 11 | MR. SIMONS: Yeah, I think that what the courts
|
| 12 | will do is not just say, well, let's get on with it and
|
| 13 | let's get to the competitive effects. It is a real
|
| 14 | screening event, a big one, and it also seriously
|
| 15 | impacts what happens when lawyers counsel their clients.
|
| 16 | If there is some chance that your client is going to be
|
| 17 | deemed to have a big market share, at least most lawyers
|
| 18 | I know will give advice that is much more conservative
|
| 19 | than if their shares are 30 percent. So, it makes a big
|
| 20 | difference in the real world.
|
| 21 | I think the judges do focus on it, and it is
|
| 22 | important in court now, and there is a serious question
|
| 23 | in my mind about how important it should be, certainly
|
| 24 | with respect to how the Antitrust Division and the FTC
|
| 25 | exercise their prosecutorial discretion -- whether they |
104
| 1 | really need to get hung up on this or whether they
|
| 2 | really need to make a decision about what is the impact
|
| 3 | of whatever conduct we are worried about. Did it have a
|
| 4 | significant impact, and then, when we are proving in our
|
| 5 | case in court, it is a different exercise.
|
| 6 | DR. CARLTON: Okay, who did I say? Mike?
|
| 7 | DR. KATZ: You are not supposed to remind me of
|
| 8 | that. No, I would say a couple things. Part of it -- I
|
| 9 | will come back to what I said in my presentation,
|
| 10 | though, is that we can be using market definition in a
|
| 11 | number of different ways and that the level of -- we
|
| 12 | want to understand who the competitors are, because we
|
| 13 | want to figure out that is where we are going to see the
|
| 14 | competitive effects, are they harmed or not, does it
|
| 15 | matter if they are harmed, does it matter for
|
| 16 | competition and for consumer welfare. So, that level, I
|
| 17 | think we would certainly want to do market definition,
|
| 18 | but that may not be through a formal algorithm.
|
| 19 | In terms of your question about the alternative
|
| 20 | prices, I think there is a difference between asking
|
| 21 | about a but-for price and asking about certain
|
| 22 | interpretations of the competitive benchmark, because
|
| 23 | you can take a competitive benchmark to be some formula
|
| 24 | based on marginal cost or average cost or something like
|
| 25 | that, and you could ask a market power question, but you |
105
| 1 | could well conclude from that that yes, this firm has
|
| 2 | market power, but it has not done anything wrong, okay?
|
| 3 | It has market power because it has been a great
|
| 4 | innovator. So, I think that that is a different
|
| 5 | question than asking is it charging a higher price than
|
| 6 | the but-for price, because there you are asking about
|
| 7 | what would happen as a result of the specific piece of
|
| 8 | conduct. So, I think if one wants to go through the
|
| 9 | market definition exercise in that form and to have the
|
| 10 | competitive effects analysis be different than the
|
| 11 | market definition analysis, I think you can do it. One
|
| 12 | would ask about almost this more abstract or formulaic
|
| 13 | competitive price as the benchmark for market
|
| 14 | definition, and then the competitive effects analysis
|
| 15 | would look for a but-for price and would take into
|
| 16 | account a specific practice.
|
| 17 | DR. CARLTON: I just don't know how to do the
|
| 18 | first in an analytic way that is other than comparing
|
| 19 | the two prices. If I cannot compare the two prices and
|
| 20 | I have to do a competitive effects, say an econometric
|
| 21 | analysis, I do not really need market definition. So,
|
| 22 | that is why I think what judges often do is, as Joe
|
| 23 | described, is do a seat-of-the-pants analysis or I
|
| 24 | described as a seat-of-the-pants analysis, but as Joe
|
| 25 | described, that is their screen. |
106
| 1 | DR. KATZ: Well, the screen makes sense if what
|
| 2 | the plaintiff is saying is there has been successful
|
| 3 | monopolization and you end up coming out of this being
|
| 4 | convinced that here is a sensible market definition that
|
| 5 | tells me how competition works, and this particular firm
|
| 6 | does not seem to be dominant in any sense or doing well,
|
| 7 | and if you see that, then it seems to me it does pretty
|
| 8 | heavily undermine the claim that there was successful
|
| 9 | monopolization.
|
| 10 | DR. GILBERT: But that's Cellophane. I mean, it
|
| 11 | is Cellophane, did not look like they were --
|
| 12 | DR. KATZ: No, Cellophane, they did not have the
|
| 13 | sensible market definition.
|
| 14 | DR. GILBERT: Then you are back down to how do
|
| 15 | you define the market.
|
| 16 | MR. SIMONS: Dennis, think about it this way:
|
| 17 | Someone had mentioned a gap earlier, and maybe it was
|
| 18 | Andy. If you think about under section 1, right, if you
|
| 19 | prove an effect, you win, right? Under section 2, the
|
| 20 | way you are describing the state of the law, which is
|
| 21 | accurate, is it is unilateral conduct. No contract.
|
| 22 | There may be an effect, and then liability is going to
|
| 23 | turn on whether there is some high market share.
|
| 24 | DR. CARLTON: Right.
|
| 25 | MR. SIMONS: So, the question to me would be, |
107
| 1 | why do you want to do that?
|
| 2 | DR. CARLTON: I think that is right. Let me
|
| 3 | flip the question a bit.
|
| 4 | It seems to me this emphasis on market
|
| 5 | definition in section 2 cases is coming precisely
|
| 6 | because of the way judges apply these screens and
|
| 7 | that -- I cannot remember -- I think Andy mentioned it,
|
| 8 | that just like you might want to have decision processes
|
| 9 | based on market shares, you might also want to immunize
|
| 10 | certain types of safe -- have safe harbors and as well
|
| 11 | as have danger zones, and it is the fact that it seems
|
| 12 | to me that the sequential decision-making in Section 2
|
| 13 | cases is first to look at market definition as a screen
|
| 14 | and then you go to competitive effects that causes this
|
| 15 | undue emphasis on market definition, and one way around
|
| 16 | that might be -- and this is going to be a question I
|
| 17 | will ask Andy and Phil -- suppose we also allow a screen
|
| 18 | based on safe harbors and said, "No section 2 cases if
|
| 19 | you're doing X, Y and Z; no section 2 cases if market
|
| 20 | share is -- you do not have market power."
|
| 21 | Wouldn't that be a way to de-emphasize the role
|
| 22 | of market definition, which I think we are all agreeing
|
| 23 | is difficult to define in a section 2 case?
|
| 24 | Let me first ask Phil, and then he --
|
| 25 | MR. NELSON: Okay, wait a second, no market -- |
108
| 1 | DR. CARLTON: Either you do not have market --
|
| 2 | the current screen, but I am going to add to that
|
| 3 | current screen that there are certain safe harbors, and
|
| 4 | what we should do is spend more time on defining the
|
| 5 | safe harbors for conduct rather than trying to figure
|
| 6 | out can we define markets any better.
|
| 7 | MR. NELSON: So, it is conduct safe harbors,
|
| 8 | not --
|
| 9 | DR. CARLTON: Correct, yes.
|
| 10 | MR. NELSON: -- not structural safe harbors.
|
| 11 | DR. CARLTON: Correct.
|
| 12 | MR. NELSON: Okay, there was an "and" there, and
|
| 13 | I was starting to think that maybe where you wanted to
|
| 14 | go was a combination of a structural safe harbor with a
|
| 15 | conduct safe harbor, because there are certain types of
|
| 16 | conduct that might mean a lower market share, you could
|
| 17 | still have a problem, like some of these -- but I think
|
| 18 | there is a -- as I was alluding to, the importance of
|
| 19 | performance evidence, which is another way maybe of
|
| 20 | saying conduct, that you would want to start looking at
|
| 21 | some of that conduct evidence.
|
| 22 | However, I am a little worried that the problem
|
| 23 | is that a lot of this conduct is not so easy to
|
| 24 | categorize, so that when you start to try to define a
|
| 25 | safe harbor using conduct evidence, I am not sure that |
109
| 1 | you are going to find a lot of situations where you can
|
| 2 | say for sure that this is conduct that is absolutely
|
| 3 | okay, because in other contexts, it may not be.
|
| 4 | DR. CARLTON: I agree. Safe harbors make
|
| 5 | mistakes, but that is what decision theory tells us is
|
| 6 | the right thing to do.
|
| 7 | Andy?
|
| 8 | DR. GAVIL: I think the idea of defining safe
|
| 9 | harbors and danger zones, as I said, is useful, and I
|
| 10 | think you cannot do it just by using market share
|
| 11 | numbers, which has been our tendency in the past.
|
| 12 | Now, once you use a market share number, you are
|
| 13 | stuck in the, "Okay, we need to define a relevant market
|
| 14 | problem." So, I think that reducing it to certain
|
| 15 | characteristics of the market, maybe it is structural
|
| 16 | characteristics, performance characteristics, but trying
|
| 17 | to look at other kinds of measures might make the safe
|
| 18 | harbor and the danger zones a little bit more meaningful
|
| 19 | and move the attention away from market share.
|
| 20 | But one last comment, Joe said how this affects
|
| 21 | you in advising clients. That 70 percent share that has
|
| 22 | become pretty fixed for monopolization cases, that is
|
| 23 | perceived, even by defendants who do not like the market
|
| 24 | definition and market share approach analysis, that is
|
| 25 | perceived as a pretty big, significant safe harbor when |
110
| 1 | you are advising single-firm clients, and keep that in
|
| 2 | mind with all the monopolization cases.
|
| 3 | If there really is not any good, strong argument
|
| 4 | that you could be in a market with a market share that
|
| 5 | is up in that range, you are pretty much free to do
|
| 6 | whatever you want. So, if we moved away from it, I
|
| 7 | suspect you would actually hear some objections from
|
| 8 | large firms that perceive that it is actually a very
|
| 9 | useful benchmark.
|
| 10 | So, where I would come out is, I do not know
|
| 11 | that you can completely get away from the market shares,
|
| 12 | but maybe we need something like a market share plus,
|
| 13 | and not that it is a great model that we would ever want
|
| 14 | to rely on, but the concept from the Sentencing
|
| 15 | Guidelines that you have a guideline, but then you have
|
| 16 | factors that allow you to depart upward or downward, and
|
| 17 | that is sort of what Michael was talking about earlier
|
| 18 | when he was answering one of your questions, is certain
|
| 19 | factors might lead you to be cautious or less cautious
|
| 20 | in certain circumstances.
|
| 21 | DR. CARLTON: Let's see, let me skip a few
|
| 22 | questions since I am going to try and end roughly on
|
| 23 | time or maybe at most five minutes late, but let me ask
|
| 24 | a question about technology, and I am going to direct
|
| 25 | this to Rich and Mike, because you have done a lot of |
111
| 1 | work in these areas.
|
| 2 | It seems like a really hard question is where
|
| 3 | you have industries where marginal cost is low, product
|
| 4 | innovation is the key, and new products are coming out
|
| 5 | every so many years. It kind of came up a bit in the
|
| 6 | Microsoft case, and Dick will probably talk about this
|
| 7 | tomorrow, Schmalensee, but what do you mean by "market
|
| 8 | power" in those industries unless "durable" really means
|
| 9 | more than a year or two? Is that the right thing to be
|
| 10 | focusing on? If it is, if it is focused on in those
|
| 11 | industries, is it -- let me rephrase it. Is our focus
|
| 12 | on price misleading us and should we be focusing on
|
| 13 | other things?
|
| 14 | DR. GILBERT: Well, I do not view that -- you
|
| 15 | have asked a lot of hard questions. I do not think this
|
| 16 | is one of the hardest questions. I find it relatively
|
| 17 | straightforward in the sense that when you are talking
|
| 18 | about dynamic competition, Schumpeterian spiral
|
| 19 | competition, it is very much like thinking about entry
|
| 20 | analysis. There is some probability that entry will
|
| 21 | occur at some date. The question is how soon will it
|
| 22 | be, what will be the magnitude of it.
|
| 23 | There is also I think a legitimate question that
|
| 24 | even if entry is going to occur, is that going to
|
| 25 | neutralize the type of conduct we are concerned about, |
112
| 1 | or does the conduct we are concerned about promote entry
|
| 2 | or retard entry? It is my view that these are questions
|
| 3 | that can be addressed within the context of the way we
|
| 4 | do antitrust analysis generally.
|
| 5 | Now, it is, of course, the case that in high
|
| 6 | technology industries, you are more likely to get very
|
| 7 | high price-cost margins, so you are more likely to be
|
| 8 | worried about market power, but it is often benevolent
|
| 9 | market power, and if it is benevolent, you should not be
|
| 10 | doing an antitrust case. So, it is more like magnifying
|
| 11 | the things that we are concerned about but not changing
|
| 12 | the qualitative way that in my view you should take them
|
| 13 | into account when you are doing an antitrust analysis.
|
| 14 | DR. KATZ: I have a couple of things and maybe
|
| 15 | tie it to Microsoft. I mean, one of the things to
|
| 16 | remember is when the Government was looking at
|
| 17 | Microsoft, when the Government was dealing with them in
|
| 18 | the mid-nineties, everybody pointed out, "Well, look,
|
| 19 | it's such a fast changing market, and yes, it is true
|
| 20 | that Microsoft dominates personal computer software
|
| 21 | today and Apple is a distant second, and there are these
|
| 22 | other things that aficionados use, but they really have
|
| 23 | not caught on, and now here we are 12 years later and,
|
| 24 | okay, all of that's the same." So, this whole thing
|
| 25 | about the fast-paced -- and certainly Linux is doing |
113
| 1 | better than, you know, "the operating system" did, but
|
| 2 | sometimes we do tend to exaggerate the rate at which we
|
| 3 | think markets change and certainly relative to the pace
|
| 4 | of antitrust enforcement.
|
| 5 | But the other thing is, I think, Microsoft I
|
| 6 | think is an interesting case, and maybe it comes back to
|
| 7 | one of Larry White's points, that the Microsoft case, I
|
| 8 | think it is fair to say that both sides took a
|
| 9 | Schumpeterian view. Microsoft said, "Look, this is
|
| 10 | Schumpeterian competition, someone else could come
|
| 11 | along, they will displace us, because of network
|
| 12 | effects, you would expect the winner to get a very high
|
| 13 | share in operating systems, and so leave us alone,
|
| 14 | because that's how competition occurs," and the
|
| 15 | Government said, "Okay, look, this is Schumpeterian
|
| 16 | competition. If you guys didn't do bad things --" Greg
|
| 17 | is shaking his head. Now, it is true, sometimes the
|
| 18 | Government didn't say that, but I think the only
|
| 19 | sensible interpretation of what the Government was
|
| 20 | saying was, "This is a Schumpeterian market, and,
|
| 21 | Microsoft, you are trying to stop the next wave of
|
| 22 | innovation that would have displaced you," and I am
|
| 23 | saying that's somewhat like Larry's point about saying
|
| 24 | it is not just how well you are doing in some absolute
|
| 25 | sense, but whether there is a threat that you are trying |
114
| 1 | to stop that would leave you worse off.
|
| 2 | So, I mean, I think in that one is the
|
| 3 | Schumpeterian view was consistent with saying we have to
|
| 4 | intervene, although it does shift what you look at.
|
| 5 | DR. CARLTON: All right. Well, we are about out
|
| 6 | of time, so I want to end with this, to get everybody to
|
| 7 | comment on this question.
|
| 8 | In light of all the difficulties and ambiguities
|
| 9 | with the use of market definition in section 2 cases, is
|
| 10 | it your view that we should still rely on it as we do,
|
| 11 | put less reliance on it, or go to a competitive effects
|
| 12 | and forget about market definition? So, why don't we
|
| 13 | just go down the table in order.
|
| 14 | MR. NELSON: Okay, I think I am halfway between
|
| 15 | your two extremes, because I think there are -- as I say
|
| 16 | in my slides, I think that there are organizing
|
| 17 | principles and things that the exercise -- the market
|
| 18 | definition exercise helps you understand what is going
|
| 19 | on and tell either a story or an analysis that is
|
| 20 | internally consistent, but that is not to say you have
|
| 21 | to do it in every case, and there are numerous cases
|
| 22 | where you may be able to expedite things by going
|
| 23 | straight to the competitive effects bottom line.
|
| 24 | MR. SIMONS: My take would be that the DOJ and
|
| 25 | the FTC should try to come up with something that |
115
| 1 | focuses only on competitive effects, does not worry
|
| 2 | about market share, and then see what happens over time
|
| 3 | in terms of what they come up with and how operable it
|
| 4 | is. And if the thing really works, terrific, then try
|
| 5 | to get it into the courts, but not worry about that at
|
| 6 | the outset.
|
| 7 | DR. WHITE: Yes, we ought to be looking -- I
|
| 8 | have a feeling we are going to be having all of the
|
| 9 | divergence of opinion ranging from A to B. Yes, you
|
| 10 | ought to look at competitive effects more than we have,
|
| 11 | but I think there is still going to be a role for market
|
| 12 | definition. Think about the private suits, not the
|
| 13 | government suits, but the private suits that were
|
| 14 | brought against MasterCard and Visa, and these were --
|
| 15 | you know, the -- say take a WalMart case. This was a
|
| 16 | tying case, but they were not -- it was -- you could
|
| 17 | tell some stories about how if the tie was not there,
|
| 18 | there were -- there would have been more entry somewhere
|
| 19 | in -- in the credit card markets, but it was primarily
|
| 20 | the tie is preventing us merchants from doing something
|
| 21 | we would like to do.
|
| 22 | I am not sure a competitive effects analysis is
|
| 23 | going to tell you about market definition in that
|
| 24 | particular case. Of course, MasterCard and Visa were
|
| 25 | telling you, oh, all kinds of transaction media are in |
116
| 1 | the market, you know, cash and checks and everything, we
|
| 2 | do not have market power, and they were actually trying
|
| 3 | to say it with a straight face.
|
| 4 | A market definition paradigm I think would help
|
| 5 | in that kind of case, and so yes, I think we still have
|
| 6 | need. I am hoping this is 1981, and next year, some
|
| 7 | smart people are going to come in with a useful
|
| 8 | paradigm.
|
| 9 | DR. CARLTON: Andy?
|
| 10 | DR. GAVIL: I think I agree with Larry. I think
|
| 11 | it still has a role to play, but I think as you stated,
|
| 12 | I think I would agree also that we over-rely on it, and
|
| 13 | I think somewhat complex is the problem of
|
| 14 | over-reliance. I think it can lead to both false
|
| 15 | positives and false negatives, but I think with the
|
| 16 | false positives, if somebody is found to have monopoly
|
| 17 | power, to some degree, you have the backstop of the
|
| 18 | conduct inquiry.
|
| 19 | My concern is because of the high process costs
|
| 20 | in trying to prove monopoly power in this -- as you
|
| 21 | described it accurately -- sequential model, you get
|
| 22 | false negatives, and there is no backstop to that. The
|
| 23 | case ends, and the court does not look at conduct, does
|
| 24 | not look at effects. So, I think this is an example
|
| 25 | where the over-reliance may actually increase the threat |
117
| 1 | of false negatives more so than false positives.
|
| 2 | DR. GILBERT: I would join the chorus that we
|
| 3 | need more emphasis on competitive effects. A good
|
| 4 | example, not necessarily really in the section 2
|
| 5 | context, is the Oracle merger case where in my view
|
| 6 | there was some certainly interesting evidence, if not
|
| 7 | dispositive evidence, about competitive effects, but
|
| 8 | once Judge Walker determined that he could not define a
|
| 9 | market, he then concluded that there was no market, and
|
| 10 | the competitive effects were almost ignored in that
|
| 11 | case, and to me, it is like saying that I do not know
|
| 12 | exactly where downtown Los Angeles is, and therefore,
|
| 13 | there is not one. But I also can sympathize that if we
|
| 14 | did away with market definition completely, it could be
|
| 15 | highly problematic in leading to a lot of cases.
|
| 16 | DR. KATZ: Okay, well, I guess I will say, at
|
| 17 | the risk of sounding like Bill Clinton, it depends on
|
| 18 | what one means by doing market definition, and I think a
|
| 19 | lot of times what people mean is they mean applying the
|
| 20 | hypothetical monopolist test, they mean doing a
|
| 21 | concentration analysis, and they mean trying to come up
|
| 22 | with boundaries with certainty, and then slavishly
|
| 23 | applying that, and if you cannot meet that, you throw
|
| 24 | the case out.
|
| 25 | I think that way of doing things is surely |
118
| 1 | wrong, but I think we also surely do want to do some
|
| 2 | sort of market definition exercise in the sense of
|
| 3 | identifying the competitors, and I think where we have
|
| 4 | come up short is what is the right way to do it in the
|
| 5 | middle in terms of I think we still do not have a very
|
| 6 | good sense of what is the right algorithm and the right
|
| 7 | approach in different situations.
|
| 8 | We have not mapped out, so, here is exactly
|
| 9 | where you could do the hypothetical monopolist test,
|
| 10 | here is where we need to do some alternative
|
| 11 | methodology. We do not have that, and I think the
|
| 12 | courts -- sometimes, the fact that we do not have that
|
| 13 | has become an obstacle to good decision-making, as Rich
|
| 14 | was just saying in the Oracle case, but I think the
|
| 15 | bottom line is we need to figure out a better way to do
|
| 16 | market definition, and that way we will recognize that
|
| 17 | it should not be taken overly seriously or applied too
|
| 18 | mechanically.
|
| 19 | DR. CARLTON: Thank you very much. I want to
|
| 20 | thank the people at the Department of Justice and the
|
| 21 | FTC who did all of the legwork in putting this together,
|
| 22 | and I am sure, although I have not checked with them,
|
| 23 | all of the panelists, myself included, thank Larry White
|
| 24 | for not including us in his slide of dumb quotes, and I
|
| 25 | want to personally thank everybody on the panel for |
119
| 1 | coming and giving us the benefit of their substantial
|
| 2 | expertise. I have learned a lot, and I thank you all.
|
| 3 | (Applause.)
|
| 4 | (Whereupon, at 12:36 p.m., a lunch recess was
|
| 5 | taken.)
|
| 6 |
|
| 7 |
|
| 8 |
|
| 9 |
|
| 10 |
|
| 11 |
|
| 12 |
|
| 13 |
|
| 14 |
|
| 15 |
|
| 16 |
|
| 17 |
|
| 18 |
|
| 19 |
|
| 20 |
|
| 21 |
|
| 22 |
|
| 23 |
|
| 24 |
|
| 25 | |
120
| 1 | AFTERNOON SESSION
|
| 2 | (2:01 p.m.)
|
| 3 | MR. WALES: Well, good afternoon, everybody.
|
| 4 | Thanks so much for braving the cold and the snow. I
|
| 5 | think we have a very exciting panel on tap for this
|
| 6 | afternoon. For those of you who were here for this
|
| 7 | morning, I hear it was very lively, and I am hoping that
|
| 8 | we can live up to that and be lively as well.
|
| 9 | My name is Dave Wales. I am a Deputy Director
|
| 10 | here in the Bureau of Competition at the Federal Trade
|
| 11 | Commission. I will be moderating today, along with Greg
|
| 12 | Werden, the panel. Greg is the Policy Project Director
|
| 13 | At the Economic Analysis Group at the Antitrust Division
|
| 14 | of the Department of Justice. That is his official
|
| 15 | title, and you will be hearing more from him shortly.
|
| 16 | Have you been elevated perhaps?
|
| 17 | DR. WERDEN: I have never even heard of that
|
| 18 | title.
|
| 19 | MR. WALES: Is it better than the one you have?
|
| 20 | DR. WERDEN: No, not really.
|
| 21 | MR. WALES: Not really? Sorry about that, Greg.
|
| 22 | Before we get into substance, it is my job to do
|
| 23 | a little bit of the housekeeping. First off, what I
|
| 24 | would like to do is on behalf of the FTC, to really
|
| 25 | thank our friends at DOJ in putting this together, and I |
121
| 1 | think it has been phenomenal to date, and I am sure it
|
| 2 | will continue to be that way. I would also like to
|
| 3 | thank each of our five panelists today for, again,
|
| 4 | braving the weather and coming out, and I think we have
|
| 5 | got some great issues to discuss.
|
| 6 | Today and tomorrow, I guess today and tomorrow,
|
| 7 | we have the hearings on monopoly power, and I guess what
|
| 8 | I wanted to point out is that next month we will be
|
| 9 | turning to the issue of remedies, which should also be
|
| 10 | pretty interesting. Stay tuned for that. I guess what
|
| 11 | we typically do is post the schedule on each agency's
|
| 12 | web page, so look out for those.
|
| 13 | A couple housekeeping items. First, I guess we
|
| 14 | ask that people turn off their cell phones,
|
| 15 | BlackBerries, any other electronic devices that make
|
| 16 | annoying noises. Second, importantly, restrooms are out
|
| 17 | across the lobby. In case someone needs to use those,
|
| 18 | follow the signs, you cannot miss them.
|
| 19 | Third, a safety tip for everybody, I guess in
|
| 20 | the event the fire alarms do go off, please do not
|
| 21 | panic. Please walk towards the exit, and we will guide
|
| 22 | you to I guess a safe place across the street where we
|
| 23 | will gather, hopefully with warmer coats.
|
| 24 | Lastly, I guess the way we set this up is we ask
|
| 25 | that the audience please not ask questions, and we are |
122
| 1 | going to have a lively discussion today, so you can look
|
| 2 | forward to that.
|
| 3 | Many of the prior sessions talked about
|
| 4 | obviously the conduct involved in section 2 challenges,
|
| 5 | and today, what we would like to talk about is a
|
| 6 | separate topic, which is, of course, monopoly power and
|
| 7 | defining markets when monopoly power has been alleged,
|
| 8 | and I think that is a pretty important topic, one that I
|
| 9 | think when the hearings kicked off, that Herb Hovenkamp
|
| 10 | and Dennis Carlton identified as being one of the two
|
| 11 | that they thought were probably the toughest and two
|
| 12 | that needed a lot of discussion. So, hopefully we will
|
| 13 | be able to accomplish that today.
|
| 14 | I think that is pretty much what I wanted to
|
| 15 | say, Greg. I don't know, maybe you want to give your
|
| 16 | title and anything else you want to say.
|
| 17 | DR. WERDEN: Yes. Hi, I am Greg Werden, Senior
|
| 18 | Economic Counsel in the Antitrust Division, Department
|
| 19 | of Justice. I just want to add my thanks to our
|
| 20 | panelists and the staffs of the two agencies for
|
| 21 | organizing this session.
|
| 22 | MR. WALES: Great, thanks.
|
| 23 | The way the format is going to work today is
|
| 24 | similar to what we have done previously and did this
|
| 25 | morning. First, we are going to have each presenter |
123
| 1 | give about a 15 to 20-minute oral presentation, and then
|
| 2 | what we will probably do is take a break either in the
|
| 3 | middle of that or towards the end of that, we will see
|
| 4 | how long things go, after which we are going to have a
|
| 5 | moderated discussion where we will give each panelist an
|
| 6 | opportunity to respond to the other panelists and also
|
| 7 | for Greg and I to pose some questions and some
|
| 8 | principles that we think we might be able to move
|
| 9 | towards convergence on.
|
| 10 | With that, I guess what I would like to do is
|
| 11 | introduce Simon, our first speaker. Simon is a partner
|
| 12 | and co-founder of RBB Economics. He has been advising
|
| 13 | clients on competition policy issues since 1991 and has
|
| 14 | particular expertise in applying empirical techniques in
|
| 15 | the context of merger investigations. In addition to
|
| 16 | his private sector work, Simon has been seconded for a
|
| 17 | short period of time to the German Federal Cartel
|
| 18 | Office, where he gave a series of seminars on use of
|
| 19 | economics in competition law. Simon has published
|
| 20 | widely on virtually all aspects of competition law
|
| 21 | economics and is a regular speaker at competition law
|
| 22 | conferences. He is a co-author of The Economics of EC
|
| 23 | Competition Law and has worked on several hundred
|
| 24 | competition law matters spanning virtually all sectors
|
| 25 | of the economy. Thanks, Simon. |
124
| 1 | MR. BISHOP: Long intro, and you forgot to say I
|
| 2 | am from Europe. I am up first, and given that it was
|
| 3 | probably a lively session this morning, I think probably
|
| 4 | the reason I have been chosen to go first is because my
|
| 5 | topic this afternoon is probably the dryest and most
|
| 6 | technical, which is my remarks are really going to
|
| 7 | concern the Cellophane fallacy and what implications
|
| 8 | that has for a structural approach to assessing
|
| 9 | monopolization or what we Europeans talk about as an
|
| 10 | abuse of dominant position.
|
| 11 | I am also going to say that my remarks are also
|
| 12 | sort of Euro-centric in the sense of this really
|
| 13 | reflects my experience of EU cases and European national
|
| 14 | competition law cases and not really the U.S. case law;
|
| 15 | however, given that we are all in this facade, one might
|
| 16 | say, or claims that there is increasing convergence
|
| 17 | between Europe and the U.S., I hope that some of these
|
| 18 | remarks will actually carry over to U.S. antitrust.
|
| 19 | Now, in order to give this some sort of context,
|
| 20 | in Europe, as in the U.S., we are engaged in an ongoing
|
| 21 | reform of Article 82, which is the equivalent of the
|
| 22 | monopolization act, and last year, the European
|
| 23 | Commission, of which Miguel was heavily involved, issued
|
| 24 | guidelines on how to reform Article 82 and to move the
|
| 25 | current system away from a form-based approach to a much |
125
| 1 | more effects-based approach.
|
| 2 | Now, that is all very admirable, but it seems to
|
| 3 | me that within these guidelines of reform, there is the
|
| 4 | elephant in the room which no one really wants to talk
|
| 5 | about; namely, the concept of dominance. Really,
|
| 6 | dominance is also based on structural market share. In
|
| 7 | Europe, we have the two-step process, whether a firm is
|
| 8 | found to be dominant and then whether, if that firm is
|
| 9 | found to be dominant, whether that behavior constitutes
|
| 10 | an abuse of a dominant position.
|
| 11 | Now, as I said, all the focus has been on the
|
| 12 | second step, but the problem is is that within Europe,
|
| 13 | certainly how the courts have interpreted dominance and,
|
| 14 | indeed, some of Miguel's colleagues in the Commission
|
| 15 | also, is that if you are dominant, then any behavior
|
| 16 | which affects or harms competitors is almost deemed to
|
| 17 | necessarily harm competition, and if you take that
|
| 18 | approach, then that really means there is no role for an
|
| 19 | effects-based analysis within European antitrust under
|
| 20 | Article 82.
|
| 21 | It also means that the dominance, and therefore
|
| 22 | the market share calculations and market definition, are
|
| 23 | absolutely paramount in the whole assessment. Now, we
|
| 24 | all know that from the sort of 1982 U.S. Merger
|
| 25 | Guidelines, there has been pretty wide acceptance that |
126
| 1 | the hypothetical monopolist test or the SSNIP test has
|
| 2 | provided the appropriate framework for assessing and
|
| 3 | defining relevant markets. We also know that, even
|
| 4 | though we have the framework and that is well accepted,
|
| 5 | in actual individual cases, it is actually quite hard
|
| 6 | sometimes to actually implement that test. Actually, in
|
| 7 | monopolization cases or abuse of dominance cases, things
|
| 8 | are even more difficult because of the existence of the
|
| 9 | Cellophane fallacy.
|
| 10 | Now, what is the Cellophane fallacy? What are
|
| 11 | the problems? Well, in a merger context, which is where
|
| 12 | the SSNIP test or hypothetical monopolist test was first
|
| 13 | proposed, we are interested in what has the merger
|
| 14 | changed? Is it going to relax competitive constraints
|
| 15 | at prevailing price levels? Now, that has an important
|
| 16 | implication, because that says we can use existing data,
|
| 17 | observed data, to assess the strength of existing
|
| 18 | competitive constraints between products supplied by the
|
| 19 | merging parties.
|
| 20 | However, when we talk about monopolization
|
| 21 | cases, in many cases -- and some might argue in all --
|
| 22 | the relevant issue is not whether the prices can go up
|
| 23 | even further from prevailing levels, but actually, have
|
| 24 | prices already been increased above competitive levels?
|
| 25 | Now, the important implication of that is that using |
127
| 1 | observed data will tend to overstate the competitive
|
| 2 | constraint, because as we know from the famous DuPont
|
| 3 | Cellophane case, is that even a monopolist, if you put
|
| 4 | up prices far enough, something is going to start
|
| 5 | looking like an effective substitute at some point,
|
| 6 | because even monopolists face some constraint. So, the
|
| 7 | real issue here I think from the Cellophane fallacy is
|
| 8 | what implications does it have for the use of empirical
|
| 9 | analysis?
|
| 10 | Now, that is a case of sort of, well, what do we
|
| 11 | do about this? We know that the Cellophane fallacy
|
| 12 | exists, and we know that that has a big impact on how we
|
| 13 | can interpret and use existing data. Well, there are a
|
| 14 | number of approaches which have been put forward to try
|
| 15 | and address the Cellophane fallacy. One which has been
|
| 16 | put forward in a number of cases both by the European
|
| 17 | Commission and some national competition authorities in
|
| 18 | Europe is to say, "Well, the hypothetical monopolist
|
| 19 | test is only one way of defining a relevant market."
|
| 20 | Well, the question or the problem with that sort
|
| 21 | of line of argument is, they do not actually tell you
|
| 22 | what the alternative ways of defining a relevant market
|
| 23 | are, and what is good about the hypothetical monopolist
|
| 24 | test is it is forcing people to at least think about the
|
| 25 | scope for demand-side substitution and supply-side |
128
| 1 | substitution, and if those two things are not part of
|
| 2 | the approach of defining a relevant market, it seems to
|
| 3 | me that, indeed, any other alternative approach is
|
| 4 | useless for antitrust purposes.
|
| 5 | The second approach to trying to deal with the
|
| 6 | Cellophane fallacy is, "Well, let's just recalculate
|
| 7 | everything from the competitive price." Well, great
|
| 8 | idea, but if we knew what the competitive price is, then
|
| 9 | we would not need to be defining what the relevant
|
| 10 | market is. We could just say, "Well, we observed that
|
| 11 | Firm X is charging 10, we know the competitive price is
|
| 12 | 5; therefore, there must be some sort of exercise of
|
| 13 | market power going on." But that is not how the real
|
| 14 | world works.
|
| 15 | So, as a slight anecdote here, I was reading in
|
| 16 | some of the trial transcripts in the Microsoft case, one
|
| 17 | of the economists I think it was for the DOJ was asked,
|
| 18 | "Well, what is the competitive price that Microsoft
|
| 19 | should charge?" The answer was, "Lower than they
|
| 20 | currently charge," which seems to me sort of just
|
| 21 | demonstrate the difficulties of actually re-adjusting
|
| 22 | what the competitive price is. So, that is not going to
|
| 23 | get us anywhere.
|
| 24 | The third approach is, "Well, let's just ignore
|
| 25 | the Cellophane fallacy; pretend it does not happen." |
129
| 1 | Well, again, that is not going to work, because if you
|
| 2 | ignore it and just apply empirical analysis, you are
|
| 3 | going to tend to define relevant markets too widely, and
|
| 4 | therefore, not capture some market power when we should
|
| 5 | be capturing it.
|
| 6 | The fourth approach which has been proposed,
|
| 7 | which is, "Well, let's do away with market definition
|
| 8 | altogether. It is difficult -- we have got the
|
| 9 | Cellophane fallacy, you know, we are very smart economic
|
| 10 | professors or consultants, and we can just sort out --
|
| 11 | you know, market definition is just an interim step. We
|
| 12 | can go straight to the answer." Well, personally, I am
|
| 13 | a bit more humble than that, and I think if we see the
|
| 14 | relevant market definition and the structural analysis
|
| 15 | for what it is, i.e., an intermediate step, I think it
|
| 16 | is important that we keep that step.
|
| 17 | Secondly, if you do away with it, it actually
|
| 18 | introduces real scope for ad hoc analysis. There is a
|
| 19 | real -- we know that particularly in the areas of
|
| 20 | exclusionary abuses or exclusionary power, trying to
|
| 21 | discriminate between behavior which just merely harms
|
| 22 | competitors and is therefore procompetitive from that
|
| 23 | which harms competitors and drives them out of the
|
| 24 | market and leads to harm to consumers is very, very
|
| 25 | difficult, and really, the market definition structural |
130
| 1 | screen provides a good touchstone to prevent people from
|
| 2 | adopting "I know abusive behavior when I see it."
|
| 3 | So, I think that sort of a summary of this is
|
| 4 | really we are stuck with the hypothetical monopolist
|
| 5 | test, the SSNIP test, as a framework for thinking about
|
| 6 | how we define relevant markets, and we are also stuck
|
| 7 | with the Cellophane fallacy. We need to accept that it
|
| 8 | exists. So, what are my proposed implications for the
|
| 9 | sort of policy?
|
| 10 | Well, a structural analysis still can provide a
|
| 11 | very useful filter, and even recognizing the existence
|
| 12 | of the Cellophane fallacy, I think we can go through a
|
| 13 | number of steps, that we can define relevant markets
|
| 14 | which are consistent with the basic principles of the
|
| 15 | hypothetical monopolist test. So, if someone proposes a
|
| 16 | relevant market and that it does not seem to be
|
| 17 | consistent with the principles of demand-side
|
| 18 | substitution or supply-side substitution, then it is not
|
| 19 | a relevant market. So, I think even just using the
|
| 20 | SSNIP test as a thought process can actually provide a
|
| 21 | useful discipline on how to define relevant markets.
|
| 22 | Secondly, we know the Cellophane fallacy exists,
|
| 23 | but if the parties are arguing for a wide market
|
| 24 | definition, then they at least ought to be able to
|
| 25 | demonstrate that at prevailing prices, there is |
131
| 1 | substitution. Now, that means that it does not stop
|
| 2 | with saying, "Well, the price has already been increased
|
| 3 | above competitive levels and is subject to the
|
| 4 | Cellophane fallacy," but at least they should be able to
|
| 5 | show that at prevailing prices, there is a competitive
|
| 6 | constraint between product A and product B if they are
|
| 7 | arguing they are in the same relevant market.
|
| 8 | The third element I think is we can look at
|
| 9 | product characteristics in the marketplace, but again, I
|
| 10 | think we should be careful about how we look at that,
|
| 11 | and this really goes back to my first point, which is
|
| 12 | consistency with basic principles, is it is not saying
|
| 13 | that these two products are not in the same relevant
|
| 14 | market because they look different or have different
|
| 15 | product characteristics. We are saying they are not in
|
| 16 | the same relevant market because the differences in
|
| 17 | product characteristics imply that demand-side
|
| 18 | substitution or supply-side substitution is unlikely.
|
| 19 | The fourth element is that there are some cases
|
| 20 | and there is some evidence which is not subject to the
|
| 21 | Cellophane fallacy which we can use to discriminate
|
| 22 | between competing claims, and as always, there is a
|
| 23 | paper by Greg Werden, who addresses this, and I think it
|
| 24 | was from about 2000.
|
| 25 | The second policy issue is, well, we have |
132
| 1 | defined the relevant market, we have calculated some
|
| 2 | market shares, and clearly we need to put that into
|
| 3 | context. We need to take into account the scope of all
|
| 4 | barriers for entry, expansion, the scope of buyer power,
|
| 5 | whether the market is subject to bidding competition,
|
| 6 | and also general market dynamics.
|
| 7 | My final comment was really, well, let's be
|
| 8 | humble here, because we can go through all of these
|
| 9 | steps, but in a lot of cases, the available evidence
|
| 10 | will not allow us to discriminate between the wide
|
| 11 | market definition which the parties are putting forward
|
| 12 | and the narrow market definition which the agencies are
|
| 13 | going to be putting forward. Everything may be
|
| 14 | consistent with the basic principles of the hypothetical
|
| 15 | monopolist test, the parties can show that at prevailing
|
| 16 | prices there is substitution and so on and so on, and
|
| 17 | where you have got these two competing potential market
|
| 18 | definitions, sometimes that will not be a problem,
|
| 19 | because the market shares in both of those may be low,
|
| 20 | and then unlikely to have market power. Alternatively,
|
| 21 | market shares in both of those could be high, and then
|
| 22 | that is not really a problem, because the market power
|
| 23 | is reasonably high. The difficulty or the problem,
|
| 24 | potential problem, is where in one market, the narrow
|
| 25 | market, the firm has a high market share, and in the |
133
| 1 | wide market, it has a low.
|
| 2 | It seems to me when you are in those situations,
|
| 3 | all it says is, well, then we really need to have some
|
| 4 | pretty good evidence and examination of the business
|
| 5 | conduct, and this I think brings me back to where we are
|
| 6 | in Europe, is that a lot of times in Europe, with the
|
| 7 | current situation, the business conduct is not assessed
|
| 8 | on the market effects, but actually on the form of the
|
| 9 | business conduct. So, the reform in Europe is certainly
|
| 10 | going in the right direction in focusing on the form,
|
| 11 | and that is the end of my comments.
|
| 12 | Thank you.
|
| 13 | MR. WALES: Thanks very much, Simon.
|
| 14 | (Applause.)
|
| 15 | MR. WALES: Our second speaker is Miguel de la
|
| 16 | Mano. Miguel joined the European Commission in 2001 and
|
| 17 | is currently a member of the Chief Competition
|
| 18 | Economist's Team. He carries out economic analysis in
|
| 19 | mergers and commercial practices by dominant companies
|
| 20 | and their impact on the competitive structure of the
|
| 21 | markets. He is also responsible for drafting
|
| 22 | guidelines, setting the Commission's analytical
|
| 23 | framework in these areas, a key area. He completed
|
| 24 | graduate studies in economics at The Institute For the
|
| 25 | World Economics in Kiel, Germany and The European |
134
| 1 | Institute at Saarbrucken University, Germany. He
|
| 2 | conducted his Ph.D. research at Oxford.
|
| 3 | With that, Miguel? Thanks.
|
| 4 | MR. de la MANO: Thank you very much. It is
|
| 5 | definitely a pleasure and also a great honor to
|
| 6 | participate on this panel today together with so many
|
| 7 | distinguished and well-experienced practitioners.
|
| 8 | I will try to contribute to this issue basically
|
| 9 | by offering a view or an assessment of the way in which
|
| 10 | dominance or the role that dominance plays today in
|
| 11 | competition policy assessment in Europe and which, as
|
| 12 | you know, is enshrined in Article 82, which is the
|
| 13 | equivalent of section 2 here in the U.S.
|
| 14 | As you also know and as Simon has remarked, the
|
| 15 | Commission is in the process of reviewing its policy in
|
| 16 | the area of Article 82, and like every type of reform,
|
| 17 | it is somewhat case-dependent, and we are constrained by
|
| 18 | case law and case practice; however, we believe that the
|
| 19 | time is right basically to align the implementation or
|
| 20 | the enforcement of Article 82 to current thinking and
|
| 21 | current economic knowledge, and, of course, to a more
|
| 22 | modern analytical framework.
|
| 23 | So, I will basically start by making a somewhat
|
| 24 | obvious remark, yet actually crucial, which is that in
|
| 25 | the context of the analysis of monopolization in Europe, |
135
| 1 | dominance is a necessary condition. That is how the
|
| 2 | system has been set up, and the EU Treaty actually
|
| 3 | prohibits single-firm conduct that harms consumers only
|
| 4 | when undertaken by a dominant company, and normally, to
|
| 5 | ensure the efficiency of the decision-making process,
|
| 6 | this also means that the first step of the analysis is
|
| 7 | to establish whether or not a single firm actually is in
|
| 8 | a dominant position or not. It is not a must, but that
|
| 9 | is just the best way forward. If a single firm is not
|
| 10 | dominant, then there is no need to proceed any further.
|
| 11 | At the same time, a somewhat more subtle point,
|
| 12 | this also rules out what in the U.S. is attempted
|
| 13 | monopolization. If you are not dominant in the first
|
| 14 | place in the EU, basically there is nothing you can do
|
| 15 | that will violate Article 82, and I think this is an
|
| 16 | important point, because it somewhat dispels the myth
|
| 17 | that in the EU, there is a serious concern or serious
|
| 18 | worry with type II errors; namely, false acquittals. I
|
| 19 | think personally that is not the case.
|
| 20 | But what are the reasons for this institutional
|
| 21 | setup? I can think basically of two primary reasons.
|
| 22 | Number one is to provide legal certainty. Surely it is
|
| 23 | better for firms to know in what circumstances they may
|
| 24 | be liable to and they are obligated to. There is also
|
| 25 | another reason, which is that we should not forget, it |
136
| 1 | was member states that have delegated the powers to a
|
| 2 | rather independent body, namely the European Commission,
|
| 3 | to enforce competition policy in their name, and when
|
| 4 | delegating such powers, member states want some
|
| 5 | assurances that these powers will not be abused, and
|
| 6 | therefore, forcing the Commission to start off by
|
| 7 | assessing whether or not a firm is dominant imposes some
|
| 8 | sort of discipline, which understandably was necessary
|
| 9 | for member states to delegate such powers.
|
| 10 | However, unfortunately, despite the best wishes
|
| 11 | of everybody at the time, maybe 30 years ago, it has not
|
| 12 | fully worked, and I think there are three reasons why it
|
| 13 | has not fully worked, which I would like to share with
|
| 14 | you and hopefully also in doing so contribute to the
|
| 15 | thinking that is taking place here in the U.S. with
|
| 16 | respect to monopolization.
|
| 17 | The first reason why they do not work is the
|
| 18 | concept of dominance is somewhat elusive. The member
|
| 19 | states put it into Article 82; however, no definition
|
| 20 | was actually provided. That was left for the courts to
|
| 21 | develop one over time.
|
| 22 | However, as is normal, the courts were actually
|
| 23 | reacting to cases that were brought to them, and they
|
| 24 | were not necessarily thinking in the abstract, well,
|
| 25 | what is it that dominance should mean? How should it be |
137
| 1 | defined? But instead, we are reacting to the
|
| 2 | circumstances.
|
| 3 | Of course, it became increasingly complex and
|
| 4 | increasingly difficult to understand exactly what
|
| 5 | dominance is as time went by and European courts were
|
| 6 | issuing rulings where the concept of dominance was
|
| 7 | mentioned or in some cases defined.
|
| 8 | Of course, what happened ultimately is that,
|
| 9 | before the Commission, it became increasing difficult to
|
| 10 | identify what is dominance, and therefore, the more
|
| 11 | difficult it was, the more elements which would normally
|
| 12 | go into the competitive assessment creeped into the
|
| 13 | assessment of dominance, up to a point where it seems,
|
| 14 | at least to me, that as Simon pointed out before,
|
| 15 | assessing dominance became an end in itself to the
|
| 16 | extent that once dominance had been established, it was
|
| 17 | not just a necessary condition but almost sufficient for
|
| 18 | a finding of abuse.
|
| 19 | Now, I think that these three concerns can be
|
| 20 | corrected, and this is, of course, the rationale for the
|
| 21 | review process, and I would just like to share with you
|
| 22 | the three ways in which I think this can be done.
|
| 23 | So, first of all, again, a rather obvious
|
| 24 | statement, but somewhat important in a context where
|
| 25 | European courts have said that the dominant firms have a |
138
| 1 | special responsibility, whatever that might mean,
|
| 2 | dominance should be defined or equated with substantial
|
| 3 | market power. Now, of course, all firms have some
|
| 4 | market power, but most of them have very little, and
|
| 5 | accordingly, the relevant question in antitrust cases
|
| 6 | should not be whether market power is present or not --
|
| 7 | it always is -- but whether it is important, that is,
|
| 8 | whether it is substantial.
|
| 9 | In going back to the sort of most established
|
| 10 | definition of dominance by the ECJ, dominance is said to
|
| 11 | be a situation where a company has the power to behave
|
| 12 | to an appreciable extent independently of its
|
| 13 | competitors, customers and ultimately its consumers, and
|
| 14 | a close look at this definition suggests, indeed, that
|
| 15 | dominance can be equated to significant market power,
|
| 16 | and this is because a firm is dominant if its decisions
|
| 17 | are fairly insensitive to reactions of competitors and
|
| 18 | customers. That is what the "to an appreciable extent"
|
| 19 | actually means. Of course, no firm is fully independent
|
| 20 | of customers and competitors, that we know from economic
|
| 21 | theory, but to an appreciable extent, it might well be.
|
| 22 | The measure of this sensitivity, of the
|
| 23 | sensitivity to the actions of others, is given by an
|
| 24 | elasticity, which is, again, the other side of the way
|
| 25 | that economists would measure market power in practice. |
139
| 1 | So, we end up with a situation where to behave
|
| 2 | independently to an appreciable extent can be definitely
|
| 3 | equated to an ability to significantly and profitably
|
| 4 | durably increase prices, and therefore, there should be
|
| 5 | no more debate about what is dominance, just substantial
|
| 6 | market power.
|
| 7 | Now, how is this substantial market power to be
|
| 8 | established? Well, again, this is not new to anyone,
|
| 9 | but I would argue that first market shares have to be
|
| 10 | significant, and significant in two senses. First, they
|
| 11 | have to be significant in that they must be important,
|
| 12 | high, but also significant in that they are actually
|
| 13 | providing a good proxy for the relative insensitivity of
|
| 14 | the single firm to the actions and reactions of its
|
| 15 | competitors and customers. There is, again, a good
|
| 16 | paper by Greg Werden which talks about assigning market
|
| 17 | share and how difficult this process actually is.
|
| 18 | The second point is that barriers to entry and
|
| 19 | expansion have to be significant, and by this I would
|
| 20 | like to emphasize that we mean in the absence of the
|
| 21 | conduct, not barriers to entry in general, but in the
|
| 22 | absence of the conduct, if the conduct itself actually
|
| 23 | increases barriers to entry or barriers to expansion.
|
| 24 | Now, that is part of the anticompetitive effects of such
|
| 25 | conduct, and therefore, it should not be seen as an |
140
| 1 | element that plays a role in establishing dominance.
|
| 2 | Of course, there are other elements like
|
| 3 | dynamics of the market, there should be no technological
|
| 4 | leapfrogging, and buyer power, it cannot be shown that
|
| 5 | the customers have very little countervailing buyer
|
| 6 | power.
|
| 7 | Now, I will try to make here a rather
|
| 8 | provocative statement, but in my view, the acid test,
|
| 9 | the way to ensure whether a company is dominant or not,
|
| 10 | is to ask, well, is it the most efficient in the market?
|
| 11 | Because if it is, it is likely to have high market
|
| 12 | shares, it is likely to be very difficult to enter
|
| 13 | successfully and profitably, and it is also going to be
|
| 14 | very difficult possibly to leapfrog.
|
| 15 | However, one might argue, well, isn't this just
|
| 16 | the old efficiency offense? Well, I do not think this
|
| 17 | is an offense, because I personally think there is
|
| 18 | nothing wrong with being dominant. There is no offense
|
| 19 | in being dominant, and companies should not feel that an
|
| 20 | assessment of dominance actually implies that this is
|
| 21 | going to lead to a finding of anticompetitive behavior
|
| 22 | on their part. Quite the opposite, a finding of
|
| 23 | dominance should in most cases just mean that they are
|
| 24 | probably the most efficient company out there.
|
| 25 | This takes me to the final point, which is that |
141
| 1 | dominance is not only a screen. It is not an end in
|
| 2 | itself. It is just a screen to try and filter out, as
|
| 3 | Simon was saying, those situations where there might be
|
| 4 | scope for significant harm to consumers resulting from
|
| 5 | certain conduct from other situations where this is very
|
| 6 | unlikely to happen.
|
| 7 | Now, it is clear that if a practice is shown to
|
| 8 | be anticompetitive, the firm must be dominant, but
|
| 9 | proving that a practice is anticompetitive is hard, and
|
| 10 | it takes a lot of time and resources. Therefore, it
|
| 11 | seems like assessing dominance can play a very important
|
| 12 | role in acting as a screen, and it is also a screen that
|
| 13 | bites. It bites because large firms may not necessarily
|
| 14 | be dominant if innovation is taking place at a rapid
|
| 15 | place, if there is fierce competition between large
|
| 16 | players, for instance, in the concept of bidding
|
| 17 | markets, or if there is strong disciplining by potential
|
| 18 | entrants or customers.
|
| 19 | Now, I am just going to briefly go into a
|
| 20 | non-hypothetical example, which unfortunately I am not
|
| 21 | allowed to get into further details of the market, but
|
| 22 | where actually I will be able to show to you that the
|
| 23 | Commission takes very seriously the dominance screen and
|
| 24 | it actually works in practice.
|
| 25 | We had a case not long ago where the defendant |
142
| 1 | had very high market shares in a homogenous good market,
|
| 2 | above 60 percent. There were very important and
|
| 3 | significant barriers to entry, like large overcapacity
|
| 4 | on the part of the dominant company, declining demand,
|
| 5 | high fixed costs to establish new facilities, but also
|
| 6 | strong learning effects in the process. It was common
|
| 7 | practice in the industry to use very long-term
|
| 8 | contracts, which, of course, we argued would limit
|
| 9 | customer switching, and not the least of which the
|
| 10 | defendant seemed to be in a very strong position to fend
|
| 11 | entry given that it had the broadest product range and
|
| 12 | the largest financial resources. So, with this criteria
|
| 13 | on the table, one would very easily conclude that this
|
| 14 | company is actually dominant.
|
| 15 | Well, actually, the Commission concluded it was
|
| 16 | not, and this was on five counts. First, there was
|
| 17 | significant buyer concentration. The top three
|
| 18 | customers took 70 percent of the market. There was
|
| 19 | product homogeneity, which allowed them to switch
|
| 20 | suppliers without incurring significant switching costs,
|
| 21 | and buyers, indeed, have dual sourcing strategy to shift
|
| 22 | volumes between suppliers with little transaction costs.
|
| 23 | Rival suppliers had significant overcapacity which they
|
| 24 | could use to expand, and therefore, there were no
|
| 25 | barriers to expansion. It was also found that the |
143
| 1 | competition mechanism was bidding for large and very
|
| 2 | occasional contracts, just every few years.
|
| 3 | So, I would just like to conclude with two
|
| 4 | remarks, one on market shares and one on market
|
| 5 | definition, linking it to what Simon has said. First,
|
| 6 | on market shares, it is, often said that there should be
|
| 7 | a bright line safe harbor, and also that, only firms who
|
| 8 | are market leaders can ever be dominant. I think the
|
| 9 | latter makes no economic sense, and this is clear given
|
| 10 | the application of unilateral effects in the area of
|
| 11 | merger control, and, of course, at least in the context
|
| 12 | of European competition policy, the dominance concept
|
| 13 | plays a role both in mergers and antitrust, so they are
|
| 14 | interlinked.
|
| 15 | However, bright line safe harbors do make sense;
|
| 16 | however, I believe the threshold should be set rather
|
| 17 | low, and this is for four reasons. First of all, rivals
|
| 18 | might be constrained. For example, in the electricity
|
| 19 | industry, this happens very often. You might have
|
| 20 | strong multi-market presence, like in the airline
|
| 21 | industry, if you have one company who is number two in a
|
| 22 | number of routes and the number one company in each one
|
| 23 | of the routes is a different one, one can argue that
|
| 24 | this company who was number two everywhere is actually
|
| 25 | more dominant or has more significant market power given |
144
| 1 | this multi-market context than anyone who just has a
|
| 2 | leadership position in one individual route.
|
| 3 | Market leaders are more constrained by
|
| 4 | regulation than nonleaders, and that can be the case in
|
| 5 | certain industries, such as telecoms, and the leader may
|
| 6 | be more constrained by close substitutes or by new
|
| 7 | entry, for example, in the case of pharma. There was a
|
| 8 | case of AstraZeneca in the EU not long ago where this
|
| 9 | was clearly an issue.
|
| 10 | So, what are the policy implications for not
|
| 11 | arguing that only if you are the market leader, you can
|
| 12 | be dominant? There are at least two. One is that for
|
| 13 | consistency, I will just mention unilateral effects in
|
| 14 | mergers, but also, to leave the door slightly open for
|
| 15 | attempted monopolization in the EU, in the EU policy.
|
| 16 | Then just one very short and final remark on
|
| 17 | market delineation, which I will just start by saying
|
| 18 | that I agree with everything that Simon has said, but
|
| 19 | unfortunately, even though I think we ought to be humble
|
| 20 | and I definitely agree with that, the EU Commission is
|
| 21 | forced to be arrogant, because in a sense, we are
|
| 22 | obliged to take decisions. We have to say what we think
|
| 23 | about the market. We cannot leave definitions open. We
|
| 24 | have to say whether we think it is narrow or we think it
|
| 25 | is wide, whether or not we win the case, and this is a |
145
| 1 | problem.
|
| 2 | This is a problem because we cannot just say,
|
| 3 | well, you know, let's ignore the Cellophane fallacy or
|
| 4 | let's think about the Cellophane fallacy as something
|
| 5 | that plays a very significant role and there is nothing
|
| 6 | we can do about it, so we just be humble. That we
|
| 7 | cannot afford to do.
|
| 8 | However, I think we do not have to lose all
|
| 9 | hope, because when thinking about the role or the
|
| 10 | assessment that dominance plays, particularly thinking
|
| 11 | of dominance as a screen, I think that even if we
|
| 12 | recognize that the hypothetical monopoly test, the SSNIP
|
| 13 | test, is, indeed, a useful conceptual framework to
|
| 14 | identify competitors that are constraining a single
|
| 15 | firm, the assessment of dominance actually goes a step
|
| 16 | further, and not just ask the question, well, which are
|
| 17 | the firms that are there constraining the incumbent, but
|
| 18 | actually asking, well, how much are they constraining
|
| 19 | the incumbent?
|
| 20 | So, in trying to figure out how much is the
|
| 21 | incumbent being constrained or the defendant being
|
| 22 | constrained, we can also have a good glimpse into which
|
| 23 | other firms that are part of that particular market, and
|
| 24 | therefore, market delineation can in some cases -- not
|
| 25 | always, but in some cases -- be a by-product of the |
146
| 1 | dominance assessment, and this obviously simply reflects
|
| 2 | that market definition is a means to an end, and what
|
| 3 | the real issue is is market power.
|
| 4 | Thank you very much for your attention.
|
| 5 | (Applause.)
|
| 6 | MR. WALES: Thank you, Miguel.
|
| 7 | Next up we have Tom Krattenmaker. Dean
|
| 8 | Krattenmaker is currently Of Counsel in the Washington,
|
| 9 | D.C. office of Wilson Sonsini Goodrich & Rosati, where
|
| 10 | he focuses on antitrust, telecommunications and trade
|
| 11 | regulation issues. Immediately prior to joining Wilson
|
| 12 | Sonsini, Tom was an attorney in the Federal Trade
|
| 13 | Commission's Bureau of Competition, Office of Policy and
|
| 14 | Coordination, where I had the pleasure of working with
|
| 15 | him for too short a time, but really enjoyed my time
|
| 16 | working with him. In that role he principally served as
|
| 17 | legal adviser to the bureau directors and to attorneys
|
| 18 | investigating and litigating antitrust cases and advised
|
| 19 | on several Bureau and Commission public reports.
|
| 20 | Previously he served as senior counsel in the Department
|
| 21 | of Justice's Antitrust Division and held positions at
|
| 22 | the Federal Communications Commission, including Chief
|
| 23 | of Telecommunications Merger Review and Director of
|
| 24 | Research and Co-Director of the Network Inquiry Special
|
| 25 | Staff. Tom has spent more than 30 years in legal |
147
| 1 | education. He was a Professor at the University of
|
| 2 | Connecticut, Professor and Associate Dean at Georgetown
|
| 3 | University and the Dean of William & Mary School of Law.
|
| 4 | Thanks, Tom.
|
| 5 | MR. KRATTENMAKER: Hello. I'd like to begin by
|
| 6 | thanking Dave and Greg for giving me this monopoly
|
| 7 | platform for 15 or 20 minutes and am particularly
|
| 8 | appreciative for you surrounding the platform with the
|
| 9 | entry barriers with your declaration that there be no
|
| 10 | questions from the audience.
|
| 11 | I also would love to be able to take refuge in
|
| 12 | the defense offered by Miguel that he was forced to be
|
| 13 | arrogant. The problem is that there is at least one
|
| 14 | member of the audience I see here who was one of my law
|
| 15 | school classmates, so he knows darn well that I have
|
| 16 | chosen to be arrogant. So, what I would like to say
|
| 17 | honestly is that I am going to sound more assured about
|
| 18 | my views than I am. I have asked that on my tombstone
|
| 19 | they write something like, "Often wrong but never in
|
| 20 | doubt," so if you really do not like what I am saying,
|
| 21 | say, "Oh, Tom's just trying to be provocative again."
|
| 22 | Dave can tell you that he has said that many times and
|
| 23 | enabled himself to get home without going home in a funk
|
| 24 | or thinking that they have to let me go the next day.
|
| 25 | The other thing I want to say at the beginning |
148
| 1 | is that aside from the fact that I am quite honestly
|
| 2 | flattered to have been invited to join this group, I am
|
| 3 | more interested in trying to respond to questions than
|
| 4 | saying anything in particular, so please do send up a
|
| 5 | flag after 10 or 15 minutes, and I will just stop. I
|
| 6 | have four points to make, and if we only get three of
|
| 7 | them out, I am sure I will be able to smuggle the fourth
|
| 8 | one in somewhere later on.
|
| 9 | I am speaking largely off a text -- I am not
|
| 10 | going to read it to you -- of an article that I
|
| 11 | published with a couple of really outstanding antitrust
|
| 12 | lawyers and scholars, Bob Lande and Steve Salop in the
|
| 13 | Georgetown Law Journal in 1987 called Monopoly Power and
|
| 14 | Market Power in Antitrust Law. It turns out that even
|
| 15 | though that is 20 years ago, I think it is still right,
|
| 16 | so if you want to have a look at that, that is where I
|
| 17 | am coming from.
|
| 18 | The first point I wanted to make I think is one
|
| 19 | where we could say I am preaching to the choir, so I
|
| 20 | will go through it quickly, but it is not a trivial
|
| 21 | point, and that is, what do we mean by market power? I
|
| 22 | think my sense is that in this room, we are all
|
| 23 | co-religionists; that is, we all think that market power
|
| 24 | is the ability to price profitably for a significant
|
| 25 | period of time above the competitive level for that |
149
| 1 | market.
|
| 2 | I might just stop to observe that that has
|
| 3 | hardly been the history, the unbroken history, of
|
| 4 | antitrust. We have had many other tests of whether
|
| 5 | something is anticompetitive or not. Justice Douglas
|
| 6 | once opined that a merger was anticompetitive because it
|
| 7 | would lead to moving the corporate headquarters of the
|
| 8 | firm from a small town on the West Coast to big, bad New
|
| 9 | York City. Justice Black once told us that a merger was
|
| 10 | anticompetitive because there would be fewer
|
| 11 | single-store grocery stores in Los Angeles.
|
| 12 | We seem to have, at least at this point in time,
|
| 13 | a consensus that we have an economic concept of market
|
| 14 | power, and it is the ability profitably to price above
|
| 15 | competitive levels for a significant period of time, and
|
| 16 | I know that for crystallizing that definition, one of
|
| 17 | the people we really have to thank for that is Greg.
|
| 18 | Another question that I think I was asked to
|
| 19 | address is what is the difference between monopoly power
|
| 20 | and market power? Now, syntactically, "monopoly" sounds
|
| 21 | like -- it says, well, how can you have monopoly power
|
| 22 | unless you have complete control over a relevant market?
|
| 23 | You must have to have a 100 percent share of a relevant
|
| 24 | antitrust market that is surrounded by entry barriers.
|
| 25 | I suppose -- I do not know, I didn't look at a |
150
| 1 | dictionary, I should have -- you could say that is it.
|
| 2 | That is certainly not the case law definition,
|
| 3 | and I think, again, within the current antitrust
|
| 4 | community, nobody would doubt that. I think the right
|
| 5 | answer is that it is the same as market power. There
|
| 6 | are some cases out there where there is noise in the
|
| 7 | opinions that suggests that there is some kind of
|
| 8 | difference between market power in monopoly power, but
|
| 9 | it does not seem to make any sense. That is, market
|
| 10 | power and monopoly power and antitrust law are and
|
| 11 | should be synonymous. They can occur in various
|
| 12 | degrees, but they are qualitatively the same.
|
| 13 | Of course, the analogy that came to my mind was
|
| 14 | basketball. I am supposed to leave here tonight and
|
| 15 | play in a basketball game. Yes, you can tell by looking
|
| 16 | at me I am our team's power forward, and monopoly power
|
| 17 | and market power are the same in the same sense that a
|
| 18 | shot is the same. It goes in or it does not go in. It
|
| 19 | goes in the basket or does not go in the basket.
|
| 20 | Now, some are worth one point, some are worth
|
| 21 | two points, some are worth three points. You could have
|
| 22 | lots of market power or little bits of market power, but
|
| 23 | it is the same thing. It is not like being tall. You
|
| 24 | could be very tall or not very tall or sort of tall,
|
| 25 | but -- no, this is like shots in basketball. |
151
| 1 | I guess I have waited long enough for some wag
|
| 2 | to say, "Well, what about goal tending?" The answer to
|
| 3 | that, "If you figure that out, you have got the whole
|
| 4 | rationale for the per se rule," but you did not want me
|
| 5 | to talk about per se rules? Okay, I will go to the next
|
| 6 | thing.
|
| 7 | Market power, monopoly power, are really the
|
| 8 | same thing. They are qualitatively the same thing. We
|
| 9 | mean the same thing by it. It is helpful to distinguish
|
| 10 | between I think two types of market power. The DuPont
|
| 11 | formulation that is quoted a lot is that monopoly power
|
| 12 | is -- DuPont is the same one that introduced the
|
| 13 | Cellophane fallacy -- the power to control prices or
|
| 14 | exclude competition.
|
| 15 | That sounds like it is two things, doesn't it?
|
| 16 | Power to control price or the power to exclude
|
| 17 | competition, arguing it is really the same, but the
|
| 18 | reason you see that or the reason you sometimes see this
|
| 19 | noise in the cases about there are these different
|
| 20 | things is that the intuition the judges have is that it
|
| 21 | might make a difference what kind of market power you
|
| 22 | have or how you are exercising it. We put names on them
|
| 23 | in the paper, but I do not have to use names.
|
| 24 | One way to exercise market power is by
|
| 25 | restricting your own output, cutting your own output, |
152
| 1 | sometimes in concert with that of other people in the
|
| 2 | market who are happy to join with you. I would call
|
| 3 | that collusive market power. We called it Stiglerian in
|
| 4 | honor of George Stigler because it is the kind of market
|
| 5 | power he wrote about.
|
| 6 | The other way that one might exercise market
|
| 7 | power is not by restricting one's own output but by
|
| 8 | restricting rivals' output, letting market output
|
| 9 | decline and letting your price rise through no
|
| 10 | restriction in your own output. That I would call
|
| 11 | exclusionary market power or market power obtained or
|
| 12 | exercised by exclusionary means. In the paper we called
|
| 13 | it Bainian, after Joe Bain, an economist who had written
|
| 14 | a lot about entry barriers and exclusionary issues.
|
| 15 | My second submission to you is that -- while
|
| 16 | market power and monopoly power are the same kind of
|
| 17 | concept and that we do have a notion of what it means
|
| 18 | that we tend to agree on -- that it will help us if we
|
| 19 | distinguish between whether we are talking about
|
| 20 | collusion or exclusion, or if you like the little
|
| 21 | labels, Stiglerian or Bainian market power. Now, why is
|
| 22 | that the case?
|
| 23 | The article is about market power in antitrust
|
| 24 | law. We are here talking about section 2. So, let me
|
| 25 | try to explain with respect to section 2 cases, monopoly |
153
| 1 | or attempted monopoly cases, why it might make a
|
| 2 | difference to think about the source of the market power
|
| 3 | or the type of market power that we are talking about.
|
| 4 | Point one, market and monopoly power include the
|
| 5 | power to keep prices from falling to competitive levels.
|
| 6 | I do not think we forget this a lot. We usually just
|
| 7 | say it is the ability to raise prices, but when
|
| 8 | confronted with the ability to keep prices from falling,
|
| 9 | we usually recognize that as market power, but you
|
| 10 | should in case you did not.
|
| 11 | If you had a horse and buggy industry that was
|
| 12 | perfectly competitive, a hundred firms each producing 1
|
| 13 | percent of all horse and buggy output, if they managed
|
| 14 | to exclude one firm and that firm was the first firm
|
| 15 | that was going to produce the automobile, they have
|
| 16 | nevertheless exercised market power even though it was a
|
| 17 | completely competitively organized industry. It is
|
| 18 | market power. It is market power to be able to keep
|
| 19 | prices from falling to competitive levels. Fencing out
|
| 20 | rivals who have the ability to bring in a new technology
|
| 21 | or simply be able to produce products at a much lower
|
| 22 | cost is an exercise of market power.
|
| 23 | Secondly, and connected to that, I believe it is
|
| 24 | not correct to insist on a threshold showing of market
|
| 25 | power if the conduct complained of is acquisition and |
154
| 1 | exercise of market power by excluding rivals. If you
|
| 2 | are talking about a section 2 monopoly case, and you are
|
| 3 | saying what they are going to do is restrict their own
|
| 4 | output and profitably price for a long time above
|
| 5 | competitive levels, it is probably correct for the
|
| 6 | reasons that Simon and Miguel have already talked
|
| 7 | about -- although it was not the principal purpose of
|
| 8 | their talk, but they explained it -- to insist on some
|
| 9 | kind of threshold of market power. It is kind of hard
|
| 10 | to imagine how a firm with only 40 percent of the market
|
| 11 | can restrict its own output profitably for a long period
|
| 12 | of time and thereby price above competitive levels all
|
| 13 | by itself.
|
| 14 | That is not true if you are talking about
|
| 15 | exclusionary behavior. Exclusionary behavior can create
|
| 16 | the market power. You do not necessarily need to
|
| 17 | already control a market in order to be able to engage
|
| 18 | in exclusionary behavior that winds up creating
|
| 19 | effective market power. You might still have a
|
| 20 | threshold.
|
| 21 | If you do the math, he said -- referring to
|
| 22 | other people because he is not a mathematician -- but if
|
| 23 | I understand the literature right, the raising rivals'
|
| 24 | costs literature, you may want to have kind of a
|
| 25 | threshold that does have to do with size, like relative |
155
| 1 | disparity in size. It is unlikely that a firm that has
|
| 2 | got 5 percent of the market is going to be able to,
|
| 3 | through exclusionary tactics, drive out rivals who are
|
| 4 | two and three times as big if it were the smallest firm
|
| 5 | in the market, but to say that one needs to have a kind
|
| 6 | of a dominant firm presence before one could ever be
|
| 7 | tagged with the offense of monopolization under section
|
| 8 | 2 is just not right unless you are -- because you appear
|
| 9 | to be forgetting what I've called Bainian or
|
| 10 | exclusionary market power.
|
| 11 | A third lesson from this that is relevant to
|
| 12 | section 2 cases, I think, is that it seems to me that we
|
| 13 | frequently hear it said that the mere exercise of market
|
| 14 | power is not prohibited by antitrust, and I think there
|
| 15 | is a statement to that effect in the Trinko decision by
|
| 16 | the Supreme Court a year and a half ago. Indeed, if I
|
| 17 | recall correctly, Justice Scalia not only said it, but
|
| 18 | he said you sort of welcome that kind of behavior
|
| 19 | because it is a signal to people to come enter the
|
| 20 | market. There are high prices. You can come in and do
|
| 21 | something. There is nothing wrong with exercising
|
| 22 | market power if you have got it. The question is how
|
| 23 | you got it.
|
| 24 | Well, once again, I think that probably is true
|
| 25 | for collusive or Stiglerian market power. It is |
156
| 1 | probably correct that a firm that has got 90 percent of
|
| 2 | the market, if they acquired it lawfully, to say that
|
| 3 | when they raised -- when they restrict output and raise
|
| 4 | price, that is an antitrust offense, that is a very
|
| 5 | tough nut to crack, a very hard argument to make,
|
| 6 | because what are you going to do about it? What is your
|
| 7 | remedy? How are you going to decide whether they raised
|
| 8 | price too high?
|
| 9 | But if you have in mind the possibility that you
|
| 10 | might be talking about a section 2 case based on
|
| 11 | exclusionary market power, it is just not right, because
|
| 12 | you would attack the exclusionary act, and sometimes you
|
| 13 | can distinguish between the exclusionary act and other
|
| 14 | types of behavior with respect to the market power. The
|
| 15 | most obvious example would be, I think, if I could build
|
| 16 | off Miguel's example.
|
| 17 | He gave that terrific example of the industry
|
| 18 | where, when you first looked at it, you might think
|
| 19 | dominance, and then you find all these other aspects
|
| 20 | here. If this had been an industry in which the issue
|
| 21 | had been an exclusive dealing arrangement that was
|
| 22 | having the effect of denying vital inputs to rivals, not
|
| 23 | only does it not require, in order for that to be a
|
| 24 | successful antitrust strategy, that the firm have a
|
| 25 | dominant share to begin with, but it is also not the |
157
| 1 | case that if it has got a position of dominance, if it
|
| 2 | is a monopoly, that then the mere exercise of monopoly
|
| 3 | power is permissible. It is not the case at all, and,
|
| 4 | indeed, that is an area where I think the European law
|
| 5 | is ahead of ours, because it clearly reflects that is
|
| 6 | the abuse of dominance.
|
| 7 | Finally, I had one more. It is relevant to
|
| 8 | antitrust law, but it is not relevant to the Federal
|
| 9 | Trade Commission or the Department of Justice. One of
|
| 10 | the lovely things about working for the -- there are
|
| 11 | many nice things about working for the FTC and the
|
| 12 | Department of Justice that I think, you know, the most
|
| 13 | are that you always think you are on the right side and
|
| 14 | you have these wonderful people to work with, but
|
| 15 | another thing is you never have to worry about standing,
|
| 16 | because if you see something wrong out there, you can go
|
| 17 | after it.
|
| 18 | Out in the private sector, you have got to have
|
| 19 | standing, and I think another lesson that you learn from
|
| 20 | distinguishing between these types of market power or
|
| 21 | these types of means of acquiring or exercising market
|
| 22 | power is relevant to competitor standing. Competitor
|
| 23 | standing should not be an issue in most section 2 cases
|
| 24 | involving Bainian or exclusionary market power, because
|
| 25 | the action is actually targeted at the competitor. |
158
| 1 | On the other hand and for the same reason,
|
| 2 | consumer standing, even though the person who may suffer
|
| 3 | the effects is the consumer, consumer standing may be
|
| 4 | quite risky, both because there is a more direct subject
|
| 5 | of the harm, that is, the competitor, and therefore,
|
| 6 | there is the risk of double damages, and so following
|
| 7 | things like Associated General contractors and Illinois
|
| 8 | Brick, consumer standing in monopoly cases may be
|
| 9 | difficult, and consumer standing in attempted monopoly
|
| 10 | cases I don't think the Supreme Court has ever addressed
|
| 11 | it, but there is a growing body of case law in the lower
|
| 12 | courts now that consumers just do not have standing to
|
| 13 | bring attempted monopoly cases.
|
| 14 | Most section 2 cases are these Bainian
|
| 15 | exclusionary power type, and you can see the reason for
|
| 16 | that is that the harm is not directed at the consumer,
|
| 17 | and if it is merely an attempted monopoly, there is no
|
| 18 | follow-through on the part of the consumer.
|
| 19 | Well, enough for that commercial. Again, I have
|
| 20 | tried to suggest really just two things to you. One is
|
| 21 | that we have a concept of market power that we are at
|
| 22 | least presently comfortable with, and that is no
|
| 23 | different from the notion of monopoly power for the same
|
| 24 | reason that we are comfortable with the conception of
|
| 25 | market power. We are talking about what is the goal of |
159
| 1 | antitrust, what are we trying to target our antitrust
|
| 2 | rules to do, and it is to prevent undue concentrations
|
| 3 | of power where power means the ability to profitably
|
| 4 | price above competitive levels for a significant period
|
| 5 | of time.
|
| 6 | Secondly, that it will help to keep your eye on
|
| 7 | the ball, to dig a little bit deeper and say, are we
|
| 8 | talking about market power that is going to be
|
| 9 | manifested by restricting one's own output, either by
|
| 10 | one's self or in concert with one's competitors, or are
|
| 11 | we talking about market power that is going to be
|
| 12 | manifested or acquired by driving one's rivals out of
|
| 13 | the market and thereby gaining the power to exercise
|
| 14 | higher prices without necessarily restricting one's own
|
| 15 | output? I think it has a number of potential lessons
|
| 16 | for section 2, and maybe we will explore some more about
|
| 17 | that as we talk through the questions.
|
| 18 | MR. WALES: Thanks, Tom.
|
| 19 | (Applause.)
|
| 20 | MR. WALES: Okay, next up we have Irwin Stelzer.
|
| 21 | Irwin is a Senior Fellow and Director of Hudson
|
| 22 | Institute's Economic Policy Studies Group. Prior to
|
| 23 | joining the Hudson Institute, Dr. Stelzer was Resident
|
| 24 | Scholar and Director of Regulatory Policy Studies at the
|
| 25 | American Enterprise Institute. He also is a U.S. |
160
| 1 | economic and political columnist for The Sunday Times
|
| 2 | and The Courier Mail, a contributing editor of The
|
| 3 | Weekly Standard, and a member of the board of the
|
| 4 | Regulatory Policy Institute at Oxford, a member of the
|
| 5 | Advisory Board of the American Antitrust Institute, and
|
| 6 | adviser to the U.S. Trade Representative.
|
| 7 | Dr. Stelzer founded National Economic Research
|
| 8 | Associates, NERA, and served as its president for many
|
| 9 | years. He also served as a Managing Director of the
|
| 10 | investment banking firm Rothschild, Inc., and Director
|
| 11 | of the Energy and Environmental Policy Center at
|
| 12 | Harvard. His academic career includes teaching
|
| 13 | appointments at Cornell, the University of Connecticut
|
| 14 | and NYU. He has been elected a visiting fellow at
|
| 15 | Nuffield College, Oxford, and he is a former member of
|
| 16 | the Faculty of Practicing Law.
|
| 17 | DR. STELZER: Thank you very much. Can you hear
|
| 18 | me in the back? Thank you for inviting me to this,
|
| 19 | although I fear I may be sailing under false pretenses.
|
| 20 | Let me clear up one of them. Although I am at the
|
| 21 | Hudson Institute, I do not want to appear here as
|
| 22 | somebody who is a disinterested scholar. I do have
|
| 23 | clients, some of whom are accused of being dominant,
|
| 24 | others of whom think dominant firms pick on them, but my
|
| 25 | views go back before most of you were born. I, too, |
161
| 1 | still play basketball, but I have learned a trick, which
|
| 2 | is I yell "Get that rebound" to other people.
|
| 3 | I am going to leave any comment on specific
|
| 4 | cases to my co-panelists, because they are more familiar
|
| 5 | with them than I. I will say, if I am permitted one
|
| 6 | vignette, I gave up trying to be involved in specific
|
| 7 | cases when I was sitting on a witness stand in Tucson,
|
| 8 | Arizona, and the judge summoned counsel to the bench and
|
| 9 | said, "We have to talk about schedule." The first
|
| 10 | lawyer said, "Well, you know, my daughter's getting
|
| 11 | married in May, and that's going to tie me up." The
|
| 12 | other guy said, "Well, you know, in June, I really was
|
| 13 | planning a fishing trip." The judge said, "Well,
|
| 14 | September, I cannot really do," and so they put
|
| 15 | everything off about a year. In the middle of this, I
|
| 16 | said, "Can I tell you something about my schedule, Your
|
| 17 | Honor?" He said, "Don't be ridiculous." I suddenly
|
| 18 | realized three lunatics were deciding how I was going to
|
| 19 | live my life for the next year, and I am not doing this
|
| 20 | anymore. So, I speak to you as a person who used to
|
| 21 | testify in these cases.
|
| 22 | I have submitted a much longer, unconscionably
|
| 23 | long paper, which I assume is available to those who
|
| 24 | want it, and I will therefore restrict my comments to a
|
| 25 | very few, and also, I want to try out ideas. I am not |
162
| 1 | wedded to what I am about to say. I assumed we were
|
| 2 | here to try out ideas, not to hand down edicts, and I
|
| 3 | thought that is why I would try concentrating on pricing
|
| 4 | practices by dominant firms.
|
| 5 | Simon Bishop said if you are dominant the
|
| 6 | practice is questionable; my feeling is if the practices
|
| 7 | are questionable, you are probably dominant. Simon says
|
| 8 | he is a bit more humble than doing away with market
|
| 9 | definition. Those of you who have ever tried to do any
|
| 10 | market definition know that only the non-humble would
|
| 11 | attempt the elasticity measurements and the other things
|
| 12 | involved in it. So, the notion that we must begin with
|
| 13 | market definition because that is somehow a constraint,
|
| 14 | and anybody who has read any decisions of the EU knows
|
| 15 | that it is a very, at best -- you defined it as a loose
|
| 16 | constraint. I think it is looser even than that.
|
| 17 | I am not certain that going through the agony of
|
| 18 | market definition gives you a degree of precision, some
|
| 19 | sort of constraint on the examiner. It may, but
|
| 20 | given -- if you go through it, I am not so sure that
|
| 21 | beauty is in the sight of the beholder as with any other
|
| 22 | part of economic analysis. I am not wedded to market
|
| 23 | definition, and I would like to explore the possibility
|
| 24 | that we might want to do away with that exercise
|
| 25 | altogether in deciding about dominance. |
163
| 1 | I recognize that that would unemploy half of the
|
| 2 | economics profession, leaving only that part that knows
|
| 3 | about exclusionary practices still existing, but I do
|
| 4 | think we should think -- think -- about the possibility
|
| 5 | that defining relevant markets, defining product
|
| 6 | characteristics, all of that is a kind of very elastic
|
| 7 | process that we could do away with.
|
| 8 | Let me suggest instead -- and I really mean
|
| 9 | suggest. There is this kind of academic politeness
|
| 10 | about "let me suggest," meaning "I really know that." I
|
| 11 | do not use the language that way. I really mean to
|
| 12 | suggest that we consider that it is the practices that
|
| 13 | reveal dominance and not dominance that reveals the
|
| 14 | practices.
|
| 15 | I have read some of the proceedings, and it
|
| 16 | seems to me there is a great deal of sort of motherhood
|
| 17 | and apple pie stuff in this record. It is certainly
|
| 18 | true, we do not want to prevent vigorous competition
|
| 19 | that results in lower prices to consumers. Who would
|
| 20 | want to prevent vigorous competition? Certainly
|
| 21 | Microsoft did not want to prevent vigorous competition,
|
| 22 | it says. Yes, we want firms to develop pricing plans
|
| 23 | that benefit consumers; yes, we want to give businessmen
|
| 24 | as much certainty as possibility; and yes, we want to
|
| 25 | reduce the role of lawyers in the board room and leave |
164
| 1 | it to businessmen. But I do not think that means that
|
| 2 | pricing practices should be unscrutinied by antitrust
|
| 3 | enforcement authorities regardless of any finding of
|
| 4 | dominance.
|
| 5 | What we do not want to condone is long-term harm
|
| 6 | to the competitive process, therefore to consumers, by
|
| 7 | approving short-run price reductions aimed at creating
|
| 8 | barriers to entry or preserving market positions that
|
| 9 | are unrelated to efficiency. Now, again, I would not
|
| 10 | try to measure efficiency of a firm, because I do not
|
| 11 | think I know how to do that. There may be people who
|
| 12 | know how to do that, and when people say to you they are
|
| 13 | going to measure costs, they are going to compare costs,
|
| 14 | I would urge any one of you who agrees that that is a
|
| 15 | terrific idea to determine any cost of any large firm,
|
| 16 | and you tell me what range you think would make you feel
|
| 17 | comfortable in that determination, especially since you
|
| 18 | are usually dealing with someone who does not want you
|
| 19 | to find out, and so I think you are going to have a very
|
| 20 | difficult problem.
|
| 21 | What you have to do is examine a firm's pricing
|
| 22 | practices in the context of the firm's total behavior.
|
| 23 | You cannot look at a thread in a tapestry in order to
|
| 24 | get a picture of whether or not a firm is engaging in
|
| 25 | exclusionary practices. |
165
| 1 | I will give you an example. If you had in the
|
| 2 | record that a firm had offered a million dollars to a
|
| 3 | customer not to deal with a competitor, you would say,
|
| 4 | "Well, gee, we can't tolerate that." But it is very
|
| 5 | easy to manipulate a pricing schedule in a large
|
| 6 | multi-product firm to accomplish the exact same thing,
|
| 7 | to reduce the cost of the incremental order to pretty
|
| 8 | close to nil by simply manipulating the pricing
|
| 9 | schedules and the relationship of past to future
|
| 10 | deliveries.
|
| 11 | In other words, it seems to me, again, that
|
| 12 | firms spend millions, hundreds of millions, on discovery
|
| 13 | in antitrust cases, and the discovery is really
|
| 14 | discovery that will tell you whether the firm is
|
| 15 | dominant, whether the firm is engaging in exclusionary
|
| 16 | practices, with far greater certainty than would any
|
| 17 | measure of its market share.
|
| 18 | I think, also, you can tell -- I hate to use
|
| 19 | this word because I think it is old-fashioned -- you can
|
| 20 | divine intent from looking at what discovery turns up.
|
| 21 | Now, by that I do not mean that the statement by an
|
| 22 | enthusiastic salesman who says "I just rubbed out the
|
| 23 | competition in Florida" or something like that should be
|
| 24 | taken at face value, but I think you can determine the
|
| 25 | intent of a variety of competitive weapons wielded by a |
166
| 1 | firm by examining the entire record of its behavior,
|
| 2 | which brings me to the last question -- I said I would
|
| 3 | not take my full time -- and that is, has what I just
|
| 4 | said reduced certainty?
|
| 5 | A lot of my clients talk about certainty, they
|
| 6 | want certainty, so you say, "Well, you want certainty?
|
| 7 | There are two kinds of certainty you can have.
|
| 8 | Everything you do is subject to a per se rule. That is
|
| 9 | certainty. How about that?"
|
| 10 | "No, that is not what I particularly had in mind
|
| 11 | by 'certainty.'"
|
| 12 | "Well, the other form of certainty is to say,
|
| 13 | 'Well, almost everything you do is okay.'"
|
| 14 | "Well, I think that is lousy public policy."
|
| 15 | Certainty is simply not available in this
|
| 16 | business. That is it. It is good for the lawyers. It
|
| 17 | is bad for the businessmen. In making their decisions,
|
| 18 | they have to listen for counsel and decide what to do
|
| 19 | about the legal advise they get. It is simply one
|
| 20 | aspect of the many risks they take, just like guessing
|
| 21 | at interest rates. Certainty is not there. It cannot
|
| 22 | be had unless some of the more distinguished members of
|
| 23 | this panel can give it. I cannot.
|
| 24 | Thank you very much.
|
| 25 | (Applause.) |
167
| 1 | MR. WALES: Last, but not least, we have Joe
|
| 2 | Sims. Joe is a senior antitrust partner at Jones Day
|
| 3 | here in D.C. His practice is concentrated on antitrust
|
| 4 | and related areas of governmental regulation and
|
| 5 | includes litigation counseling, agency practice before
|
| 6 | state and federal courts, antitrust enforcement agencies
|
| 7 | and various specialized agencies where competition
|
| 8 | policy or antitrust issues arise. Joe is a member of
|
| 9 | the American Bar Association, Antitrust Law Section, and
|
| 10 | has served as chair of numerous committees on the
|
| 11 | Antitrust Law Section. He's a Fellow of the American
|
| 12 | Bar Foundation and a member of the American Law
|
| 13 | Institute. He regularly writes and lectures on
|
| 14 | antitrust and related subjects and is listed in The Best
|
| 15 | Lawyers in America, The World's Leading Lawyers, and
|
| 16 | Who's Who Legal.
|
| 17 | Joe, thanks.
|
| 18 | MR. SIMS: Thank you, Dave.
|
| 19 | Let me start with a point about my perspective,
|
| 20 | which will also be true for at least Irwin and Tom. I
|
| 21 | had the revelation when preparing for this and looking
|
| 22 | back at some of the older cases that I have been
|
| 23 | practicing antitrust law for about a third of the time
|
| 24 | that we have had antitrust laws, which is kind of a
|
| 25 | scary thought if you think about it, but it is true |
168
| 1 | nonetheless. A little depressing, too.
|
| 2 | During that time, no one has ever confused me,
|
| 3 | unlike most of these people on the panel, as a scholar.
|
| 4 | I do not cite footnotes in cases. Sometimes I cannot
|
| 5 | even remember what a case holding was. I do not write
|
| 6 | law review articles. I write commentaries, not as
|
| 7 | eloquent as Irwin's commentaries, but it is a less
|
| 8 | taxing discipline than law review articles. So, I view
|
| 9 | my role here as offering the practice perspective. I
|
| 10 | know Tom is a practicing lawyer, but his scholarship is
|
| 11 | so impressive that I have always viewed him as an
|
| 12 | academic at heart. So, I am going to approach what I
|
| 13 | have to say in that light, focusing not on the theory,
|
| 14 | but on the practice.
|
| 15 | Fortunately, jurisprudence and for that matter
|
| 16 | economics and antitrust is very heavily fact-weighted.
|
| 17 | The jurisprudence and the economics almost always take a
|
| 18 | back seat to the facts, at least in the long run.
|
| 19 | Antitrust law in the United States, where it is really
|
| 20 | law enforcement and not regulation, is mostly about the
|
| 21 | facts and how the facts are presented. This is true
|
| 22 | whether you are talking about agencies or judges. It is
|
| 23 | certainly true when you are talking about juries.
|
| 24 | Of course, the case law is important. Bad case
|
| 25 | law is not desirable. It is a good idea, if we can, |
169
| 1 | which we do now and have from time to time, have
|
| 2 | competent, intelligent people running the antitrust
|
| 3 | agencies, but all of that fades in importance to the
|
| 4 | unique facts at play in any particular case.
|
| 5 | During at least my practicing lifetime, we have
|
| 6 | moved steadily away from what we used to spend a lot of
|
| 7 | time at, which was antitrust by sloganeering, to more
|
| 8 | careful analysis of the facts. If you remember, Derek
|
| 9 | Bok called for more certainty and bright line rules in
|
| 10 | section 7 cases more than 30 years ago. Well, that
|
| 11 | actually had some resonance for a while, but that
|
| 12 | concept was seriously injured by Bill Baxter's Merger
|
| 13 | Guidelines and probably finally killed by the 1992
|
| 14 | edition of the Guidelines. When the analysis focuses on
|
| 15 | competitive effects and not on market shares or
|
| 16 | concentration or other slogans, the notion of broadly
|
| 17 | applicable bright lines disappears.
|
| 18 | So, today, in merger cases, we do not really
|
| 19 | have any clear rules. All the facts are in play. Every
|
| 20 | case is unique, and while the outcome needs to comport
|
| 21 | generally with stated case law and regulatory guidance,
|
| 22 | the operative word is "generally."
|
| 23 | This is equally true in section 2 matters. We
|
| 24 | have come a long way from American Tobacco or Alcoa or
|
| 25 | even Grinnell, which I was shocked to see was decided |
170
| 1 | just four years before I graduated from law school. It
|
| 2 | seems like a very old case, and with some obvious
|
| 3 | exceptions, like, Aspen Ski and maybe Kodak, the general
|
| 4 | direction of Supreme Court decisions over my lifetime
|
| 5 | has been to gradually cabin in the reach of section 2,
|
| 6 | in significant part by insisting upon a focus on the
|
| 7 | facts as opposed to reliance on the mostly populist
|
| 8 | rhetoric about market dominance and relative size that
|
| 9 | dominated section 2 jurisprudence in earlier times.
|
| 10 | A good deal of this, of course, reflects the
|
| 11 | fact that our markets have matured -- that many more
|
| 12 | markets today, maybe most markets, are truly
|
| 13 | contestable, which was not always the case -- but
|
| 14 | nevertheless, we do not have very many clear rules in
|
| 15 | section 2 today.
|
| 16 | I think this is generally a good thing, but it
|
| 17 | does, as Irwin pointed out, inevitably carry with it
|
| 18 | uncertainty of outcomes in particular cases. I noticed
|
| 19 | in looking back at some of the earlier hearings that the
|
| 20 | Microsoft representative, perhaps understandably, took
|
| 21 | the position of wishing that there was more clarity in
|
| 22 | the law. It is a common business position. I think it
|
| 23 | is a short-sighted business position.
|
| 24 | To pick up on Irwin's point, if we really did
|
| 25 | have more clarity, we would have more restrictive rules. |
171
| 1 | I do not have any doubt that if you have to choose
|
| 2 | between clear restrictive rules and clear unrestrictive
|
| 3 | rules, it is where that line would be drawn. I do not
|
| 4 | think that would be useful for the public interest in
|
| 5 | the long term, and it would not even be useful for
|
| 6 | business at least in the medium to long term. It would
|
| 7 | make the advisory job easier, but that is about it.
|
| 8 | So, with this context, these kinds of hearings
|
| 9 | are really a great idea, especially if they try, as I
|
| 10 | think they have, to take the long view of an important
|
| 11 | area of law. More discussion will produce more
|
| 12 | understanding and will also demonstrate, as these
|
| 13 | hearings pretty clearly have, that there is an enormous
|
| 14 | variety of views on section 2 jurisprudence and policy.
|
| 15 | Indeed, I would argue that this might be more true today
|
| 16 | than it has been in my practicing lifetime.
|
| 17 | We still have, of course, the strong populist
|
| 18 | supporters of very aggressive section 2 enforcement. We
|
| 19 | still have plenty of conservative "let the market work"
|
| 20 | advocates. But we also today have an incredible variety
|
| 21 | of economists and law professors and others who
|
| 22 | articulate an amazing range of interesting approaches to
|
| 23 | the identification and analysis of market power. Tom
|
| 24 | Krattenmaker and Steve Salop obviously are responsible
|
| 25 | for maybe the single most visible effort in this field, |
172
| 1 | but there are a lot of people keeping them company with
|
| 2 | new and interesting ideas, including, of course, Greg
|
| 3 | Werden and others on this panel.
|
| 4 | So, there is no end to possible options for new
|
| 5 | section 2 approaches, but there is also clearly no
|
| 6 | consensus on any particular approach, with the possible
|
| 7 | exception that we really ought to pay attention to the
|
| 8 | facts. It is very hard for me to imagine how we can
|
| 9 | productively create clear rules or safe harbors for
|
| 10 | section 2 using market shares or, for that matter,
|
| 11 | anything else. Given this lack of consensus on where we
|
| 12 | ought to draw the lines and the truism, that, at least
|
| 13 | over the long run, markets are a lot better at
|
| 14 | identifying and responding to consumer demand than
|
| 15 | courts or regulators or most academics, the chances of
|
| 16 | finding consensus bright lines that really do advance
|
| 17 | the public interest are pretty low. But it is
|
| 18 | nonetheless worth talking about, and so these hearings
|
| 19 | are a good idea.
|
| 20 | Any legal discipline like antitrust where the
|
| 21 | operative legal standard is in one form or another the
|
| 22 | rule of reason is going to be messy and unpredictable.
|
| 23 | Facts are highly variable, and their perception and
|
| 24 | analysis by humans is even more so. There is the
|
| 25 | additional problem that courts and regulators, even very |
173
| 1 | thoughtful ones that take the time to think about and
|
| 2 | listen to various points of view, are inevitably better
|
| 3 | at evaluating the past than they are at predicting the
|
| 4 | future. They are too often focused on fixing
|
| 5 | yesterday's problems without really having a very clear
|
| 6 | picture of how that is going to affect tomorrow.
|
| 7 | Because of this, we ought to try to be cautious
|
| 8 | about interfering with markets, doing so only when we
|
| 9 | are pretty darn confident that the intervention will
|
| 10 | make things better. I have written on this for 25
|
| 11 | years, describing (in very gross and simplistic terms,
|
| 12 | of course) the two basic approaches in antitrust as "do
|
| 13 | no harm" and "can we help". The "can we help" school
|
| 14 | tends to be a lot more confident about their and a
|
| 15 | court's ability to improve market performance than I am,
|
| 16 | but the "do no harm" school has been in clear ascendency
|
| 17 | in the past several years, both at the federal agencies
|
| 18 | and at the Supreme Court.
|
| 19 | This certainly does not mean that it would not
|
| 20 | be great if these hearings could find a way to produce
|
| 21 | some clear consensus and let us feel comfortable in
|
| 22 | drawing some more bright lines like we have in the per
|
| 23 | se rule against price fixing, or in the section 2
|
| 24 | analog, the below-cost requirement for finding predatory
|
| 25 | pricing. But my reading of the results so far -- and I |
174
| 1 | have read at least summaries of all of the hearings --
|
| 2 | does not leave me with the impression that we have yet
|
| 3 | identified that consensus.
|
| 4 | As I said, I am not sure this is a bad thing.
|
| 5 | One of the most important -- maybe the most important --
|
| 6 | reasons the antitrust laws have continued to serve us so
|
| 7 | well after more than a century is that they are pretty
|
| 8 | darn flexible. Congress, of course, passes a lot of
|
| 9 | statutes where, in effect, buck the problem to the
|
| 10 | courts or a regulatory agency, but it rarely works as
|
| 11 | well as it has in this field.
|
| 12 | I think that is because, in general and over the
|
| 13 | long term, the rule of reason is a pretty accurate
|
| 14 | description of what courts really do -- and regulators
|
| 15 | too, for that matter. They generally try to figure out
|
| 16 | what is reasonable under the circumstances with a strong
|
| 17 | bias most of the time -- let's put the Robinson-Putman
|
| 18 | Act to the side as an outlier -- toward leaving markets
|
| 19 | free to work their magic.
|
| 20 | As long as this is the operative legal regime
|
| 21 | under section 2, we will have uncertainty about
|
| 22 | particular cases and there will be uncertainty about how
|
| 23 | a particular fact pattern is analyzed. This approach
|
| 24 | has costs, of course, including, most importantly, the
|
| 25 | inadvertent deterrence of procompetitive behavior, but I |
175
| 1 | suspect the costs are less than would be the case with
|
| 2 | either bright line rules that miss the mark or
|
| 3 | impractical tests that over-deter because of ambiguity.
|
| 4 | So, I do not think we really need a whole bunch
|
| 5 | of new rules; nevertheless, if we could come up with
|
| 6 | them, we should, and so I am glad we are looking at it.
|
| 7 | We have to remember, however, that there is a difference
|
| 8 | between section 1 and section 2 and a very good reason
|
| 9 | for the difference. Section 1 deals with joint conduct,
|
| 10 | and while there are many times when joint conduct can be
|
| 11 | neutral or procompetitive, there are obvious and very
|
| 12 | real circumstances where there are competitive risks
|
| 13 | from joint conduct, cartel behavior being the most
|
| 14 | obvious. Given this, it is tolerable to have some
|
| 15 | potentially overreaching penumbras of illegality,
|
| 16 | although as we get more cases like Daugher, even this is
|
| 17 | gradually reduced.
|
| 18 | But Section 2, by contrast, is aimed at
|
| 19 | unilateral conduct, and over-enforcement here would
|
| 20 | threaten the very essence of competition. We want firms
|
| 21 | to be monopolists or to try to be monopolists. The less
|
| 22 | risky we make that effort, the less aggressively firms
|
| 23 | will try. So, section 2 cases should be hard to bring;
|
| 24 | they should be harder to win. Successful cases should
|
| 25 | be rare, because true monopolists with durable monopoly |
176
| 1 | power are rare as determined by how hard it is to name
|
| 2 | some. It is kind of hard to do, actually.
|
| 3 | That's why Microsoft was such an attractive
|
| 4 | case. It was one of the few instances where you could
|
| 5 | look at it and say, "Doggone it, it looks like they do
|
| 6 | have a monopoly." If we can devise some rules or
|
| 7 | guidelines to help us advance this cause, that is great.
|
| 8 | My guess is we cannot, so we ought to let the market --
|
| 9 | in this case, the market for judicial decisions over the
|
| 10 | long run -- create and enforce the rules, and the result
|
| 11 | will be just fine.
|
| 12 | Thanks.
|
| 13 | (Applause.)
|
| 14 | MR. WALES: Thanks, Joe.
|
| 15 | Okay, as we said, we are going to take a
|
| 16 | 15-minute break. So, why don't we reconvene at 3:35.
|
| 17 | Thanks.
|
| 18 | (A brief recess was taken.)
|
| 19 | DR. WERDEN: Okay, let's get started again.
|
| 20 | What we are going to do for the next little
|
| 21 | while is start by putting one or two questions to each
|
| 22 | of the speakers, in turn, and then letting the other
|
| 23 | panelists, if they like, comment on what has been said,
|
| 24 | and we are going to take the panelists in the order that
|
| 25 | they spoke, so I am going to start with Simon, and my |
177
| 1 | question, Simon, is, while there is clearly a dominance
|
| 2 | threshold under Article 82, there really is an open
|
| 3 | question as to how high the bar is for dominance, and I
|
| 4 | think the way Miguel described it, the bar is and ought
|
| 5 | to be quite low. What do you think about that?
|
| 6 | MR. BISHOP: Okay, well, contrary to what Irwin
|
| 7 | might have suggested, most of my clients are actually
|
| 8 | dominant firms, so on that basis, I think, you know, the
|
| 9 | 40 percent threshold, which is enshrined in Article 82,
|
| 10 | is a pretty reasonable threshold to have. I mean, if
|
| 11 | your market share is below 40 percent, then you can do
|
| 12 | whatever you like. If you are above that, then we move
|
| 13 | into the effects and the assessment of the behavior
|
| 14 | under consideration. It does not mean if you are above
|
| 15 | 40 percent, what you are doing is necessarily
|
| 16 | anticompetitive.
|
| 17 | DR. WERDEN: But you wouldn't say that all the
|
| 18 | firms above 40 percent are dominant, of course, would
|
| 19 | you?
|
| 20 | MR. BISHOP: Absolutely not, and that is why I
|
| 21 | said in my talk, you know, the market share is only one
|
| 22 | factor. You have got to take into account a lot of
|
| 23 | other factors to assess whether that 60 percent, say, is
|
| 24 | representative of significant market power.
|
| 25 | DR. WERDEN: Do any of the other panelists wish |
178
| 1 | to offer a view as to how high the bar should be set in
|
| 2 | the United States where I think most observers think it
|
| 3 | is set considerably higher than in Europe?
|
| 4 | MR. KRATTENMAKER: Or whether there should be a
|
| 5 | bar at all, I guess.
|
| 6 | MR. SIMS: But, Tom, wouldn't you say that there
|
| 7 | shouldn't be a bar, I would think?
|
| 8 | MR. KRATTENMAKER: Yes.
|
| 9 | MR. WALES: So, the answer is there is no bar.
|
| 10 | MR. KRATTENMAKER: Or what I would say is, bar
|
| 11 | to what?
|
| 12 | DR. WERDEN: Bar to proceeding.
|
| 13 | MR. KRATTENMAKER: You mean, like, a
|
| 14 | post-behavior section 2 case where the claim is what I
|
| 15 | called collusive or Stiglerian power? Sure.
|
| 16 | DR. WERDEN: Well, if you want to go down that
|
| 17 | road, in an actual monopolization case, where the
|
| 18 | defendant is alleged to have acquired a monopoly, the
|
| 19 | courts have set the bar fairly high on what it means to
|
| 20 | have a monopoly and generally have required, in fact, a
|
| 21 | 70 percent share protected by pretty high barriers to
|
| 22 | entry.
|
| 23 | MR. KRATTENMAKER: Yes, right, right. I think
|
| 24 | if they acquired that monopoly by, for example,
|
| 25 | acquiring a lot of rivals by purchasing firms, that |
179
| 1 | would probably be an appropriate threshold to do. Now,
|
| 2 | you do not see cases like that because we have had
|
| 3 | section 7, so almost all section 2 cases now are what I
|
| 4 | would call exclusionary or Bainian type, and yeah, that
|
| 5 | is right.
|
| 6 | I think it is not correct to say you could not
|
| 7 | possibly have market power if you have got 66 percent of
|
| 8 | the market.
|
| 9 | DR. WERDEN: So, in the Microsoft case, if their
|
| 10 | share had been 10 percent, you would have looked on
|
| 11 | things pretty much the same way?
|
| 12 | MR. KRATTENMAKER: You know, there were so many
|
| 13 | facts at issue in the Microsoft case...
|
| 14 | No, as I tried to indicate, it does not seem to
|
| 15 | me that you utterly disregard market share, Greg, but as
|
| 16 | I understand it -- and I am still learning this area --
|
| 17 | the ability to exclude can oftentimes be a factor of
|
| 18 | relative size, but the idea that it requires dominance
|
| 19 | of the entire market I think is quite wrong.
|
| 20 | DR. STELZER: Given what Microsoft did and
|
| 21 | proved itself capable of doing, did you have to bother
|
| 22 | measuring its market share? I mean, nobody who didn't
|
| 23 | have huge market dominance, i.e., 90, 80, 40, could do
|
| 24 | those things, could make an equipment manufacturer pay
|
| 25 | them for stuff that was not in the machine. I mean, you |
180
| 1 | have got to have an awful lot of market power to do
|
| 2 | that. You want to measure market power because lawyers
|
| 3 | make you do it, but as a matter of policy, in the case
|
| 4 | of any firm that can pull off what Microsoft pulled off,
|
| 5 | you could skip the whole market share measurement stuff
|
| 6 | and just say, if they did this, they have market power,
|
| 7 | they have abused it.
|
| 8 | MR. KRATTENMAKER: I probably ought to let Joe
|
| 9 | pick up on that, but I will say -- I mean, I know a
|
| 10 | little bit about Microsoft. I mean, you might be able
|
| 11 | to say that, but if what you are doing is talking about
|
| 12 | the part of the case where they allegedly misrepresented
|
| 13 | whether their programs -- either how it interfaced with
|
| 14 | Java, I do not know that you needed to have a dominant
|
| 15 | market share in order to lie.
|
| 16 | DR. STELZER: No, no, I was talking about where,
|
| 17 | if you decided to put a competitor's product in the
|
| 18 | machine, they charged you for each machine whether you
|
| 19 | put their stuff in it or not.
|
| 20 | MR. KRATTENMAKER: No, I've gotcha. I take
|
| 21 | it -- I mean, I am sympathetic to your viewpoint, but it
|
| 22 | is conduct-specific. For certain kinds of conduct, you
|
| 23 | might infer market power from the fact of the behavior.
|
| 24 | DR. STELZER: What they do, I shall know them.
|
| 25 | MR. SIMS: On this point, I am more with Tom |
181
| 1 | than Irwin, I think, surprisingly enough. Market
|
| 2 | definition and whatever you draw from that market
|
| 3 | definition is a tool that you want to use when it is
|
| 4 | necessary and useful to figure out what the competitive
|
| 5 | effects of the conduct at issue are. So, there are some
|
| 6 | where, careful market definition is not all that
|
| 7 | important.
|
| 8 | MR. BISHOP: But I think, I mean, some of the
|
| 9 | difference between the U.S. people at that end of the
|
| 10 | table and the Europeans down here is really -- sort of
|
| 11 | reflects some of the sort of philosophical,
|
| 12 | institutional differences, and I'll say institutional
|
| 13 | because I think my personal philosophy is going to be
|
| 14 | closer to that end of the table than a lot of Europeans,
|
| 15 | and I think that that is a point which Joe talked about,
|
| 16 | you know, is do no harm, which is, you know, very much a
|
| 17 | high threshold before you would start intervening, then
|
| 18 | sure, maybe you don't need a market share bright line
|
| 19 | test, but in Europe, the institutional philosophy is
|
| 20 | much more -- you know, there are a lot of markets, the
|
| 21 | EU, the Commission or the competition authorities can
|
| 22 | intervene in to make things better, and in that
|
| 23 | situation, in that sort of institutional setup, then
|
| 24 | having a bright line test which says, "If you do not
|
| 25 | |
182
| 1 | have a market share of above 40 percent or whatever, you
|
| 2 | can do whatever you like," seems to me an important
|
| 3 | safeguard to prevent people coming in and start messing
|
| 4 | around with your industry, which is very costly and
|
| 5 | potentially extremely disruptive to the firm's business
|
| 6 | model if that firm has got no market power at all.
|
| 7 | DR. STELZER: But that is kind of the "stop me
|
| 8 | before I kill again" argument, right? You need --
|
| 9 | because you know that you really could be irresponsible
|
| 10 | and do bad things, you better have some sort of rule
|
| 11 | that stops you from doing it on the theory that the
|
| 12 | rule, is the lesser of the evils. It is a substitute
|
| 13 | for judgment.
|
| 14 | MR. BISHOP: No, it's not. It is a substitute
|
| 15 | for deciding when a competition authority can bring an
|
| 16 | action against a business.
|
| 17 | DR. WERDEN: Or in the United States, substitute
|
| 18 | for a jury trial.
|
| 19 | MR. SIMS: Well, there is that pretty critical
|
| 20 | difference between the U.S. and Europe in that in
|
| 21 | Europe, the Commission generally gets to say yea or nay,
|
| 22 | and in the United States, the FTC and the DOJ never get
|
| 23 | to say yea or nay. Unlike the EU, they have to go to a
|
| 24 | court and convince a court.
|
| 25 | I think what Simon is postulating is that some |
183
| 1 | kind of -- if I could borrow the word -- durable
|
| 2 | guidelines that, would last beyond a particular
|
| 3 | administration of the Commission and thus constrain the
|
| 4 | current occupant of those decision-making positions is a
|
| 5 | good substitute, partial though it may be, for what we
|
| 6 | have here in the courts.
|
| 7 | DR. WERDEN: Okay, that was fun. Let's move on
|
| 8 | to a question for Miguel.
|
| 9 | I was very intrigued by your very clear point
|
| 10 | that the suspect conduct in an Article 82 case cannot
|
| 11 | itself be what creates the barrier to entry that is
|
| 12 | required, in turn, for the firm to be dominant, so that
|
| 13 | if it was possible to have a firm with a whopping share
|
| 14 | protected only by the suspect conduct in the case,
|
| 15 | otherwise you would be flooded with competition, then
|
| 16 | that firm isn't dominant? Is that your submission?
|
| 17 | MR. de la MANO: Indeed, and there is the
|
| 18 | problem that we have in the EU, that we do not really
|
| 19 | have a standard which allows us to pursue attempted
|
| 20 | monopolization.
|
| 21 | DR. WERDEN: No, let the firm be 80 percent. It
|
| 22 | is 80 percent, but the only thing keeping out
|
| 23 | competition is this guy's anticompetitive conduct. Now,
|
| 24 | the guys at the end of the table would go after this guy
|
| 25 | at 5 percent it sounds like, but let's put that aside. |
184
| 1 | He's 80 percent, and he's doing bad stuff, and he's
|
| 2 | keeping the competition out. If he didn't keep doing
|
| 3 | the bad stuff, the competition would come in. They
|
| 4 | might even swamp him.
|
| 5 | MR. de la MANO: So, let me now link that
|
| 6 | question to the previous question to Simon, which is
|
| 7 | where should we put the threshold for the finding of
|
| 8 | dominance, and, of course, Simon has argued 40 percent
|
| 9 | might be a good place. I am not sure it is a good
|
| 10 | place, and there are a number of reasons why 40 percent
|
| 11 | might be too high.
|
| 12 | First of all, dominance is going to be a
|
| 13 | necessary requirement, and in some cases, like the
|
| 14 | situation you just presented, it may well be that if the
|
| 15 | practice is preventing entry in the market, but in
|
| 16 | assessing dominance, what we are ultimately assessing is
|
| 17 | the situation without such practice. That's why
|
| 18 | dominance is a screen. In a case like that, it would
|
| 19 | not be possible to be brought forward by the European
|
| 20 | Commission.
|
| 21 | Now, that clearly -- you might say, "Well,
|
| 22 | that's wrong," and that's why you have attempted
|
| 23 | monopolization in the U.S. and we do not have it, but a
|
| 24 | second reason why if dominance acts as a screen, we have
|
| 25 | to be very careful in not setting the market share |
185
| 1 | threshold for a finding of dominance far too high.
|
| 2 | There is a third reason, which is, as has
|
| 3 | already been highlighted by Simon before, which is
|
| 4 | market definition is an imprecise exercise. Now, I
|
| 5 | think everybody here will argue that in some cases, if a
|
| 6 | company has a share slightly above 40 percent, slightly
|
| 7 | below 40 percent, you know, it probably doesn't make
|
| 8 | much of a difference, but if you have a threshold at 40
|
| 9 | percent, it is critical.
|
| 10 | So, even though in practice, a firm with 35 or
|
| 11 | 45 percent is probably likely to have much more -- the
|
| 12 | same kind of market power, in theory, this is a
|
| 13 | threshold at which it either -- the Commission is going
|
| 14 | to intervene or not, whereas if you had a lower
|
| 15 | threshold -- and, of course, market definition is going
|
| 16 | to be critical there. It is going to determine whether
|
| 17 | or not the Commission is going to intervene or not. If
|
| 18 | you have a lower threshold, then the precision of the
|
| 19 | market definition exercise matters much less, because if
|
| 20 | you had it wrong and the market definition was actually
|
| 21 | too narrow or too wide, but you are wedding yourself
|
| 22 | into the 20-30 percent threshold, it doesn't really
|
| 23 | matter.
|
| 24 | As long as you are below 25 percent, even if
|
| 25 | you've got market definition wrong, it is for certain, |
186
| 1 | almost for certain, that there are going to be no
|
| 2 | problems, and therefore, there should be no intervention
|
| 3 | whatsoever.
|
| 4 | DR. STELZER: To ask a practical question, what
|
| 5 | makes you look at something in the first place? You go
|
| 6 | into a bunch of market share studies and you say, "Oops,
|
| 7 | here's a 40-percenter, I'll go after him"? Or is it
|
| 8 | some practice that makes you look?
|
| 9 | MR. de la MANO: The latter, essentially a
|
| 10 | complainant would --
|
| 11 | DR. STELZER: Simon says no.
|
| 12 | MR. BISHOP: Well, Miguel said it right. It is
|
| 13 | some complainant submits a case.
|
| 14 | DR. STELZER: Right. Now, as I understand the
|
| 15 | EU attitude, it differs from the American. Here my
|
| 16 | economist friends believe that if the complaint comes
|
| 17 | from a competitor, it is therefore tainted somehow. It
|
| 18 | is the use of the legal system as a strategic device.
|
| 19 | That is different from the EU, and I think the EU is
|
| 20 | right but is the EU sticking with the notion that the
|
| 21 | fact that a complaint comes from a competitor does not
|
| 22 | taint the complaint?
|
| 23 | MR. de la MANO: Well, practically in all
|
| 24 | cases -- probably in all cases that I have been involved
|
| 25 | in, the complaint has come from the competitor, some |
187
| 1 | outliers where a consumer may bring the case, but it is
|
| 2 | very, very rare. When that happens, because we have an
|
| 3 | opportunistic system, the Commission, of course, has to
|
| 4 | take in mind the private interests of the complainant
|
| 5 | and how that might taint their submissions, but
|
| 6 | ultimately the Commission is obliged to give its
|
| 7 | decision, whether it is a decision to intervene, and
|
| 8 | therefore -- and that would be trying an independent
|
| 9 | objection sent to the dominant company or allegedly
|
| 10 | dominant company, or there would be a rejection of the
|
| 11 | complaint, which would be a formal rejection, would be
|
| 12 | written and sent to the complainant.
|
| 13 | So, either way, the Commission basically has to
|
| 14 | make up its mind, and in doing so, has to definitely
|
| 15 | take into account to find out if the evidence that has
|
| 16 | been brought forward to it is submitted by parties which
|
| 17 | have their own interests at heart.
|
| 18 | DR. WERDEN: Tom, I have a question for you.
|
| 19 | You seem to be saying that the mere exercise of
|
| 20 | exclusionary market power is a section 2 offense all of
|
| 21 | the time, but I want to clarify if you mean without
|
| 22 | regard to the potential of that conduct to create or
|
| 23 | maintain something we would call monopoly power.
|
| 24 | MR. KRATTENMAKER: I do not mean that.
|
| 25 | DR. WERDEN: Okay, that's great. |
188
| 1 | MR. KRATTENMAKER: Thank you.
|
| 2 | DR. WERDEN: Anybody want to follow up on that?
|
| 3 | MR. KRATTENMAKER: Irwin says no.
|
| 4 | DR. WERDEN: Well, say it out loud.
|
| 5 | DR. STELZER: But brevity is so much the soul of
|
| 6 | wit that I hated -- I just preferred to let your answer
|
| 7 | hang out there.
|
| 8 | MR. KRATTENMAKER: Sort of like a beautiful
|
| 9 | arcing three-point shot that's probably right dead bang
|
| 10 | through, nothing but the net, exactly, just let it sit
|
| 11 | there.
|
| 12 | DR. STELZER: Right, see, but I play basketball
|
| 13 | at 10,000 feet.
|
| 14 | MR. KRATTENMAKER: Of course you do. You are a
|
| 15 | good guy.
|
| 16 | DR. STELZER: I was trying out ideas. I am not
|
| 17 | sure. Tom, tell me why you think about that.
|
| 18 | MR. KRATTENMAKER: Oh.
|
| 19 | DR. STELZER: How, as a practical matter, you
|
| 20 | would tell in a case.
|
| 21 | MR. KRATTENMAKER: Because there is lots of --
|
| 22 | because the whole point about the competitive process is
|
| 23 | to beat your rivals, and so inferring from the fact that
|
| 24 | practice has an untoward effect on rivals, that it
|
| 25 | therefore violates the antitrust laws, it is just too -- |
189
| 1 | to coin a phrase -- over-inclusive.
|
| 2 | DR. STELZER: Yeah, okay, but -- I guess I was
|
| 3 | thinking in terms of defending the competitive process,
|
| 4 | not competitors.
|
| 5 | MR. KRATTENMAKER: Yeah, right.
|
| 6 | DR. STELZER: And that's harder.
|
| 7 | MR. KRATTENMAKER: Well, I agree. I mean, the
|
| 8 | fact that you inflict some sort of inefficiency on your
|
| 9 | rival, you could say, "Gee, that's bad, and we ought to
|
| 10 | stop it," and that's kind of like the Klor's case.
|
| 11 | That's Klor's against Broadway-Hale. I mean, they might
|
| 12 | have done something bad, and we could care for less that
|
| 13 | there were a hundred other stores in that city, and, I
|
| 14 | mean, there is a way I used to tell that. I mean, I
|
| 15 | went back to the record and examined that case, and it
|
| 16 | turns out that the reason that there was this dispute
|
| 17 | here was that the owner of Broadway-Hale had a
|
| 18 | ne'er-do-well son who had impregnated and run away with
|
| 19 | the daughter of Klor's, and this was an alienation of
|
| 20 | affection suit brought as a Sherman Act case.
|
| 21 | Now, of course, that is not true, but I tell
|
| 22 | that story and the students believe it, and so that's
|
| 23 | the long way of saying I do not think that section 1 --
|
| 24 | of course, we are not talking about section 1 -- was
|
| 25 | meant to federalize the tort of alienation of affection. |
190
| 1 | So, not only are you supposed to beat up on your rivals,
|
| 2 | but not everything you do to your rivals is either
|
| 3 | necessarily commercially motivated or motivated to drive
|
| 4 | monopoly profits.
|
| 5 | MR. SIMS: And, Irwin, if you don't demand that
|
| 6 | the conduct have at least a high likelihood of creating
|
| 7 | durable monopoly power, then you really do have a
|
| 8 | serious risk of sticking your nose into the market where
|
| 9 | you are going to do more harm than good, because
|
| 10 | differentiating between exclusionary practices on some
|
| 11 | grounds other than whether they have the potential to
|
| 12 | create durable market power seems to me to be very hard.
|
| 13 | DR. STELZER: But you used the term "durable"
|
| 14 | about five times. What do you mean?
|
| 15 | MR. SIMS: I mean more than temporary.
|
| 16 | MR. KRATTENMAKER: There you go.
|
| 17 | DR. WERDEN: Your turn, Irwin, as if you haven't
|
| 18 | talked enough.
|
| 19 | You seem not to at all be a fan of limiting
|
| 20 | principles, and I want to push the limit on limiting
|
| 21 | principles. Are you suggesting, for example, that the
|
| 22 | Brooke Group rule was a really bad idea?
|
| 23 | DR. STELZER: I don't have any idea.
|
| 24 | DR. WERDEN: You don't think that in a predatory
|
| 25 | pricing case, a plaintiff should have to show pricing |
191
| 1 | below some measure of cost?
|
| 2 | DR. STELZER: Oh, no, I think that's ridiculous,
|
| 3 | and I'll tell you why. First of all, I don't believe
|
| 4 | you can measure marginal cost. I've spent a lot of time
|
| 5 | trying to do that.
|
| 6 | DR. WERDEN: The courts do not like marginal
|
| 7 | cost either.
|
| 8 | DR. STELZER: I'll take any kind of cost you
|
| 9 | want. I don't think you can do it. I've been in enough
|
| 10 | proceedings at regulatory agencies where people are
|
| 11 | supposed to measure costs to know that.
|
| 12 | Second of all, the real question with predatory
|
| 13 | pricing is not whether the person prices below or at
|
| 14 | some concept of cost and has a prospect of recoupment,
|
| 15 | but think of it this way. You are walking along and you
|
| 16 | want to have a picnic, and there's a sign that says, "No
|
| 17 | trespassing." You figure, what the hell. You throw
|
| 18 | down your blanket, you have a nice picnic, and you
|
| 19 | leave, right?
|
| 20 | Now you are walking along and there's another
|
| 21 | field where you want to have a picnic and there's a no
|
| 22 | trespassing sign, and there are about four or five
|
| 23 | corpses lying around. Are you going to have a picnic
|
| 24 | there? I don't think so.
|
| 25 | So, what we are talking about is the kind of |
192
| 1 | practices that are entry-deterring in the technical
|
| 2 | jargon, that scare the hell out of people, because
|
| 3 | remember, this is more and more an age in which the
|
| 4 | financing of new companies is done by venture
|
| 5 | capitalists, and if you have ever been to a meeting with
|
| 6 | a venture capitalist -- these are not very nice people,
|
| 7 | many of them -- the first thing they want to know is
|
| 8 | what is the range of practices available to the
|
| 9 | incumbent competitors to keep you out or to destroy you
|
| 10 | if you get in. That is what they want to know.
|
| 11 | I mean, have you got a good idea? Yeah. Are
|
| 12 | you a pretty good manager? Yeah. Can I suck most of
|
| 13 | the value out of your enterprise? Yeah. And then they
|
| 14 | want to know what are the incumbents going to do to you,
|
| 15 | and if you go to enough meetings where people describe
|
| 16 | what Microsoft might do to you or what other companies
|
| 17 | might do to you, a lot of the stuff we are talking about
|
| 18 | becomes irrelevant. Entry-deterrence is the problem.
|
| 19 | Will they cut prices? Yes, they might. Is that okay?
|
| 20 | Well, that's a tough one. That's very hard.
|
| 21 | I know this sounds mushier than you'd like it to
|
| 22 | be. People who say I am going to measure costs and then
|
| 23 | I am going to measure market share -- in the Sirius/XM
|
| 24 | merger, right, they are going to take one data point and
|
| 25 | they are going to measure cross-elasticities and all |
193
| 1 | that other stuff? Ridiculous.
|
| 2 | So, what I am saying is in a practical world in
|
| 3 | which new firms are being created, in which technology
|
| 4 | is increasingly important, in which small businesses and
|
| 5 | new entrants are the manufacturers of macroeconomic
|
| 6 | growth, I would lean pretty hard in the direction of
|
| 7 | being very skeptical about the range of competitive
|
| 8 | tools permitted to incumbents, to powerful incumbents,
|
| 9 | for macroeconomic reasons, for microeconomic reasons,
|
| 10 | and -- dare I say it, even though Judge Bork is a
|
| 11 | colleague of mine -- for equity reasons.
|
| 12 | DR. WERDEN: Are you suggesting that if the
|
| 13 | incumbent is happily pricing at 100 and somebody has a
|
| 14 | new idea and comes in and sells it at 80 and the
|
| 15 | incumbent says, "Well, I better knock my price down to
|
| 16 | 80 or I am not going to make any sales," he's already in
|
| 17 | trouble?
|
| 18 | DR. STELZER: No, I am saying you have to look
|
| 19 | at a lot of things. You see, that's the trouble. You
|
| 20 | are trying to pick out one thing that will tell you what
|
| 21 | the hell is going on in this industry. You can't do
|
| 22 | that.
|
| 23 | DR. WERDEN: Okay. Well, I concede that I can't
|
| 24 | do that. So, what do I do?
|
| 25 | DR. STELZER: You look at the entire range of |
194
| 1 | business practices of the company. You look at the
|
| 2 | durability of its market share. You look at the history
|
| 3 | of the notices it has posted in the past when
|
| 4 | competitors try to come in, and you try to make a
|
| 5 | decision as to whether those were imposing
|
| 6 | inefficiencies on the potential competitors or not.
|
| 7 | MR. WALES: Go ahead, Tom.
|
| 8 | MR. KRATTENMAKER: I want to come to Irwin's
|
| 9 | partial defense now --
|
| 10 | DR. STELZER: Oh, God.
|
| 11 | MR. KRATTENMAKER: -- on Brooke Group but make a
|
| 12 | comment about -- to make a comment about what Joe said,
|
| 13 | too.
|
| 14 | On what Irwin said, you know, pricing below
|
| 15 | cost, I am really not so sure. Recoupment, yes, and the
|
| 16 | short answer to your question, Greg, is you have got to
|
| 17 | show that they will be able to get their price back up.
|
| 18 | When we all sit around and decide that we have this
|
| 19 | common mantra and we decide to chant it, whatever this
|
| 20 | antitrust religion is that we have, you have to be
|
| 21 | careful to think about it once in a while.
|
| 22 | Saying it has got to be below the pricing firm's
|
| 23 | cost is to smuggle in the old efficient competitor rule
|
| 24 | into the marketplace. If it is the case that the firm
|
| 25 | can by pricing right down to its cost drive out four |
195
| 1 | firms and leave us with one firm instead of five in a
|
| 2 | market, some people may say that drives us to more
|
| 3 | efficient production, and other people will say that is
|
| 4 | going to tend to drive prices further away from costs.
|
| 5 | It depends on which value you think is important in
|
| 6 | antitrust.
|
| 7 | I think it would be better to have a discussion
|
| 8 | about that than the silly stuff in Brooke Group about
|
| 9 | what we happen to know because we happen to put on black
|
| 10 | robes and so we are infallible, that people often try
|
| 11 | predatory pricing and rarely succeed, a statement which
|
| 12 | I believe had no support. There might be a footnote
|
| 13 | there, but it doesn't cite any empirical work.
|
| 14 | So, I don't mean to say that I am opposed to
|
| 15 | Brooke Group, but what I mean to say is you don't look
|
| 16 | askance at somebody and say, "You mean they wouldn't
|
| 17 | price below cost?" Irwin is talking about a somewhat
|
| 18 | different set of values and in this case a very
|
| 19 | defensible set of values, particularly if you do keep
|
| 20 | the recoupment link, I would say.
|
| 21 | The other comment, I mean, I think this is the
|
| 22 | right time to make it, I thought Joe had one of the most
|
| 23 | interesting observations I've heard in a long time about
|
| 24 | the bright line rules and fact-based rules, and that's
|
| 25 | exactly what has happened to merger law in the whatever |
196
| 1 | years since Joe and I first started studying merger law,
|
| 2 | but it's not what's going on in section 2, and these are
|
| 3 | hearings about section 2.
|
| 4 | You've got some cases that were sort of driven
|
| 5 | down to fact-based. Aspen Ski is one of those where
|
| 6 | they looked in the record and found that there were some
|
| 7 | angry skiers in Atlanta, and Kodak copiers is one of
|
| 8 | those, but we have some bright line cases, too,
|
| 9 | Weyerhaeuser, Brooke Group, the 11th Circuit decision in
|
| 10 | Schering-Plough, that say, do not tell me any facts.
|
| 11 | All I want to hear is some theory.
|
| 12 | So, in section 2, we are in -- I'll shut up here
|
| 13 | now in a minute -- in section 2, we are at this funny
|
| 14 | point where we haven't moved to Joe's Nirvana, and I
|
| 15 | think we need to face that.
|
| 16 | MR. SIMS: See, it is interesting. I agree with
|
| 17 | you on Brooke Group and Weyerhaeuser. Those are
|
| 18 | essentially safe harbor decisions.
|
| 19 | MR. KRATTENMAKER: Yeah.
|
| 20 | MR. SIMS: But I would vehemently disagree with
|
| 21 | you on Aspen Ski and Schering-Plough. I think that
|
| 22 | Aspen Ski is certainly not fact-based. You can't do a
|
| 23 | fact-based analysis of Aspen Ski and conclude that there
|
| 24 | was an antitrust violation there.
|
| 25 | MR. KRATTENMAKER: No, the fact they found turns |
197
| 1 | out not to be a violation -- turns out not to be an
|
| 2 | anticompetitive act, but --
|
| 3 | MR. SIMS: Well, that's certainly true, and I
|
| 4 | think Schering-Plough I think did focus on the facts,
|
| 5 | and the fact that was determined -- that was found to be
|
| 6 | determinative in Schering-Plough was the existence of
|
| 7 | the patent and the scope of that patent. That's a
|
| 8 | fact-based analysis to me, not rule-based.
|
| 9 | DR. STELZER: Can I ask you something about
|
| 10 | Aspen Ski, because I am not a lawyer --
|
| 11 | MR. SIMS: Sure.
|
| 12 | DR. STELZER: -- although I was involved in that
|
| 13 | case just because I happened to be in Aspen at the time
|
| 14 | and the plaintiff couldn't afford anybody and I was
|
| 15 | free.
|
| 16 | MR. SIMS: I remember actually visiting you in
|
| 17 | Aspen periodically.
|
| 18 | DR. STELZER: Right. Well, come this summer,
|
| 19 | because I don't have judges setting my schedules
|
| 20 | anymore.
|
| 21 | Let me ask you something. There was an
|
| 22 | unchallenged determination of the relevant market.
|
| 23 | MR. SIMS: Yes, that was the --
|
| 24 | DR. STELZER: Now, is that a fact or is that not
|
| 25 | a fact? |
198
| 1 | MR. SIMS: That was a lawyer error, actually.
|
| 2 | That was a stipulated market which any good antitrust
|
| 3 | lawyer wouldn't have done.
|
| 4 | DR. STELZER: All right. So, we are now down
|
| 5 | to, if I understood it, it is not a fact if it is
|
| 6 | determined by a judge and a jury but it is a lawyering
|
| 7 | error. Is that right? So, that makes it not a fact.
|
| 8 | MR. KRATTENMAKER: That's our position and we
|
| 9 | are sticking to it.
|
| 10 | DR. STELZER: Okay, that's all right, I just
|
| 11 | wanted to know.
|
| 12 | DR. WERDEN: Moving right along, Joe, I am not
|
| 13 | entirely sure I understand your position. I am not sure
|
| 14 | that you go so far as to say clarity is bad. I think
|
| 15 | your position more is that hoped for clarity isn't going
|
| 16 | to come in a useful way, to which my follow-up question
|
| 17 | is, well, aren't there things like the Brooke Group rule
|
| 18 | that would form conduct-based safe harbors that might be
|
| 19 | a good idea? For example, that it is okay to introduce
|
| 20 | a new product even if that causes your competitor to
|
| 21 | fail?
|
| 22 | MR. SIMS: Well, I wouldn't have any problem
|
| 23 | with that rule, but I think you'd have a lot of trouble
|
| 24 | getting broad consensus on it.
|
| 25 | DR. WERDEN: I am willing to try. Let's see |
199
| 1 | what we can do here on the panel.
|
| 2 | MR. SIMS: You might find some people that think
|
| 3 | that's what Microsoft did and does and is doing --
|
| 4 | introducing new products that are creating competitive
|
| 5 | harms; at least I think that's the theory in the EU's
|
| 6 | current preoccupation with Microsoft. So, I am fine
|
| 7 | with a Brooke-type safe harbor for new product
|
| 8 | introductions. I am not exactly sure how you'd set it
|
| 9 | out so that you left it open for the one in a however
|
| 10 | many times that might be anticompetitive, but I'd be
|
| 11 | fine with that. I doubt seriously that you would get
|
| 12 | broad consensus on that.
|
| 13 | My point is that there is not incredibly broad
|
| 14 | consensus on the Brooke Group rule, which is I think
|
| 15 | about the only effective safe harbor in section 2 now.
|
| 16 | So, I am not sure that you would have a very easy time
|
| 17 | coming up with consensus on any others. I am happy to
|
| 18 | see you try, and I could come up with a number that I'd
|
| 19 | be comfortable with, but I doubt that I'd get everybody
|
| 20 | to join with me.
|
| 21 | DR. WERDEN: Well, we can give you 30 more
|
| 22 | seconds. How many can you give me in 30 seconds?
|
| 23 | MR. SIMS: Well, new product design would be
|
| 24 | fine. I mean, in general, new products and product
|
| 25 | design decisions, I am involved now in defending Apple |
200
| 1 | in the iPod tying cases. We shouldn't have to go
|
| 2 | through all the hassle that we are going to have to go
|
| 3 | through to get rid of those cases. So, I am perfectly
|
| 4 | happy with that if you can find enough consensus to
|
| 5 | implement it.
|
| 6 | DR. WERDEN: Do I hear any dissenters?
|
| 7 | DR. STELZER: Well, I was just curious, Joe,
|
| 8 | what about what they call fighting brands in the
|
| 9 | cigarette industry?
|
| 10 | MR. SIMS: What about them?
|
| 11 | DR. STELZER: That's a new product.
|
| 12 | MR. SIMS: Is there anything wrong with that?
|
| 13 | DR. STELZER: Is there anything wrong with that?
|
| 14 | MR. SIMS: No, I don't see anything wrong with
|
| 15 | that. Did it impair competition in some way?
|
| 16 | DR. STELZER: It had very negative effects on
|
| 17 | some of the competitors who made the brands.
|
| 18 | MR. SIMS: That's different.
|
| 19 | DR. STELZER: But it sends a notice that you are
|
| 20 | going to come in --
|
| 21 | MR. SIMS: Look, I happen to know an awful lot
|
| 22 | about the cigarette business, unfortunately, because I
|
| 23 | just did a merger there a couple years ago. There are
|
| 24 | one heck of a lot of independent sellers of cigarettes
|
| 25 | in the cigarette business. In fact, they have driven |
201
| 1 | the market share of the market leaders down, and more
|
| 2 | importantly, they have taken away a big part of their
|
| 3 | margin, which is why the FTC decided not to challenge
|
| 4 | the merger of the number two and number three players.
|
| 5 | DR. STELZER: Okay.
|
| 6 | MR. KRATTENMAKER: I worked on that case, too,
|
| 7 | and some of what Joe just said is true.
|
| 8 | DR. WERDEN: Probably some of what Joe says is
|
| 9 | always true; it is a question of how much.
|
| 10 | MR. KRATTENMAKER: I was on the other side, I'm
|
| 11 | sorry, I was doing it for the FTC.
|
| 12 | MR. de la MANO: I would defend, Greg, that
|
| 13 | particular bright line rule.
|
| 14 | DR. WERDEN: Okay. When is a new product
|
| 15 | introduction a bad thing for consumers?
|
| 16 | MR. de la MANO: I think that's the wrong way to
|
| 17 | put the question. I think no bright line rule is going
|
| 18 | to work unless you define it very, very carefully, and
|
| 19 | you will --
|
| 20 | DR. WERDEN: Of course. That's what your job
|
| 21 | is.
|
| 22 | MR. de la MANO: Well, that's what we found in
|
| 23 | the new product rule that we were given by the court in
|
| 24 | the area of refusal to supply, the new product test,
|
| 25 | that -- it sounds fine in the context of that particular |
202
| 1 | case, I admit, but we just do not know what's a new
|
| 2 | product.
|
| 3 | DR. WERDEN: Well, but if we are going to take a
|
| 4 | European approach to this question, then perhaps we
|
| 5 | should appeal to our ordoliberal traditions where, what
|
| 6 | we say in English, competition on the merits was a
|
| 7 | fundamental principle. That was legal without regard to
|
| 8 | its effect, and there are reasons to believe that this
|
| 9 | concept is embraced by Article 82.
|
| 10 | Now, as far as I can tell, no European court has
|
| 11 | ever said that that actually means something, but it
|
| 12 | should mean something, shouldn't it?
|
| 13 | MR. de la MANO: Definitely.
|
| 14 | DR. WERDEN: Okay, what does it mean?
|
| 15 | MR. de la MANO: Well, the problem is that if
|
| 16 | you put the question in terms of would a new product
|
| 17 | ever constitute the situation where it could lead to
|
| 18 | consumer harm, I think the answer is always going to be
|
| 19 | no. That is competition on the merits. That is a
|
| 20 | situation where there's going to be traditional value to
|
| 21 | consumers, that's pretty obvious, but the difficult
|
| 22 | thing for a competition agency is to define or identify
|
| 23 | whether that product is, indeed, new, and there are many
|
| 24 | situations where what might appear on the face of it to
|
| 25 | be a new product, from the perspective of certain |
203
| 1 | customers, but is just an extension or an additional
|
| 2 | feature that's added to an old product, but if that
|
| 3 | additional feature serves the purpose of preventing
|
| 4 | entry, then maybe there is a problem.
|
| 5 | DR. WERDEN: I agree there's always going to be
|
| 6 | a fine line, and Irwin correctly pointed out that the
|
| 7 | fine line is Brooke Group is a serious problem. We
|
| 8 | can't figure out costs well. But that doesn't mean
|
| 9 | there's something fundamentally wrong with the
|
| 10 | principle.
|
| 11 | MR. de la MANO: Absolutely not. It's not just
|
| 12 | a good bright line for enforcement.
|
| 13 | DR. WERDEN: You are coming to that decision
|
| 14 | awfully fast. How long have you been applying it?
|
| 15 | MR. de la MANO: I don't think we have had a
|
| 16 | single case in the IMS where we have actually been able
|
| 17 | to define a new product as of -- that's a few years.
|
| 18 | DR. WERDEN: Of course, the bright line rule
|
| 19 | there is that you can refuse to license. That solves
|
| 20 | that problem, doesn't it?
|
| 21 | MR. de la MANO: Yeah, solves that one, yeah.
|
| 22 | DR. WERDEN: Okay.
|
| 23 | MR. WALES: Should we move on to the principles?
|
| 24 | Go to the first one.
|
| 25 | DR. WERDEN: Okay, I hope you people can see |
204
| 1 | this. We are going to read these.
|
| 2 | MR. WALES: I actually have them in hard copies
|
| 3 | and we can pass them out.
|
| 4 | DR. WERDEN: Okay. We are going to read them
|
| 5 | into the record in any event.
|
| 6 | We have in most of our sessions, but not this
|
| 7 | morning, gone through what we call the propositions
|
| 8 | where we put up a declarative sentence and ask the
|
| 9 | panelists whether they agree or disagree and why.
|
| 10 | The first one we have here is, "Monopoly power
|
| 11 | is the long-term ability of a firm to earn greater than
|
| 12 | a competitive return on investment."
|
| 13 | It's not the most orthodox definition of
|
| 14 | monopoly power, but it happens to be the almost verbatim
|
| 15 | the definition in one of the leading economics
|
| 16 | textbooks, and it focuses attention on something that in
|
| 17 | principle we might be able to figure out, although it's
|
| 18 | not going to be easy, whether a firm is earning more
|
| 19 | than a competitive rate of return.
|
| 20 | So, Tom, why don't you start.
|
| 21 | MR. KRATTENMAKER: I think it is good enough for
|
| 22 | government work.
|
| 23 | DR. WERDEN: Good enough for the courts of the
|
| 24 | United States of America?
|
| 25 | MR. KRATTENMAKER: Not having tried to do a case |
205
| 1 | under this test, I would want to think some more about
|
| 2 | whether I'd rather be going and getting evidence about
|
| 3 | competitive returns than I would about prices and costs,
|
| 4 | Greg. So, I cannot answer your question. I am
|
| 5 | obviously -- as a lawyer, I am, of course, hind-bound, I
|
| 6 | am always looking backwards, and so I am happier with a
|
| 7 | test that focuses on price than competitive return if
|
| 8 | you give me 30 seconds to think about it, but --
|
| 9 | DR. WERDEN: Well, that's fine. It doesn't say
|
| 10 | here what the evidence would be, and I think it would be
|
| 11 | prices and costs in some cases, most cases, but the
|
| 12 | question then is going to be, what price and what cost?
|
| 13 | MR. KRATTENMAKER: Thank you for modifying this
|
| 14 | as we go. It has changed from long-term to long-run, it
|
| 15 | has changed from competitive return to pricing above
|
| 16 | costs. I think it is basically right, but I want to say
|
| 17 | the devil's in the details, but there are some details
|
| 18 | that would need to be worked out, but sure.
|
| 19 | DR. STELZER: Would you accept --
|
| 20 | MR. KRATTENMAKER: As you know, I'd also say
|
| 21 | that's also market power. I do not know, is that the
|
| 22 | next question? Do we have another question about that?
|
| 23 | DR. STELZER: Can I ask you a question?
|
| 24 | DR. WERDEN: Please.
|
| 25 | DR. STELZER: Would you substitute cost of |
206
| 1 | capital for competitive return on investment?
|
| 2 | DR. WERDEN: Possibly.
|
| 3 | DR. STELZER: Okay. Have you ever been in a
|
| 4 | utility case where they're determining the cost of
|
| 5 | capital?
|
| 6 | DR. WERDEN: We hardly ever do that anymore,
|
| 7 | thank God.
|
| 8 | DR. STELZER: You hardly ever do it, but if you
|
| 9 | walk down the block, there's a lot of people doing it.
|
| 10 | There's economists doing it all the time and there's a
|
| 11 | huge dispute about it, but I think cost of capital is at
|
| 12 | least more precise as far as the literature goes than a
|
| 13 | competitive return on investment. So, if you want to
|
| 14 | play with this, I think you should do it in terms of
|
| 15 | cost of capital, because there are all sorts of ways of
|
| 16 | measuring cost of capital, and no one will know -- they
|
| 17 | won't know with as much precision what you are talking
|
| 18 | about when you talk about a competitive return.
|
| 19 | DR. WERDEN: Well, coming back to Tom's
|
| 20 | question, if you want to put this in terms of prices and
|
| 21 | costs, the question, as I said, is what price and what
|
| 22 | cost?
|
| 23 | MR. KRATTENMAKER: Sure.
|
| 24 | DR. WERDEN: And in particular, the difference
|
| 25 | between monopoly power and market power, it is |
207
| 1 | conventional, at least, although there are some
|
| 2 | dissenters, to define market power as the ability to
|
| 3 | price above short-run marginal cost, but hardly anybody
|
| 4 | would say that the right definition of monopoly power is
|
| 5 | the ability to price above short-run marginal cost,
|
| 6 | because that would give us too many monopolists.
|
| 7 | MR. KRATTENMAKER: I think your second sentence
|
| 8 | is correct and your first sentence is wrong.
|
| 9 | DR. WERDEN: So, what is the definition of
|
| 10 | market power?
|
| 11 | MR. KRATTENMAKER: I believe that market power
|
| 12 | has a durability component as well, the last time I read
|
| 13 | the Guidelines, nontransitory.
|
| 14 | MR. WALES: So, shorter, Tom, is that the point?
|
| 15 | It is shorter than monopoly power?
|
| 16 | MR. KRATTENMAKER: No, it is the same.
|
| 17 | MR. WALES: So, both qualitative and
|
| 18 | quantitative? I guess you made the point that
|
| 19 | qualitatively, they're the same, but are they also
|
| 20 | quantitatively the same?
|
| 21 | MR. KRATTENMAKER: Oh, I think each of them
|
| 22 | comes in degrees, Dave, I'm sorry. To go back to my
|
| 23 | metaphor -- they could turn out to be a one-point shot,
|
| 24 | a two-point shot, a three-point shot. I don't think it
|
| 25 | would serve us any value to say, well, if it is a |
208
| 1 | two-point shot, it is market power, and if it is a
|
| 2 | three-point shot, it is monopoly power. I don't -- as a
|
| 3 | matter of moving the cases along, I don't see the point.
|
| 4 | DR. WERDEN: Well, let me put the question,
|
| 5 | then, doesn't it make sense to have a significant
|
| 6 | threshold in a section 2 case that is different and
|
| 7 | higher than the threshold of market power in a section 1
|
| 8 | case? And don't the cases pretty much say that's the
|
| 9 | law now?
|
| 10 | MR. KRATTENMAKER: No. Yes.
|
| 11 | DR. WERDEN: Okay, at least that was clear.
|
| 12 | MR. BISHOP: But, I mean, the European
|
| 13 | perspective, I mean there is some debate in Europe about
|
| 14 | whether we can characterize firms which are dominant and
|
| 15 | those firms which are super-dominant, which is sort of,
|
| 16 | you know, similar to this, and my sense is that, you
|
| 17 | know, why bother introducing this new term, you know,
|
| 18 | "super-dominant"? If we are just going to use the
|
| 19 | dominance as a threshold step to deciding whether we
|
| 20 | need to investigate in more detail the competitive
|
| 21 | conduct, whether a firm is dominant or super-dominant
|
| 22 | doesn't really make any difference in that decision.
|
| 23 | DR. WERDEN: Okay, let's move to the second
|
| 24 | proposition. I think Joe spoke precisely these words,
|
| 25 | and I want to see how much consensus we have on the |
209
| 1 | proposition that monopoly power is rare.
|
| 2 | MR. WALES: If we can go back to Miguel.
|
| 3 | MR. de la MANO: Well, in line with any
|
| 4 | consensus that monopoly -- it makes very little sense to
|
| 5 | distinguish between market power and monopoly power for
|
| 6 | the reasons that have been explained on both sides of
|
| 7 | where I am sitting, I would say monopoly power is fairly
|
| 8 | common. The key question is, however, how much of it do
|
| 9 | you really need to show or need to have before you
|
| 10 | decide to investigate any further? Being shown monopoly
|
| 11 | power is not anything in itself; it is the practice
|
| 12 | itself, the conduct.
|
| 13 | DR. WERDEN: I think you have identified one of
|
| 14 | the major differences in attitude between the European
|
| 15 | school and ours. Our courts are really hard sells on
|
| 16 | the subject of monopoly power. It is an empirical fact
|
| 17 | that it is very hard to convince a court that a firm has
|
| 18 | a monopoly in the United States, and it's not that hard,
|
| 19 | it seems, in Europe.
|
| 20 | I think you have already cast your vote that it
|
| 21 | is probably too hard in the United States. Anybody else
|
| 22 | want to weigh in on that?
|
| 23 | MR. KRATTENMAKER: Well, yeah. I mean, I think
|
| 24 | that Miguel has really laid his finger on it. If we
|
| 25 | then say that you possess market or monopoly power if |
210
| 1 | you face a downward-sloping demand curve, I think it may
|
| 2 | well be that many, perhaps most firms, do, but the
|
| 3 | second thing I was going to say is this question,
|
| 4 | monopoly power is rare, is exactly why I went to law
|
| 5 | school instead of graduate school in economics. You
|
| 6 | have to ask an economist who does not I/O theory, but
|
| 7 | I/O reality, how often this happens. Isn't this what
|
| 8 | Joe Bain spent his life trying to do, but --
|
| 9 | DR. WERDEN: I don't think so, but --
|
| 10 | MR. KRATTENMAKER: Okay.
|
| 11 | DR. WERDEN: Anyone else?
|
| 12 | MR. de la MANO: Can I reverse the question?
|
| 13 | DR. WERDEN: Rare is power monopoly?
|
| 14 | MR. de la MANO: No. Do you think
|
| 15 | contestability of a market is rare?
|
| 16 | DR. WERDEN: I think it is unheard of.
|
| 17 | MR. de la MANO: Well, there you go.
|
| 18 | DR. WERDEN: I am not sure where I am.
|
| 19 | MR. BISHOP: How does that follow?
|
| 20 | MR. de la MANO: Well, it follows that if
|
| 21 | contestability is the opposite of monopoly power and
|
| 22 | contestability is unheard of, it must be because most
|
| 23 | firms have market power.
|
| 24 | DR. WERDEN: Well, but then you are equating
|
| 25 | market and monopoly power, and I am not buying into that |
211
| 1 | one.
|
| 2 | MR. de la MANO: Okay.
|
| 3 | MR. BISHOP: And I guess it also relates to
|
| 4 | entry to a market. You can have firms with high market
|
| 5 | shares subject to effective competitive constraints
|
| 6 | because the small rivals could easily expand.
|
| 7 | DR. WERDEN: Okay, a third proposition, and this
|
| 8 | is something that Simon already said. "The Cellophane
|
| 9 | fallacy likely does not apply in attempt to monopolize
|
| 10 | cases." Of course, he didn't use that language, because
|
| 11 | that's American language, but here we have an offense of
|
| 12 | attempt to monopolize in which the defendant doesn't
|
| 13 | start out dominant, but it is alleged that he would end
|
| 14 | up dominant with a dangerous probability through the
|
| 15 | activities that he's engaged in, and in defining the
|
| 16 | market in such a case, the proposition is that the
|
| 17 | Cellophane fallacy probably isn't a problem.
|
| 18 | Simon I think already said yes, that's true. Do
|
| 19 | we have any other views?
|
| 20 | MR. BISHOP: Easy one.
|
| 21 | DR. WERDEN: I think that's an easy one. I like
|
| 22 | easy ones.
|
| 23 | Next, "When the Cellophane fallacy does apply,
|
| 24 | which is not a significant number of cases, the proper
|
| 25 | benchmark price in market delineation is the market |
212
| 1 | price absent the challenged conduct, which is normally
|
| 2 | not the competitive price."
|
| 3 | It is often said, perhaps rashly and wrongly --
|
| 4 | we are going to find out -- that you should go down to
|
| 5 | the competitive price to do the market definition
|
| 6 | analysis. This proposition says no, you should look at
|
| 7 | some kind of but-for price, and Simon, what do you think
|
| 8 | about that?
|
| 9 | MR. BISHOP: Interesting theoretical question.
|
| 10 | The answer is sort of, maybe, but I think in the sort of
|
| 11 | practical reality, it makes no difference. You don't
|
| 12 | know what the but-for price is; you don't know what the
|
| 13 | competitive price is.
|
| 14 | DR. WERDEN: As a practical matter, you may be
|
| 15 | exactly right, but let us suppose you could actually
|
| 16 | figure these things out. What would you do?
|
| 17 | DR. STELZER: And if my grandmother had wheels,
|
| 18 | she'd be a bus.
|
| 19 | MR. BISHOP: If you think about these things,
|
| 20 | then all we need to do is be concerned with the
|
| 21 | Cellophane fallacy or anything. The whole antitrust
|
| 22 | would be very, very easy.
|
| 23 | MR. SIMS: And that is how we get ourselves into
|
| 24 | the messes that we get ourselves into, is pretending
|
| 25 | that we can ignore reality. |
213
| 1 | MR. KRATTENMAKER: I think this is a very
|
| 2 | interesting concept, and it might be right, but I didn't
|
| 3 | understand the earlier question, and I don't mean this
|
| 4 | as a challenge, Greg, but if you -- if we know both the
|
| 5 | market price absent the challenged conduct and we also
|
| 6 | know the competitive price?
|
| 7 | DR. WERDEN: Yes.
|
| 8 | MR. KRATTENMAKER: And you are making two
|
| 9 | statements, which is that those are normally
|
| 10 | different --
|
| 11 | DR. STELZER: Right, and then which is the
|
| 12 | benchmark?
|
| 13 | MR. KRATTENMAKER: And then I would choose one?
|
| 14 | DR. WERDEN: Yeah. I am not saying these things
|
| 15 | are easy to figure out. They are not. I agree with
|
| 16 | Simon.
|
| 17 | DR. STELZER: They are impossible. It's not
|
| 18 | that they are not easy.
|
| 19 | MR. KRATTENMAKER: I am only clarifying the
|
| 20 | question. The question assumes that I know these two
|
| 21 | prices that are in here, and so you are asking -- you
|
| 22 | are making a statement and asking us about a statement
|
| 23 | and a value choice.
|
| 24 | DR. WERDEN: I'll let you know everything that
|
| 25 | you'd like to know. |
214
| 1 | MR. KRATTENMAKER: Okay, I know the market price
|
| 2 | absent the challenged conduct, and I know the
|
| 3 | competitive price, and I know that the market price
|
| 4 | absent the challenged conduct is higher than the
|
| 5 | competitive price.
|
| 6 | DR. WERDEN: Yes.
|
| 7 | MR. KRATTENMAKER: Simon's the expert, but I'd
|
| 8 | be inclined to say that the right answer whatever the
|
| 9 | empirical fact is, that the right answer is you focus
|
| 10 | not on the price absent the challenged conduct but on
|
| 11 | the competitive price, but I thought his basic answer
|
| 12 | was correct --
|
| 13 | DR. WERDEN: Why?
|
| 14 | MR. KRATTENMAKER: -- which is, you know, I do
|
| 15 | not know either better than the other.
|
| 16 | DR. WERDEN: I don't want you to give an answer
|
| 17 | now. I want to know why.
|
| 18 | MR. KRATTENMAKER: Because that is what we are
|
| 19 | more likely to be able to assess the supply and demand
|
| 20 | responses to, that --
|
| 21 | MR. BISHOP: But doesn't --
|
| 22 | MR. KRATTENMAKER: -- as the market definition
|
| 23 | process asks us to do.
|
| 24 | MR. BISHOP: But this comes down to, I mean,
|
| 25 | there's practically no difference. I mean, if you knew |
215
| 1 | what the competitive price was in every single industry,
|
| 2 | antitrust policy would be extremely easy, just go around
|
| 3 | and tell firms that you are not allowed to price more
|
| 4 | than the competitive price.
|
| 5 | MR. de la MANO: I wouldn't be so drastic on
|
| 6 | that, Simon. I think the question has merit. I do not
|
| 7 | know what the theoretical answer to this is, but I think
|
| 8 | from a practical standpoint, I actually think it could
|
| 9 | be easier in some cases to assess what the price would
|
| 10 | be in the absence of the conduct given that we are very
|
| 11 | unlikely to see, going back in time, a market which is
|
| 12 | currently not competitive that might have been
|
| 13 | competitive in the past, but it is very likely to see a
|
| 14 | situation that a few years ago, a market being a
|
| 15 | monopoly was one where that conduct was absent, and it
|
| 16 | might be possible to compare or even do some natural
|
| 17 | experiments across regions, even contemporaneously, to
|
| 18 | compare what is the precise situation where the conduct
|
| 19 | is absent. So, this theoretical conversation, were it
|
| 20 | to be valid, I think in practice, it could be very
|
| 21 | useful.
|
| 22 | MR. BISHOP: Well, I still think that, you know,
|
| 23 | either benchmark means that the inferences that you can
|
| 24 | draw from, you know, the available data is similar to
|
| 25 | the same issues, whether it is a competitive price or a |
216
| 1 | price absent the conduct. Just seriously, from a
|
| 2 | practical point of view, I do not think it makes any
|
| 3 | difference at all. We can have a, you know, good, you
|
| 4 | know, theoretical debate in saying which one is the
|
| 5 | appropriate one, but from a practical point of view, I
|
| 6 | do not think there is any difference whatsoever.
|
| 7 | DR. WERDEN: We have pretty much covered this
|
| 8 | one, but we are going to put it up anyway, see if
|
| 9 | anybody has anything more to add.
|
| 10 | "A market-share based safe harbor is appropriate
|
| 11 | in monopoly cases."
|
| 12 | MR. BISHOP: Yes.
|
| 13 | DR. WERDEN: Okay, we have one yes.
|
| 14 | MR. de la MANO: Two.
|
| 15 | MR. SIMS: What's the number?
|
| 16 | DR. WERDEN: That's the next slide.
|
| 17 | MR. SIMS: I can't answer it without the number.
|
| 18 | DR. WERDEN: Pick your own number.
|
| 19 | MR. KRATTENMAKER: I say no to this sentence
|
| 20 | because it has a singular noun.
|
| 21 | MR. SIMS: If you give me -- if you give me a,
|
| 22 | you know, 70 percent or an 80 percent number, I might be
|
| 23 | very comfortable with that.
|
| 24 | DR. WERDEN: Okay, we have got a vote for 70 or
|
| 25 | 80 percent. We might not have unanimity on 70 or 80 |
217
| 1 | percent.
|
| 2 | DR. STELZER: What is it appropriate to? If it
|
| 3 | is appropriate as a general prosecutorial guide for guys
|
| 4 | picking cases to bring, along with the feasibility of
|
| 5 | relief, then it might be useful, but --
|
| 6 | DR. WERDEN: If it is a safe harbor, it is a
|
| 7 | rule that courts are going to use on summary judgment to
|
| 8 | kick out cases.
|
| 9 | DR. STELZER: Then I would say no.
|
| 10 | MR. SIMS: And I know Tom says no. He has to
|
| 11 | say no.
|
| 12 | MR. KRATTENMAKER: Yes, I did. I already said
|
| 13 | no. I would say yes, it might make sense to have one
|
| 14 | safe harbor --
|
| 15 | DR. WERDEN: You're saying yes, but you're
|
| 16 | coming in with a low number, right, 25?
|
| 17 | MR. de la MANO: I find it hard to understand
|
| 18 | this myth, which I alluded to before, that in Europe we
|
| 19 | have a serious concern with type II errors, yet when it
|
| 20 | comes to using market share safe harbors, there is
|
| 21 | consensus here on this side of the table that they can
|
| 22 | be used. Isn't that a sign that you want to leave open
|
| 23 | the possibility to bring any type of case, irrespective
|
| 24 | of market shares being rather low?
|
| 25 | MR. SIMS: Well, no, that's not my reason at |
218
| 1 | least. My reason for being nervous about safe harbors
|
| 2 | unless they're very high is the concern that the safe
|
| 3 | harbor set too low will end up with serious
|
| 4 | over-enforcement above that number.
|
| 5 | MR. BISHOP: Okay, but this comes back to the
|
| 6 | sort of philosophical or institutional, philosophical
|
| 7 | differences between the EU and the U.S., because
|
| 8 | personally, I would set the threshold at 70-80 percent,
|
| 9 | but I'd much prefer in the EU to have one of 40 percent
|
| 10 | than to have no threshold at all.
|
| 11 | MR. SIMS: Okay, and that's a fair point given
|
| 12 | the regulatory environment that you find yourself in.
|
| 13 | MR. WALES: I guess one question I had, Tom, is
|
| 14 | I thought I had read where you talked about the
|
| 15 | possibility of having different thresholds perhaps for
|
| 16 | different types of -- your two types of conduct. You
|
| 17 | had the conduct where someone acts to reduce output on
|
| 18 | their own as opposed to acting to exclude rivals, and I
|
| 19 | guess you kind of left open the proposition I thought
|
| 20 | that perhaps you might be willing to look for markets
|
| 21 | with the former and not the latter.
|
| 22 | MR. KRATTENMAKER: No, I might be willing to
|
| 23 | look for one for each. That's why I said, my objection
|
| 24 | to this is that it -- that the noun is singular.
|
| 25 | DR. WERDEN: Do you have some numbers in mind? |
219
| 1 | MR. KRATTENMAKER: Do I have numbers in mind?
|
| 2 | No, but I think you might well be able to come up with
|
| 3 | market share based safe harbor for exclusionary conduct
|
| 4 | section 2 cases.
|
| 5 | MR. WALES: I have a question for --
|
| 6 | MR. KRATTENMAKER: But it wouldn't, in my view,
|
| 7 | be an appropriate -- it wouldn't be the same threshold
|
| 8 | that would be appropriate for collusion-based section 2
|
| 9 | type cases, which are generally rare but still can be
|
| 10 | out there.
|
| 11 | MR. WALES: A quick question for Miguel, I guess
|
| 12 | where does 40 come from in terms of setting the
|
| 13 | threshold level in the European Commission?
|
| 14 | MR. de la MANO: Well, as far as I know, it is
|
| 15 | from a case, but, I mean, I think the thing is -- I
|
| 16 | think the discussion is also highlighting this -- there
|
| 17 | is a question as to, you know, what is the threshold
|
| 18 | going to be used for? If you believe that once you are
|
| 19 | above the threshold, basically the case has been proven,
|
| 20 | then clearly you want to have as high a threshold as
|
| 21 | possible.
|
| 22 | If, on the other hand, you believe as I do, at
|
| 23 | least, that the threshold is just the first step, just
|
| 24 | the screen to sort of ditch the cases which are
|
| 25 | obviously not a problem, if you have sufficient |
220
| 1 | discipline imposed upon yourself as a competition
|
| 2 | authority in what you need to prove further, there is no
|
| 3 | problem in having a low threshold. In fact, it is
|
| 4 | probably better to have a low threshold, because that
|
| 5 | makes the assessment of your facts credible.
|
| 6 | Otherwise, if you have a threshold at a sort of
|
| 7 | middle level, such as 40 or 50 percent, there is always
|
| 8 | going to be a group of people who think, a-ha, okay, so
|
| 9 | this discipline you say you have, that you are going to
|
| 10 | go after -- assessing the effects afterwards, after
|
| 11 | showing dominance, it is not really true, because as
|
| 12 | soon as you are above 50, it is really easy to assess
|
| 13 | the facts, and therefore, there is no credibility to the
|
| 14 | second discipline, as it were.
|
| 15 | MR. BISHOP: Okay, but I would take a different
|
| 16 | view, and sort of just to be clear here, when I said
|
| 17 | that dominance in Europe is then inferred to be an abuse
|
| 18 | of, you know, of that market power, that's not my
|
| 19 | position. That's the position of the European courts,
|
| 20 | that most of the issues we are talking about here are
|
| 21 | exclusionary, and the courts have held that any harm to
|
| 22 | a competitor necessarily leads to harm to competition,
|
| 23 | and therefore, given that sort of standard by the
|
| 24 | European courts, there is no room, really, for an
|
| 25 | effects-based system. |
221
| 1 | So, as you lower the threshold from 40 percent
|
| 2 | to 25 percent, it makes things much worse in Europe
|
| 3 | unless the Commission is going to be very clear that
|
| 4 | they are going to take on the courts and that court
|
| 5 | reasoning, that you can infer harm to competitors
|
| 6 | necessarily translates to harms to competition, that,
|
| 7 | you know, the Commission is going to take that square
|
| 8 | on, because if they do not, any lowering away from the
|
| 9 | 40 percent to just come out of case law is just going to
|
| 10 | make things worse.
|
| 11 | MR. de la MANO: The court has already told us a
|
| 12 | few months ago that it is willing to reconsider its
|
| 13 | previous positions on this matter, and in the Glaxo
|
| 14 | decision -- and actually, it is actually an area of
|
| 15 | Article 81, cartels or agreements, but it has made it
|
| 16 | very clear that it is very open and willing to see a
|
| 17 | more effects-based analysis on the part of the
|
| 18 | Commission both in the area of assessing possible harm
|
| 19 | to consumers, but also in the area of assessing
|
| 20 | efficiencies. So, I think the courts are open to be
|
| 21 | challenged by the Commission on this point.
|
| 22 | MR. BISHOP: Well, I would just say, you know,
|
| 23 | let's wait and see, stick with 40 percent and then see
|
| 24 | how they move before lowering the threshold.
|
| 25 | MR. WALES: Let's go to the next one. |
222
| 1 | DR. WERDEN: Skip the next one and go one
|
| 2 | further.
|
| 3 | MR. KRATTENMAKER: Can we mail in our answers to
|
| 4 | the one, number seven?
|
| 5 | DR. WERDEN: If you like. It is about
|
| 6 | econometrics. Did you want to handle it, Tom?
|
| 7 | MR. KRATTENMAKER: Of course. I mean, that's
|
| 8 | the most fun, is talking about something that we do not
|
| 9 | know. I thought it was a really interesting and
|
| 10 | provocative question. I think it is largely correct,
|
| 11 | but I would have some comments on it, but go ahead.
|
| 12 | DR. WERDEN: We are nearing our end point.
|
| 13 | MR. KRATTENMAKER: No, go ahead.
|
| 14 | DR. WERDEN: As our end point, we are going to
|
| 15 | take this last proposition from the Syufy case, one of
|
| 16 | our failures in court.
|
| 17 | "In evaluating monopoly power, it is not market
|
| 18 | share that counts, but the ability to maintain market
|
| 19 | share."
|
| 20 | MR. KRATTENMAKER: Could there be anything more
|
| 21 | incorrect?
|
| 22 | DR. WERDEN: I imagine that there could, but let
|
| 23 | me just add that I think what the quote is trying to say
|
| 24 | is the point that Joe made several times, which is
|
| 25 | durability is crucial in monopoly power. |
223
| 1 | MR. KRATTENMAKER: I see, okay.
|
| 2 | DR. WERDEN: And monopoly power requires much
|
| 3 | more durable power over price than market power does.
|
| 4 | MR. KRATTENMAKER: Gotcha.
|
| 5 | MR. SIMS: When I read this, my answer was, I do
|
| 6 | not know exactly what these words mean --
|
| 7 | MR. KRATTENMAKER: Okay.
|
| 8 | MR. SIMS: -- but if they mean durable market
|
| 9 | power, then --
|
| 10 | MR. KRATTENMAKER: If they mean entry barriers
|
| 11 | and -- okay, you are saying they're importing it, okay.
|
| 12 | DR. STELZER: As a practical problem with that,
|
| 13 | it is an easy matter in any case to find someone who
|
| 14 | will tell you why whatever monopoly power or market
|
| 15 | power you see is not durable. I have had people tell me
|
| 16 | that monopoly power in the transmission of electricity
|
| 17 | is not durable because they have some innovation in
|
| 18 | mind.
|
| 19 | In other words, you can fill the courtroom with
|
| 20 | experts who will tell you why market power that has
|
| 21 | persisted for 150 years is really not durable given some
|
| 22 | new technology or given some new something, but --
|
| 23 | DR. WERDEN: But they're wrong, aren't they?
|
| 24 | But you are saying that they're wrong?
|
| 25 | DR. STELZER: They're wrong. |
224
| 1 | DR. WERDEN: Okay.
|
| 2 | DR. STELZER: So I would be very careful about
|
| 3 | introducing a test that says not only do you have to
|
| 4 | have market power, but it has to be proved to be durable
|
| 5 | in order to create a problem, because that's an
|
| 6 | impossible test to meet.
|
| 7 | MR. SIMS: It is true, and I think everybody
|
| 8 | should admit that it is true, that the more you get away
|
| 9 | from slogans and general rhetorical concepts and the
|
| 10 | closer you get to careful analysis of the facts, the
|
| 11 | less enforcement you are going to have, because it is
|
| 12 | harder. It is harder for plaintiffs, whether they're
|
| 13 | the Government or private plaintiffs, to prove a case if
|
| 14 | they have to slog their way through the facts.
|
| 15 | That's why the per se rule is so attractive to
|
| 16 | plaintiffs' lawyers in damage cases, because they do not
|
| 17 | have to prove anything. So, you know, that's an
|
| 18 | inevitable result of being more wedded to factual
|
| 19 | analysis than setting up bright-line rules. I don't
|
| 20 | think it is a reason not to do it, but it is a result
|
| 21 | that we ought to be -- that we ought to recognize and
|
| 22 | accept.
|
| 23 | MR. WALES: Anybody else?
|
| 24 | DR. WERDEN: Well, we are a few minutes past our
|
| 25 | official end time, so why don't we wrap it up and take |
225
| 1 | one last opportunity to thank our panelists.
|
| 2 | (Applause.)
|
| 3 | MR. WALES: Thank you very much. I guess we are
|
| 4 | adjourned.
|
| 5 | (Whereupon, at 4:34 p.m., the hearing was
|
| 6 | adjourned.)
|
| 7 |
|
| 8 |
|
| 9 |
|
| 10 |
|
| 11 |
|
| 12 |
|
| 13 |
|
| 14 |
|
| 15 |
|
| 16 |
|
| 17 |
|
| 18 |
|
| 19 |
|
| 20 |
|
| 21 |
|
| 22 |
|
| 23 |
|
| 24 |
|
| 25 | |
226
| 1 | C E R T I F I C A T I O N O F R E P O R T E R
|
| 2 | DOCKET/FILE NUMBER: P062106
|
| 3 | CASE TITLE: SECTION 2 HEARING
|
| 4 | DATE: MARCH 7, 2007
|
| 5 |
|
| 6 | I HEREBY CERTIFY that the transcript contained
|
| 7 | herein is a full and accurate transcript of the notes
|
| 8 | taken by me at the hearing on the above cause before the
|
| 9 | FEDERAL TRADE COMMISSION to the best of my knowledge and
|
| 10 | belief.
|
| 11 |
|
| 12 | DATED: 3/12/2007
|
| 13 |
|
| 14 |
|
| 15 |
|
| 16 | SUSANNE BERGLING, RMR-CLR
|
| 17 |
|
| 18 | C E R T I F I C A T I O N O F P R O O F R E A D E R
|
| 19 |
|
| 20 | I HEREBY CERTIFY that I proofread the transcript
|
| 21 | for accuracy in spelling, hyphenation, punctuation and
|
| 22 | format.
|
| 23 |
|
| 24 |
|
| 25 | DIANE QUADE |
|